Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGRP,Agouti-related protein,40516,0.267826126757832,0.00458969624500974,0.258830322117613,0.276821931398051,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN1,CCN family member 1,40280,0.37011776015315,0.00675851122157958,0.356871078158854,0.383364442147446,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES1,Liver carboxylesterase 1,40352,0.273056525596419,0.00687159917220113,0.259588191218905,0.286524859973933,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F7,Coagulation factor VII,40376,0.118911303598708,0.00266852447685541,0.113680995624072,0.124141611573345,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FURIN,Furin,40411,0.125239715419233,0.00302704809589276,0.119306701151283,0.131172729687183,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCG,Pro-glucagon,39980,0.462193500879589,0.0112014845306135,0.440238591199587,0.484148410559592,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHR,Growth hormone receptor,37671,0.103905509165043,0.00258164268082766,0.0988454895106206,0.108965528819465,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.284817062632941,0.00671212634480219,0.271661294997129,0.297972830268754,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INHBC,Inhibin beta C chain,40332,0.151906234559696,0.00384629949761974,0.144367487544361,0.159444981575031,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0913709810661053,0.00195364267596097,0.0875418414212218,0.0952001207109888,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LDLR,Low-density lipoprotein receptor,40356,0.413289991498207,0.00371565892813578,0.406007299999061,0.420572682997353,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPL,Lipoprotein lipase,40359,-0.17109376696498,0.00411798210116567,-0.179165011883265,-0.163022522046695,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFGE8,Lactadherin,40332,0.215685935630274,0.0036074466156137,0.208615340263671,0.222756530996877,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPY,Pro-neuropeptide Y,40489,0.359923035653654,0.00563102868948846,0.348886219422256,0.370959851885051,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.124073207788814,0.00280497838269041,0.11857545015874,0.129570965418887,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROC,Vitamin K-dependent protein C,40372,0.0940236021494566,0.00226628589888757,0.089581681787637,0.0984655225112762,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RARRES2,Retinoic acid receptor responder protein 2,40424,0.174454582126629,0.00413291953483574,0.16635405983835,0.182555104414907,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.124057211566572,0.00296308927800457,0.118249556581683,0.129864866551461,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRAP1,Proline-rich acidic protein 1,37998,0.148679382221519,0.00380523639733624,0.14122111888274,0.156137645560298,1.11253693739944e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.146736037791983,0.00380551818016859,0.139277222158852,0.154194853425113,1.11480856317681e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF9,Protein turtle homolog A,37990,0.275647778174369,0.00716067579217259,0.261612853621711,0.289682702727027,9.63921272161621e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL27,C-C motif chemokine 27,40359,0.205572078859641,0.00538055725512936,0.195026186639588,0.216117971079695,1.18200955706439e-305
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC39A5,Zinc transporter ZIP5,40341,0.184807494153463,0.00484642287259942,0.175308505323168,0.194306482983758,1.6114164002196e-304
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADIPOQ,Adiponectin,38013,-0.227714061558846,0.00598686164718037,-0.239448310387319,-0.215979812730372,7.04038099267084e-301
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTR,Transthyretin,37871,0.0863295313137765,0.00230283844242971,0.0818159679666143,0.0908430946609388,1.32394585612632e-292
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRP1,Neuropilin-1,40424,-0.0947977763698949,0.0025547742268845,-0.0998051338545885,-0.0897904188852013,3.62106191564958e-289
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL23,C-C motif chemokine 23,40422,0.137317117936161,0.00372098732795313,0.130023982773373,0.14461025309895,3.65637762928643e-286
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTH,Parathyroid hormone,37572,0.26081434110449,0.00711768028244949,0.246863687750889,0.274764994458091,5.81506194983246e-280
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS15,Enteropeptidase,40305,0.301535607476247,0.00836389318256982,0.28514237683841,0.317928838114083,1.25452002011503e-273
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG2,Desmoglein-2,40332,-0.0860364476794442,0.00245707401029763,-0.0908523127396276,-0.0812205826192609,8.05313221627577e-259
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APCS,Serum amyloid P-component,37882,0.114261286582433,0.00325530188994292,0.107880894878145,0.120641678286721,2.60322307195115e-258
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPM,Carboxypeptidase M,40415,0.109124687578957,0.00312374991744886,0.103002137740757,0.115247237417156,1.03386370161766e-257
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.254296232731131,0.00733070163319103,0.239928057530076,0.268664407932185,5.07838355431173e-254
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFPI,Tissue factor pathway inhibitor,40309,0.0978573849921689,0.00283947232876226,0.0922920192277948,0.103422750756543,4.71183410687418e-251
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.27305399940492,0.00800861516178458,0.257357113687822,0.288750885122018,6.06587436346071e-246
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR37,Prosaposin receptor GPR37,40042,0.208698130230907,0.00613216277634477,0.196679091189271,0.220717169272543,5.9554947919985e-245
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.245284617288569,0.00721740656197498,0.231138500427098,0.25943073415004,1.98633097121186e-244
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.32505170604142,0.00956479619990375,0.306304705489609,0.343798706593232,2.04845721941008e-244
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.181944646834157,0.00547746425903878,-0.192680476781873,-0.171208816886441,6.44620845334024e-234
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN3,Contactin-3,40332,0.105563594755955,0.00320143450692911,0.0992887831223744,0.111838406389536,1.07347287502892e-230
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD4,T-cell surface glycoprotein CD4,40309,0.0918063298142302,0.00279347446711397,0.0863311198586868,0.0972815397697736,3.20041838856916e-229
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.0569016695668577,0.00173612570002643,0.0534988631948059,0.0603044759389095,5.00828175273352e-228
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA5,Plasma serine protease inhibitor,37835,0.0979284049963993,0.00300244329315006,0.0920436161418252,0.103813193850973,1.32255486010055e-224
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPIND1,Heparin cofactor 2,37981,0.081370784672409,0.00249606476014624,0.0764784977425224,0.0862630716022957,1.77837528960213e-224
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.200757502707337,0.00617831038642736,0.188648014349939,0.212866991064735,2.75472924039756e-224
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.43990546277907,0.0135443800861121,0.41335847781029,0.466452447747849,5.16637593355292e-224
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL6,C-X-C motif chemokine 6,40516,0.229951197016931,0.00712328962559832,0.215989549350758,0.243912844683104,1.42509137252759e-221
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.304156623793756,0.00943953914131265,0.285655127076783,0.322658120510729,1.05467888437581e-220
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.10138890192395,0.00318483694354313,0.0951466215146053,0.107631182333294,1.03725600742578e-215
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASGR1,Asialoglycoprotein receptor 1,40228,0.0854791355546048,0.00269062879570639,0.0802055031150203,0.0907527679941893,9.44704021022094e-215
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F9,Coagulation factor IX,40372,0.0522889376275834,0.00164716640678223,0.0490604914702902,0.0555173837848765,1.71344745728558e-214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFI,Complement factor I,38013,0.0576432181759818,0.00183886493617664,0.0540390429010756,0.061247393450888,2.62018114305741e-208
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAMR1,Inactive serine protease PAMR1,40332,0.0798636312522375,0.00256652908039046,0.0748332342546722,0.0848940282498028,2.09352974445947e-206
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA4,Kallistatin,37781,0.0681633459582853,0.00219335216616532,0.0638643757126012,0.0724623162039693,9.00009390550691e-205
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINF1,Pigment epithelium-derived factor,37790,0.0734344091106998,0.00237230359582998,0.0687846940628731,0.0780841241585266,3.07876885537476e-203
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCHE,Cholinesterase,37748,0.0799477356769727,0.00258804832158894,0.0748751609666584,0.085020310387287,2.04018406504901e-202
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFH,Complement factor H,37301,0.0648684517198003,0.00211446181925568,0.0607241065540592,0.0690127968855415,1.5713699926664e-199
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.235318415987579,0.00773541710584626,0.220156998460121,0.250479833515038,1.63787797629306e-197
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGR3,Anterior gradient protein 3,39963,0.166364173747756,0.00547451764735352,0.155634119158944,0.177094228336569,4.39220117911702e-197
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.0515233903867202,0.00170012832058366,0.0481911388783763,0.0548556418950642,5.08565941167286e-196
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F10,Coagulation factor X,37987,0.0720685600798629,0.00237929032599403,0.0674051510409146,0.0767319691188112,4.65643511650611e-195
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFM,Afamin,38013,0.05178347098141,0.00171015433664792,0.0484315684815801,0.0551353734812399,6.00849567395831e-195
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.325806580661702,0.0107922282173307,-0.34695934796767,-0.304653813355734,8.83684697094788e-195
NMR metabolomics,X23508.Triglycerides in Medium VLDL,P4HB,Protein disulfide-isomerase,40266,0.107102540716906,0.00355638158880947,0.100132032802839,0.114073048630972,8.58355465233774e-194
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFP,Properdin,38013,0.0601865462170215,0.00200675350689837,0.0562533093435007,0.0641197830905423,2.06720604958272e-191
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHMP6,Charged multivesicular body protein 6,37990,0.153354876240841,0.00511587144254878,0.143327768213446,0.163381984268237,3.29193963950275e-191
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUSB,Beta-glucuronidase,40419,0.160779205816519,0.00538049943621741,0.150233426921533,0.171324984711505,5.88107636359303e-191
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300LG,CMRF35-like molecule 9,40332,-0.103175940120262,0.00347266250337218,-0.109982358626871,-0.0963695216136523,7.8399795723814e-189
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.141984971974449,0.00480782267712238,0.132561639527289,0.151408304421609,1.08332420965329e-186
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.158730586535319,0.00539953680356988,0.148147494400322,0.169313678670316,6.67896185710955e-185
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.0830921394231433,0.00284191301781945,0.0775219899082172,0.0886622889380695,4.0430264052408e-183
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.0922217461024386,0.00319049373197263,-0.098475113817105,-0.0859683783877723,3.78675356753097e-179
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTA1,Glutathione S-transferase A1,40333,0.219900986901819,0.00761891547223899,0.20496791257623,0.234834061227407,1.39218352206724e-178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMBP,Protein AMBP,40470,0.0532436036679846,0.00184700356638326,0.0496234766778734,0.0568637306580958,3.3791720385538e-178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF8,Immunoglobulin superfamily member 8,40359,0.0790578947190402,0.00275416453655077,0.0736597322274007,0.0844560572106797,1.0276478840779e-176
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTA3,Glutathione S-transferase A3,39980,0.200212309794257,0.00698142334724201,0.186528720033662,0.213895899554851,2.73857470125916e-176
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.167504677218487,0.00586134332835724,-0.178992910142067,-0.156016444294906,3.01362779996603e-175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRP,Gastrin-releasing peptide,37628,0.143280029315177,0.00500799486779738,0.133464359374295,0.15309569925606,1.03605281088755e-174
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLI1,Friend leukemia integration 1 transcription factor,39980,0.284868513418417,0.0100321105702354,0.265205576700755,0.304531450136078,5.81615195072262e-173
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLA,Alpha-galactosidase A,37642,0.0944642062598904,0.00333271209458787,0.0879320905544982,0.100996321965283,1.28725001013459e-171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAT,Tissue-type plasminogen activator,40490,0.127903205356445,0.00452532491462693,0.119033568523777,0.136772842189114,1.49717627793104e-171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPB1,Beta-ureidopropionase,37990,0.238098995055982,0.00841101395931528,0.221613407695724,0.25458458241624,2.55824755921981e-171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRIP2,Cysteine-rich protein 2,40228,0.0940235173065572,0.00333621868108405,0.0874845286916325,0.100562505921482,1.55388654786008e-170
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACY1,Aminoacylase-1,40359,0.154505894824299,0.00548695937021995,0.143751454458668,0.16526033518993,2.73441276202138e-170
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAPIN,SNARE-associated protein Snapin,37959,0.148924387638869,0.00528448887498303,0.138566789443902,0.159281985833836,7.70718445584787e-170
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.191116208223603,0.00683229015581969,0.177724919518197,0.20450749692901,4.31784620921185e-168
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C9,Complement component C9,37987,-0.125125268958387,0.00448749514589423,-0.133920759444339,-0.116329778472434,2.06078804413977e-166
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LATS1,Serine/threonine-protein kinase LATS1,37598,0.215641459507137,0.00777333104842044,0.200405730652233,0.230877188362041,1.17027418421922e-164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERP44,Endoplasmic reticulum resident protein 44,40280,0.0654069808395386,0.00236512939924737,0.0607713272170138,0.0700426344620634,1.93491912280158e-164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL16,C-C motif chemokine 16,40536,0.134952615161893,0.00488831184043296,0.125371523954645,0.144533706369142,5.90942353306685e-164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLTP,Phospholipid transfer protein,40461,-0.0872448443754973,0.00316203617018161,-0.0934424352690533,-0.0810472534819413,9.3429698447099e-164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.172648331299634,0.00626103310331854,0.160376706417129,0.184919956182138,7.19069712174218e-163
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYAP1,Synapse-associated protein 1,37671,0.143603161137542,0.00521168835572246,0.133388251960326,0.153818070314758,1.47935273844867e-162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNCA,Alpha-synuclein,37671,0.289227875698088,0.010502197520284,0.268643568558332,0.309812182837845,2.14872304928313e-162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLKB1,Plasma kallikrein,37721,0.0638289935172442,0.0023230752159006,0.059275766094079,0.0683822209404094,1.08685508365069e-161
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.0531404218160367,0.00193909762525954,0.049339790470528,0.0569410531615454,1.24465892829299e-161
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF21,Fibroblast growth factor 21,40453,0.295154463356481,0.0108327653980262,0.273922243176349,0.316386683536612,7.9465801607487e-160
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUMB,Protein numb homolog,37598,0.210208413906518,0.00769655704582039,0.19512316209671,0.225293665716326,8.42940258393116e-160
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.350347235908354,0.0128813251644906,0.325099838585952,0.375594633230755,1.2852565557327e-158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL4A1,Collagen alpha-1(IV) chain,40359,-0.0993981423757816,0.00366264029562594,-0.106576917355208,-0.0922193673963548,1.38755459610743e-158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR5,Cadherin-related family member 5,40359,0.0973329561284564,0.0035987125422193,0.0902794795457065,0.104386432711206,1.49939526943719e-157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROS1,Vitamin K-dependent protein S,38013,0.062752591164284,0.00231748897916494,0.0582103127651207,0.0672948695634473,2.6353102375261e-157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCS1,Neuronal calcium sensor 1,40489,0.0712056375160157,0.00264482399092955,0.0660217824937938,0.0763894925382376,3.46385602637845e-156
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP5,Retinol-binding protein 5,40305,0.137369855928414,0.00511453746235244,0.127345362502203,0.147394349354624,1.9661331717263e-155
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINF2,Alpha-2-antiplasmin,37755,0.0335549290131952,0.00125329827460864,0.0310984643949622,0.0360113936314281,7.59559785072355e-154
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA1,Ephrin type-A receptor 1,40400,0.0843503448302235,0.0031593246723391,0.0781580684724389,0.0905426211880082,1.1352485882833e-153
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KYNU,Kynureninase,40516,0.109720410112686,0.00412832528332425,0.101628892557371,0.117811927668002,2.38934890473999e-152
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO3,Beta-enolase,37628,0.139643116330067,0.00524401718073752,0.129364842655821,0.149921390004312,3.21804081517958e-152
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATRN,"Attractin, Isoform 2",38013,0.0401679481535224,0.00151176964886346,0.03720487964175,0.0431310166652948,1.10892459605327e-151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.165158343954135,0.00623861315160532,0.152930662176989,0.177386025731282,4.31513658300711e-151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAA80,N-alpha-acetyltransferase 80,37572,0.291005733121798,0.010976136496369,0.269492505588915,0.312518960654682,6.32566175364682e-151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFR2,Fibroblast growth factor receptor 2,40411,0.0523454663145899,0.00198018216459509,0.0484643092719836,0.0562266233571963,9.46080884849467e-151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAT2,Linker for activation of T-cells family member 2,40305,0.298914198977822,0.0113092413272884,0.276748085976337,0.321080311979307,1.09079856407867e-150
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.132949369018215,0.00504397187979902,0.123063184133809,0.142835553902621,7.80055596016663e-150
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MXRA8,Matrix remodeling-associated protein 8,37671,-0.0744124623253784,0.00281939496876038,-0.0799384764641488,-0.0688864481866081,1.19783373209488e-149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KDR,Vascular endothelial growth factor receptor 2,40411,0.0615715063405334,0.00234010052066216,0.0569849093200356,0.0661581033610313,2.13771772387971e-149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.100996359502243,0.00384121660271075,0.0934675749609295,0.108525144043556,3.59165263048056e-149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.0949654623765197,0.00362282685983361,0.0878647217312459,0.102066203021794,2.41881626022908e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAB2,Stabilin-2,37998,0.0678827335861153,0.00258538923602315,0.06281537068351,0.0729500964887207,3.00542643345158e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.0657086052202066,0.00251871897176692,0.0607719160355435,0.0706452944048698,5.9131704784326e-147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F11R,Junctional adhesion molecule A,40332,0.136507169944236,0.00523766087596965,0.126241354627335,0.146772985261136,1.15435408544805e-146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP29,Synaptosomal-associated protein 29,40411,0.219349664924144,0.00844785857446813,0.202791862118187,0.235907467730102,1.27586363477588e-145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTSS1,Protein MTSS 1,37901,0.266303610503906,0.0102446397633985,0.246224116567644,0.286383104440167,2.16461063968826e-145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHBG,Sex hormone-binding globulin,37987,-0.12944286415228,0.00498828944234753,-0.139219911459281,-0.119665816845279,6.28753032952195e-145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP4,Metalloproteinase inhibitor 4,40332,-0.0973409955152992,0.00376979990878728,-0.104729803336522,-0.0899521876940761,4.73031436475583e-144
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS3,"Nitric oxide synthase, endothelial",39961,0.13077521932094,0.00507673841278066,0.12082481203189,0.14072562660999,2.54765192852136e-143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL17,C-X-C motif chemokine 17,40516,0.0979069843932796,0.00383969096278163,0.0903811901062276,0.105432778680332,1.26052662023213e-140
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.196803948161275,0.00770985245193668,0.181692637355479,0.211915258967071,2.13504886538032e-140
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOMO1,Nodal modulator 1,40332,0.0558107435689737,0.00219637716476806,0.0515058443260283,0.0601156428119191,1.17850741949627e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EEF1D,Elongation factor 1-delta,37990,0.215892546824017,0.00848232332316999,0.199267193110604,0.23251790053743,1.25348415072924e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORT1,Sortilin,40330,0.0854739105605366,0.00336490244270304,0.0788787017728386,0.0920691193482346,1.46125472805428e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM20A,Pseudokinase FAM20A,37990,0.0666310414307748,0.00261918137868728,0.0614974459285477,0.0717646369330018,1.69511611165627e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.129793602537393,0.00511093403106261,0.119776171836511,0.139811033238276,1.71684261459649e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MLN,Promotilin,40341,0.208442338149983,0.00822942315743705,0.192312668761406,0.224572007538559,8.58266464124211e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YES1,Tyrosine-protein kinase Yes,40305,0.265756534190176,0.0105169104634448,0.245143389681824,0.286369678698528,3.70392873718195e-138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0646889796105043,0.00256584746456126,0.0596599185799642,0.0697180406410444,1.49230591114718e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOST,Sclerostin,40330,0.0902588762854049,0.00358242453303292,0.0832373242006604,0.0972804283701494,2.24386124998839e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL22,C-C motif chemokine 22,40204,0.120189862769819,0.00477548715348097,0.110829907948996,0.129549817590642,4.51308780464199e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABL1,Tyrosine-protein kinase ABL1,40305,0.15831756723549,0.00629784752128901,0.145973786093763,0.170661348377216,8.9211602674466e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.185523063199551,0.00738371988626204,0.171050972222477,0.199995154176624,3.49544783426552e-136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTYMK,Thymidylate kinase,37990,0.160915456522783,0.00641629031198615,0.14833952751129,0.173491385534275,1.02602253050853e-135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FYB1,FYN-binding protein 1,40311,0.211796005797453,0.00848205895318657,0.195171170249208,0.228420841345699,5.19574234948527e-135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.1064048441673,0.00426991055264973,0.0980358194841069,0.114773868850494,1.83607153917687e-134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.204704242822808,0.00824917248629426,0.188535864749671,0.220872620895944,2.21474120623156e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.168577826727517,0.00680984221525229,0.155230535985622,0.181925117469411,9.34693048353759e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH9,Myosin-9,37998,0.257940373516968,0.0104133658874652,0.237530176377536,0.278350570656399,1.63486534858529e-132
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.0789650694619286,0.00320669536376536,0.0726799465489485,0.0852501923749087,1.91106671066531e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFB1,BPI fold-containing family B member 1,40261,-0.14070526713342,0.00571798572290708,-0.151912519150318,-0.129498015116522,3.05602862870435e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCN2,Ficolin-2,40291,0.0933960147711443,0.00380771925683035,0.0859328850277568,0.100859144514532,1.98694947797259e-130
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKB,Creatine kinase B-type,37998,-0.137539525389388,0.00562063808313415,-0.148555976032331,-0.126523074746445,1.93005226707477e-129
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTD,Biotinidase,38013,0.0468601046023011,0.00191649142479872,0.0431037814096956,0.0506164277949065,3.02614487980775e-129
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.0459144193116839,0.00188748051082207,0.0422149575104726,0.0496138811128951,2.32702526159415e-128
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL2,Angiopoietin-related protein 2,40377,0.0898915439253761,0.00370515211930783,0.0826294457715328,0.0971536420792194,1.0355766117931e-127
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SARG,Specifically androgen-regulated gene protein,37931,0.244875563941249,0.0100771212622057,0.225124406267326,0.264626721615172,1.06977835865443e-127
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TJAP1,Tight junction-associated protein 1,40411,0.185900966043837,0.00766647279041109,0.170874679374631,0.200927252713043,1.37797957953586e-127
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTBS,Di-N-acetylchitobiase,37819,0.0607811982606052,0.00251337884907005,0.0558549757164279,0.0657074208047825,1.71545736930316e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18R1,Interleukin-18 receptor 1,40516,0.0729911462497912,0.00302564772538721,0.0670608767080323,0.0789214157915502,2.44197192764326e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YTHDF3,YTH domain-containing family protein 3,40044,0.190098621403656,0.00788159271117825,0.174650699689746,0.205546543117565,3.18273781594978e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCLY,Selenocysteine lyase,40434,0.106823429330958,0.00443166871018579,0.0981373586589938,0.115509500002922,3.95505708343726e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.213103604113974,0.00884800012455228,0.195761523869851,0.230445684358096,6.43216308764903e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREG1,Protein CREG1,40145,0.0806799595800725,0.0033505316336031,0.0741129175782104,0.0872470015819346,7.73267703202435e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR2,Cadherin-related family member 2,40305,0.171572596547408,0.0071356278325322,0.157586765995645,0.185558427099171,1.66675846843084e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.152139592961254,0.00631883573324085,0.139754674924102,0.164524510998406,2.24099460974344e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL16,Pro-interleukin-16,40516,0.0899981573850838,0.00375176182142852,0.0826447042150839,0.0973516105550837,5.76164353825478e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES2,Cocaine esterase,40305,0.118851894558712,0.0049722860959752,0.109106213810601,0.128597575306823,4.43984120771396e-124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAMDC4,Apical endosomal glycoprotein,37900,0.121039672699991,0.00507142744663526,0.111099674904586,0.130979670495397,2.43333826074604e-123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPY30,Protein dpy-30 homolog,40414,0.131650822024832,0.00552720047753669,0.12081750908886,0.142484134960804,2.9937318486836e-123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.0887494118757036,0.00373471197106154,0.0814293764124229,0.0960694473389842,2.56147748182512e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EHBP1,EH domain-binding protein 1,37990,0.16461201745122,0.00693135965623633,0.151026552524996,0.178197482377443,3.49792958813363e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.0698270819141541,0.00294512691229197,0.0640546331660618,0.0755995306622463,3.70302253910509e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.112719931914095,0.00474723527090451,0.103415350783122,0.122024513045067,4.0281925731091e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEG1,Protein HEG homolog 1,37671,0.0582395762285396,0.00245420057464322,0.0534293431022389,0.0630498093548403,6.0764822123344e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXLNA,Alpha-taxilin,40228,0.196089059061933,0.00828720528534172,0.179846136702663,0.212331981421203,1.16707877506592e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS8,Prostasin,40293,0.0887142602667153,0.0037554569298887,0.0813535646841334,0.0960749558492971,2.78695986809966e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON3,Serum paraoxonase/lactonase 3,40422,-0.0600765118513119,0.0025480826386465,-0.065070753823059,-0.0550822698795648,7.60670577299249e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.184689628372968,0.00783958273105129,0.169324046220108,0.200055210525829,3.08118075753102e-120
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.12512164065623,0.00531373750739911,0.114706715141728,0.135536566170733,4.02307880504604e-120
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK1,Dickkopf-related protein 1,40471,0.130365883603935,0.00554896757979233,0.119489907147542,0.141241860060328,5.02035395151373e-120
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0464160386812226,0.00197436760787453,0.0425462781697885,0.0502857991926567,9.23024612203126e-120
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.211335849801604,0.00903236867174356,0.193632407204986,0.229039292398221,4.6664647426964e-119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTN4R,Reticulon-4 receptor,40489,0.0732291930343755,0.00315222489647639,0.0670508322372817,0.0794075538314692,1.91208529935264e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.181159038206464,0.00779501462476505,0.165880809541924,0.196437266871003,3.54288470056572e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.0646427511587432,0.00278358363106642,0.059186927241853,0.0700985750756333,5.28578793691511e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.155890745224673,0.0067226001185541,0.142714448992307,0.169067041457039,1.25101612148994e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLUL1,Clusterin-like protein 1,40338,-0.0979442450541623,0.00423148702089649,-0.106237959615119,-0.0896505304932052,1.32861330604733e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPB2,Carboxypeptidase B2,37981,0.0481064960693326,0.00207726435470746,0.0440350579341059,0.0521779342045592,2.15574131976586e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NHLRC3,NHL repeat-containing protein 3,37370,0.0686265463821167,0.00297025482704634,0.0628048469211058,0.0744482458431275,9.10389638418003e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.0805212371315624,0.00349240447312971,-0.0873663498988967,-0.0736761243642282,9.89080875070232e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HJV,Hemojuvelin,37959,0.0988636311291756,0.00428780203065811,0.0904595391490857,0.107267723109265,2.09010130787329e-115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC1B,C-type lectin domain family 1 member B,40471,0.2058512681501,0.00896533184728966,0.188279217729412,0.223423318570788,8.1448420338033e-115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.177437187843716,0.00772552529500633,0.162295158265504,0.192579217421929,1.68653125589107e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPK9,Mitogen-activated protein kinase 9,40341,0.0916075299445331,0.00399550565256297,0.0837763388655096,0.0994387210235565,1.76269630159414e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARBP2,RISC-loading complex subunit TARBP2,39961,0.168437584947804,0.00735014442591713,0.154031301873007,0.182843868022602,2.51622918976911e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORD,Sorbitol dehydrogenase,40417,0.1426158000421,0.00622549270713186,0.130413834336121,0.154817765748078,2.6530966261537e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES3,Carboxylesterase 3,40305,0.146169071791826,0.00638285978191656,0.13365866661927,0.158679476964382,3.27103498103692e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.154587666343785,0.00675388386429548,0.141350053969765,0.167825278717804,8.58662157703341e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KHK,Ketohexokinase,37628,0.137084285569547,0.00599224073779592,0.125339493723467,0.148829077415627,1.27035393300254e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FN1,Fibronectin,38013,0.0557534280136057,0.0024382606444076,0.0509744371505668,0.0605324188766447,1.40366205224692e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL13,C-X-C motif chemokine 13,40471,0.134738406610389,0.0059040673531539,0.123166434598208,0.146310378622571,1.80535485568508e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AXIN1,Axin-1,40341,0.199477307725437,0.00874606459421669,0.182335021120773,0.216619594330102,2.52322823165243e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.153185163765378,0.00674293860399466,0.139969004101549,0.166401323429208,1.7911306364382e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.130358771337008,0.00574028401977968,0.11910781465824,0.141609728015776,2.42303373211943e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.0613979655660667,0.00270122477233214,0.0561035650122957,0.0666923661198377,2.8429110085818e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.173451026226344,0.00764391945945864,0.158468944085805,0.188433108366883,3.18177021972623e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.223550285221533,0.0098668586373209,0.204211242292384,0.242889328150682,7.05262911684025e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD63,CD63 antigen,40203,0.110001000070023,0.00485490386840279,0.100485388487953,0.119516611652092,7.14046619255768e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0568632767018541,0.00250936537157476,0.0519449205735676,0.0617816328301407,1.33654919728803e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP3S2,AP-3 complex subunit sigma-2,37942,0.0980285256959336,0.00433965437226967,0.0895228031262851,0.106534248265582,6.26726996016535e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.113930286964504,0.00505550134478436,0.104021504328727,0.123839069600282,1.02590294454437e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL17,C-C motif chemokine 17,40333,0.190040751418617,0.00843335698260017,0.173511371732721,0.206570131104514,1.03267500493118e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.234417944317162,0.0103878704525987,0.214057718230068,0.254778170404255,1.10778120767188e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARF6,ADP-ribosylation factor 6,37901,0.220382185397664,0.00978108884869026,0.201211251254231,0.239553119541097,2.22657365862792e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BECN1,Beclin-1,37628,0.127711173993407,0.00567353345474325,0.11659104842211,0.138831299564703,3.90299445585299e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.200155987269424,0.00891745620453653,0.182677773108532,0.217634201430316,1.41489933690084e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUCB2,Nucleobindin-2,40447,0.0772939441879711,0.00346032770037262,0.0705117018952408,0.0840761864807015,7.3919402448038e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP20,Centrosomal protein 20,39980,0.153188519219779,0.00686016599869669,0.139742593862333,0.166634444577224,9.63552006172656e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.094426414163441,0.00423167128007312,0.0861323384544977,0.102720489872384,1.25783174755409e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADH1B,All-trans-retinol dehydrogenase,37671,0.153330420135852,0.00688090385820268,0.139843848573775,0.166816991697929,5.14966436134932e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MVK,Mevalonate kinase,40044,0.158963776768467,0.00714760082687746,0.144954479147787,0.172973074389147,6.64897779280917e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPPC,C-type natriuretic peptide,40341,0.0891937110342547,0.00401653939516365,0.081321293819734,0.0970661282487755,1.27870873833757e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KAZN,Kazrin,37901,0.214860398593833,0.00966754748647031,0.195912005520351,0.233808791667315,1.68118430154653e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNA4,Plexin-A4,40341,0.170514131241998,0.00768907309218601,0.155443547981313,0.185584714502682,2.46570045514497e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.099931902513429,0.00451529164216267,0.0910819308947901,0.108781874132068,6.45411183458169e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.134083731623555,0.00607767202020009,0.122171494463963,0.145995968783147,5.383649504174e-106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN1,Dynactin subunit 1,40489,0.13495520993855,0.00612903423852144,0.122942302831048,0.146968117046052,6.98081119831694e-106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.220266083629241,0.00999805242985672,0.200669900866722,0.23986226639176,1.05369920069471e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD2AP,CD2-associated protein,40359,0.130810873446586,0.00595379652239145,0.119141432262699,0.142480314630473,2.00604420599579e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL5,C-X-C motif chemokine 5,40309,0.234163675869004,0.0106897495812773,0.213211766689701,0.255115585048308,8.21627376036866e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAB2,Disabled homolog 2,40489,0.224834795684043,0.0102765074238841,0.20469284113323,0.244976750234855,1.40156864835417e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.142728915514264,0.00652559658322818,0.129938746211137,0.155519084817391,1.79640905286099e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.211041061898875,0.00965977338670197,0.192107906060939,0.229974217736811,2.80486285283849e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.0625673441562203,0.0028656374269098,0.0569506947994771,0.0681839935129635,3.7866977508599e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.220199209948111,0.0100932475406666,0.200416444768404,0.239981975127818,1.02032164666884e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTSS2,Protein MTSS 2,37900,0.19984936550978,0.00916078467621604,0.181894227544396,0.217804503475163,1.02398419393521e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTUD7B,OTU domain-containing protein 7B,37959,0.128473095715565,0.00588971528145416,0.116929253763915,0.140016937667216,1.06337021323235e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0569157278823805,0.00261633062594522,0.0517877198555279,0.0620437359092332,2.02636093851384e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.0491705271890354,0.00226133362240172,0.0447383132891281,0.0536027410889428,2.47479620926548e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.151590497073512,0.00697186397620044,0.137925643680159,0.165255350466865,5.13328987463266e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATG16L1,Autophagy-related protein 16-1,37901,0.171179805751723,0.00788922988003058,0.155716915186864,0.186642696316583,1.22459663931064e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FETUB,Fetuin-B,40372,0.0681953679867219,0.00314817270257619,0.0620249494896726,0.0743657864837713,1.41508211420665e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELP,P-selectin,40403,0.116093535008811,0.00537083152423478,0.10556670522131,0.126620364796311,3.73095722540605e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.134923148435421,0.00624664611152376,0.122679722056835,0.147166574814008,5.74671936159699e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP23,Synaptosomal-associated protein 23,40359,0.173422328461651,0.00810078791960298,0.157544784139229,0.189299872784073,2.90679439077781e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP85,Centrosomal protein of 85 kDa,39980,0.125809581266121,0.00587707608479834,0.114290512139916,0.137328650392326,3.22511189938934e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDLIM7,PDZ and LIM domain protein 7,40422,0.249370548159437,0.011655133013664,0.226526487452656,0.272214608866219,3.71044839651704e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PYY,Peptide YY,37562,0.189895205271267,0.00886388216481741,0.172521996228225,0.207268414314309,4.16241675245871e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPY,Pancreatic prohormone,40337,0.201177313809292,0.00941341463325883,0.182727021128104,0.219627606490479,6.27742254114743e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA3F,Semaphorin-3F,40359,0.0515105504050378,0.00241058142318378,0.0467858108155976,0.056235289994478,6.62865260579501e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.0461488789966129,0.00216174266650333,0.0419118633702664,0.0503858946229594,1.00947827225815e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNIP1,TNFAIP3-interacting protein 1,37942,0.176082659021733,0.00826740846326911,0.159878538433725,0.19228677960974,4.97652761748667e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.0982545120578516,0.00462913520912228,0.0891814070479719,0.107327617067731,1.39764130566471e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MME,Neprilysin,40305,0.160868979876913,0.00758262513941472,0.14600703460366,0.175730925150166,1.60319364213205e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IKBKG,NF-kappa-B essential modulator,40341,0.181807102180586,0.00857624479350829,0.16499766238531,0.198616541975863,2.24160411287469e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AAMDC,Mth938 domain-containing protein,37628,0.106142515953549,0.00500428393792111,0.0963341194352238,0.115950912471875,3.33161881721891e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFC,Vascular endothelial growth factor C,40411,0.110240385316288,0.00521090756247539,0.100027006493836,0.12045376413874,5.39746588648973e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP5,Fatty acid-binding protein 5,40432,0.136165855864758,0.00645287623874426,0.123518218436819,0.148813493292696,1.63932070532671e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBIN,Erbin,40305,0.20145094839141,0.00954972352264141,0.182733490287033,0.220168406495787,1.92436992269745e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSO,Cathepsin O,40516,0.0591825942017396,0.00280756289986453,0.0536797709180051,0.0646854174854741,2.53056068066777e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCR,Breakpoint cluster region protein,40341,0.179007274786321,0.00849186650419931,0.16236321643809,0.195651333134551,2.60701053152183e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R9B,Neurabin-2,40516,0.184532798686836,0.0087573470303313,0.167368398507387,0.201697198866286,2.97881307068577e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.202136244543024,0.00958817431967181,0.183343422876468,0.220929066209581,4.64062319666562e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLIN1,Perilipin-1,39961,0.0696444445443833,0.00331273538256851,0.0631514831945491,0.0761374058942176,8.96224415588727e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSD,Cathepsin D,39243,0.0782332341872657,0.00372285995162948,0.0709364286820719,0.0855300396924595,1.2479406856277e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.0739251571244506,0.0035221013524095,0.067021838473728,0.0808284757751733,1.68259946358249e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.145312869669215,0.00692164685416161,0.131746441835058,0.158879297503371,2.83583935693319e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.13514878780923,0.00644651733060405,0.122513613841246,0.147783961777214,2.92656517495273e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A4,Protein S100-A4,40411,0.112901378735643,0.00538858494106171,0.102339752251162,0.123463005220124,3.53887824004767e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.20923988748138,0.00998686554039084,0.189665631022214,0.228814143940546,6.01493073449013e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOK2,Docking protein 2,40359,0.23545029955531,0.0112515429317872,0.213397275409007,0.257503323701613,6.0647638587689e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGRN,Agrin,40422,0.0648001858901253,0.00309734831838798,0.0587293831860849,0.0708709885941657,6.62110322345011e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHACTR2,Phosphatase and actin regulator 2,37959,0.222297930412085,0.0106400533021759,0.201443425939821,0.24315243488435,2.00744948557403e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPD52L2,Tumor protein D54,37671,0.210287268619239,0.0100723428615976,0.190545476610507,0.23002906062797,2.92139784606052e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.163659576502265,0.00784786771294838,0.148277755784886,0.179041397219643,4.38398330469112e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0503761556620161,0.00241885585538689,0.0456351981854578,0.0551171131385744,4.48376594521911e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THPO,Thrombopoietin,40042,0.0742481232826217,0.00356548916196282,0.0672597645251746,0.0812364820400688,5.12496410178614e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.0400950497825938,0.00192753405042217,0.0363170830437663,0.0438730165214212,7.77157177451384e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.0402617734204319,0.00193662068163283,0.0364659968844316,0.0440575499564323,1.01729447473077e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BACH1,Transcription regulator protein BACH1,40341,0.140664577461168,0.00677612846794937,0.127383365663987,0.153945789258349,1.82321122003588e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.0880751339739292,0.0042456002977175,0.0797537573904029,0.0963965105574555,4.26655922008136e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAXX,Protein PAXX,37671,0.0876595596204282,0.00423054007959983,0.0793677010644125,0.0959514181764438,6.95520358592915e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEP,Leptin,40359,0.123226151345938,0.00595866581320853,0.111547166352049,0.134905136339827,8.92194610443645e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.0933759354898542,0.00453369384063761,0.0844898955622045,0.102261975417504,8.4777102477427e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLA2,Src-like-adapter 2,37959,0.198211601734079,0.00962765068017179,0.179341406400942,0.217081797067216,9.32447905363716e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CMIP,C-Maf-inducing protein,37900,0.157754858902485,0.00766525843953264,0.142730952361001,0.172778765443969,1.09306633352467e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINH1,Serpin H1,37714,0.247413214717926,0.0120212050651974,0.223851652790139,0.270974776645712,1.12312937389175e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL5,C-C motif chemokine 5,40403,0.191542250764585,0.00934621549507192,0.173223668394244,0.209860833134926,3.7274573281245e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THOP1,Thimet oligopeptidase,40288,0.0571528332946806,0.00279427408370208,0.0516760560906245,0.0626296104987367,8.54906298262387e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.093614258300807,0.0045820030962009,0.0846335322322533,0.102594984369361,1.29063294272066e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.190516593793991,0.00933686502121372,0.172216338352412,0.208816849235569,2.17891279599768e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.112871585187908,0.00553290544853786,0.102027090508774,0.123716079867042,2.51073142968215e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCK2,Cytoplasmic protein NCK2,40422,0.198576449618167,0.00975572711911279,0.179455224464706,0.217697674771629,5.97770606859466e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELN,Elastin,37990,0.0667648441175706,0.00328280616255286,0.060330544038967,0.0731991441961742,1.3386925300092e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDUA,Alpha-L-iduronidase,40489,0.0858156834734897,0.00422523677971874,0.0775342193852409,0.0940971475617384,1.43415668272054e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MINK1,Misshapen-like kinase 1,37942,0.175920395229782,0.00865213660061277,0.158962207492581,0.192878582966983,1.49810785450268e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.105684711083336,0.00520897941233979,0.09547511143515,0.115894310731522,2.35540740470177e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GH1,Somatotropin,40330,-0.331124949569351,0.0163417704880553,-0.36315481972594,-0.299095079412763,3.79389416437678e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.0434038694610758,0.00214325590207354,0.0392030878930117,0.04760465102914,4.72637670372677e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.216183167376285,0.0106674370187086,0.195274990819616,0.237091343932954,5.66508427883055e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN2,CCN family member 2,40358,0.108831460777205,0.00537907610265019,0.0982884716160105,0.119374449938399,6.85379931199548e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.0714837174841002,0.00354022046441012,0.0645448853738563,0.078422549594344,1.49067690504084e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BID,BH3-interacting domain death agonist,40341,0.126296224494304,0.00625532704422047,0.114035783487632,0.138556665500977,1.58120551087646e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0695033586580137,0.00343948677097098,0.0627619645869106,0.0762447527291168,1.76601349086777e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.196118840212251,0.00973042132043364,0.177047214424201,0.215190466000301,3.18268347235622e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.179427793325481,0.00890499388134595,0.161974005318043,0.196881581332919,3.51393584629758e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD6,T-cell differentiation antigen CD6,40502,0.099979366536843,0.0049644292244905,0.0902490852568416,0.109709647816844,4.2162767537484e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAT5B,Signal transducer and activator of transcription 5B,40305,0.258445670676176,0.0128543921315959,0.233251062098248,0.283640279254104,8.40742909112672e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.0745067238704512,0.00370202320408842,0.0672507583904379,0.0817626893504645,8.82600180927015e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAS6,Growth arrest-specific protein 6,40429,-0.0481849656647309,0.00240181782473464,-0.0528925286012108,-0.043477402728251,1.94719172125799e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEXIM1,Protein HEXIM1,40341,0.153034044617475,0.00763093601429449,0.138077410029458,0.167990679205492,2.28435492774909e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLSCR3,Phospholipid scramblase 3,37919,0.112176645247877,0.00559515928218805,0.101210133054789,0.123143157440966,3.96713347291961e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXO1,Forkhead box protein O1,40341,0.158194619934869,0.00790266492273122,0.142705396686315,0.173683843183422,4.67394719047247e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGF,Hepatocyte growth factor,40516,0.0640325720781151,0.00320046529032576,0.0577596601090766,0.0703054840471536,5.60122804179097e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPL,N-acetylneuraminate lyase,37990,0.0806247957804549,0.0040292562125783,0.0727274536038014,0.0885221379571084,8.36403953227849e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.0938838949865488,0.00470136491028955,0.0846692197623813,0.103098570210716,1.27763826411036e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFC,Platelet-derived growth factor C,39980,0.0554480756654149,0.00277710560568482,0.0500049486782726,0.0608912026525571,1.36004640912747e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.158859314999289,0.00796491170970723,0.143248088048263,0.174470541950315,1.95647016555303e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.203117799603426,0.0101737446980084,0.18317725999533,0.223058339211523,2.04396598220394e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USO1,General vesicular transport factor p115,40305,0.168609321874766,0.00846220037043918,0.152023409148705,0.185195234600827,2.88358236645283e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.129882544789648,0.00651944001178498,0.11710444236655,0.142660647212747,3.1617104823829e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD99L2,CD99 antigen-like protein 2,40332,0.0442891532627899,0.00222342807348025,0.0399312342387686,0.0486470722868112,3.20831194474819e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCTN3,Tectonic-3,37990,0.0543235750684392,0.00272767888419701,0.0489773244554131,0.0596698256814654,5.21743912629188e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFX1,Transcriptional repressor NF-X1,37562,0.126130092301748,0.00634855736692036,0.113686919862584,0.138573264740912,1.45251712850164e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCAM,Cell surface glycoprotein MUC18,40403,-0.0627769994356874,0.00317776188120573,-0.0690054127228506,-0.0565485861485242,7.6870252279353e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.174746811632533,0.00884927929562778,0.157402224213103,0.192091399051964,9.22199613125918e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LBR,Delta(14)-sterol reductase LBR,40471,0.120801326794017,0.00613162634038727,0.108783339166858,0.132819314421176,2.1488083751415e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRPK2,SRSF protein kinase 2,40341,0.152138673210145,0.00772723422161036,0.136993294135789,0.167284052284501,2.79772019757124e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.127078278964175,0.00644795013198165,0.114440296705491,0.139716261222859,2.88328749417545e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.190864122155669,0.00969540497011548,0.171861128414243,0.209867115897095,2.90694012750496e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.0805498562770162,0.00409586959026866,0.0725219518800897,0.0885777606739428,4.33878289775194e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.100779567892013,0.0051349940193208,0.0907149796141447,0.110844156169882,9.97583934045062e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VNN1,Pantetheinase,37987,0.132640494464747,0.00676554493650959,0.119380026389188,0.145900962540305,2.05735843958589e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.204506002866384,0.0104430096473781,0.184037703957523,0.224974301775245,2.17451813550412e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCBP2,Poly(rC)-binding protein 2,37959,0.131497383773612,0.00671181592249108,0.11834222456553,0.144652542981695,2.67072499721397e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNB3,Plexin-B3,40310,0.0852267108273787,0.00435907232428073,0.0766829290717884,0.0937704925829689,3.90763547730469e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSG,Alpha-2-HS-glycoprotein,37987,0.0494965103990037,0.00252931438809976,0.0445390541983282,0.0544539665996793,4.10338814668191e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.187639830763591,0.00959529259939002,0.168833057268787,0.206446604258396,5.42244582893335e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.203863209033104,0.0104452611947017,0.183390497091489,0.22433592097472,7.49456208107121e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACE2,Angiotensin-converting enzyme 2,40042,0.0892548644555769,0.00457307832151236,0.0802916309454127,0.0982180979657411,7.79618226067075e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EZR,Ezrin,40471,0.0431676136986711,0.00221339500723507,0.0388293594844903,0.0475058679128518,9.6908131358056e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAT,Linker for activation of T-cells family member 1,40516,0.137518631923293,0.00706310474822889,0.123674946616765,0.151362317229822,1.80462164684048e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRELD2,Protein disulfide isomerase CRELD2,40396,0.0941164029953642,0.00484156462323208,0.0846269363338293,0.103605869656899,3.29540097382492e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.165373956622231,0.00850396720674844,0.148706180897004,0.182041732347458,4.28549037854397e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YOD1,Ubiquitin thioesterase OTU1,37562,0.115564807365193,0.00594889595266203,0.103904971297976,0.127224643432411,6.74384380767708e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,A1BG,Alpha-1B-glycoprotein,38013,0.0317885238090949,0.00163839642423497,0.0285772668175944,0.0349997808005955,9.74268950204656e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT18,"Keratin, type I cytoskeletal 18",40305,0.139451498644055,0.00719582973391062,0.125347672365591,0.15355532492252,1.03929009831348e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.17472394533804,0.0090248404462942,0.157035258063304,0.192412632612777,1.55008592576399e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1S,Complement C1s subcomponent,38013,0.0375667007779687,0.00194042742712264,0.0337634630208083,0.041369938535129,2.16400004671719e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.176884179661595,0.00917307651820474,-0.194863409637276,-0.158904949685914,6.41719627055208e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.0580547277735846,0.00301289048761966,0.0521494624178501,0.0639599931293192,8.47512822163702e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MASP1,Mannan-binding lectin serine protease 1,40192,0.0428367685116276,0.00222586363987695,0.0384740757774688,0.0471994612457865,1.34344568650131e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.100631364966263,0.00523136318333984,0.090377893126917,0.110884836805609,1.52073552659231e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNMBP,Dynamin-binding protein,40228,0.110830195276687,0.00576363841004934,0.0995334639929899,0.122126926560383,1.80080340037893e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD5,Programmed cell death protein 5,40471,0.104893378246599,0.00545681068672945,0.0941980293006097,0.115588727192589,1.98006975753486e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIGYF2,GRB10-interacting GYF protein 2,37959,0.136404296968116,0.00709041413830474,0.122507085257039,0.150301508679193,2.18138966524494e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINE1,Plasminogen activator inhibitor 1,40536,0.121197803661307,0.00631339542251919,0.10882354863317,0.133572058689445,3.17609198964867e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON2,Serum paraoxonase/arylesterase 2,40042,0.0617068666327753,0.00321695252740391,0.0554016396790636,0.0680120935864869,4.50723206209623e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP43,Centrosomal protein 43,39934,0.123811542841943,0.00645456136512279,0.111160602566302,0.136462483117583,4.55319399438125e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP2B,DNA topoisomerase 2-beta,37598,0.141975724204247,0.00739565110787626,0.12748024803281,0.156471200375685,5.00002160898832e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNST,Consortin,40359,0.193125767293432,0.0100762098689728,0.173376395950246,0.212875138636619,5.75701210781388e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.147695222249684,0.00770634214734357,0.132590791640891,0.162799652858477,6.18101840265994e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.151496054360338,0.0079073097016584,0.135997727345087,0.166994381375588,1.02969258540613e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCXR,L-xylulose reductase,40411,0.0935193799462466,0.00488947380376563,0.083936011290866,0.103102748601627,1.20763207068241e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.137720463534587,0.00719618907458974,0.123615932948391,0.151824994120783,1.41615668560814e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EREG,Proepiregulin,40192,0.143600434120746,0.00751149416261382,0.128877905562022,0.158322962679469,1.47762988585614e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STC1,Stanniocalcin-1,40471,0.0740072524755205,0.00387423920411391,0.0664137436354573,0.0816007613155838,1.88886749739368e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.13778804735302,0.00720770346305419,0.123660948565434,0.151915146140606,2.09230982058361e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD36,Platelet glycoprotein 4,37598,0.0793400113243968,0.00415272689702887,0.0712006666062202,0.0874793560425734,2.77162029162684e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABEP1,Rab GTPase-binding effector protein 1,37671,0.14109791425152,0.0073861379788539,0.126621083812966,0.155574744690074,2.862082619794e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIRBP,Cold-inducible RNA-binding protein,37901,0.170004298182016,0.00891766071089323,0.152525683188665,0.187482913175367,5.70786337810129e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.115106329223752,0.0060395291338641,0.103268852121378,0.126943806326126,6.16175432560707e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HYOU1,Hypoxia up-regulated protein 1,40536,0.0384714084009802,0.00202495377489688,0.0345024990021823,0.0424403177997781,1.30097532715622e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.108836203786694,0.00572974438235952,0.0976059047972695,0.120066502776119,1.49997651233458e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP3B1,AP-3 complex subunit beta-1,37901,0.13583178918356,0.00714603427592448,0.121825562002748,0.149838016364372,1.6097671070413e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEC31A,Protein transport protein Sec31A,37628,0.136067960336372,0.00715795195655333,0.122038374501528,0.150097546171217,1.64853497930591e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.128499057185565,0.00676527434870535,0.115239119462103,0.141758994909028,2.09071102319857e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CMC1,COX assembly mitochondrial protein homolog,37990,0.159772635258544,0.00842272293034241,0.143264098315073,0.176281172202016,3.25257062988105e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.134843786363035,0.00711598037730111,0.120896464823525,0.148791107902545,3.34595244469684e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGFR,Opioid growth factor receptor,40305,0.0585148264903461,0.00308913231128395,0.0524601271602295,0.0645695258204626,3.83021330213956e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.113745768981479,0.00600580935131591,0.1019743826529,0.125517155310058,4.21047841920549e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.0506523853244425,0.00267598726529679,0.0454074502844608,0.0558973203644242,4.79884910752638e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK11,Serine/threonine-protein kinase STK11,40042,0.12903052161804,0.00682646414649397,0.115650651890912,0.142410391345168,8.41611951851278e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC27,Cell division cycle protein 27 homolog,39980,0.107654395685988,0.00569884665817222,0.0964846562359702,0.118824135136005,1.03925325625336e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.184471590466963,0.00976777973238735,0.165326742191484,0.203616438742442,1.07539666342289e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLB1,Beta-galactosidase,40228,0.0720898448407971,0.00381930574478558,0.0646040055810173,0.0795756841005768,1.34040253696343e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAG1,Dystroglycan,40422,0.0835631431986282,0.00442820326195015,0.0748838648052059,0.0922424215920505,1.4212422471639e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.187777929897344,0.00994513836780669,0.168285458696443,0.207270401098245,1.73096885795499e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBPL,FK506-binding protein-like,37901,0.104067926421817,0.00551923207702183,0.093250231550854,0.11488562129278,2.69991942077155e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUOM,Fucose mutarotase,37671,0.110001852067616,0.00584019532855664,0.0985550692236447,0.121448634911587,4.07454419344654e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASAH2,Neutral ceramidase,40228,0.0925317435784358,0.00491825967480117,0.0828919546158255,0.102171532541046,4.15361915024284e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFB,Platelet-derived growth factor subunit B,40422,0.150817438426842,0.00801756234403304,0.135103016232537,0.166531860621147,4.29070735035186e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0663015954903384,0.00352267004038155,0.0593971622111906,0.0732060287694863,5.26113973280402e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OXT,Oxytocin-neurophysin 1,40471,0.232656163895166,0.0123795004810561,0.208392342952296,0.256919984838036,5.86082671806385e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS9,Galectin-9,40350,0.0565455120202925,0.00301031691598794,0.0506452908649561,0.0624457331756288,7.11782510749075e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMMD1,COMM domain-containing protein 1,37628,0.10831263197474,0.00576111805898508,0.097020840579129,0.11960442337035,7.76438426069144e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFA,Vascular endothelial growth factor A,40456,0.103188271914255,0.0054978960582862,0.0924123956400136,0.113964148188495,9.30355847785722e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP45,Rho GTPase-activating protein 45,37671,0.144693093464654,0.00770148771283503,0.129598177547497,0.15978800938181,9.77382487122377e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.161803422672346,0.00862458554870536,0.144899234996883,0.178707610347808,1.13275513497998e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.125032294554236,0.00666848710158929,0.111962059835121,0.138102529273351,1.96008133447852e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL10,C-X-C motif chemokine 10,40422,0.118281192754395,0.0063177877128454,0.105898328837218,0.130664056671572,2.20730855724045e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGCC,Regulator of cell cycle RGCC,37959,0.131212225846085,0.00701107608682657,0.117470516715905,0.144953934976265,3.52728685903707e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MITD1,MIT domain-containing protein 1,40228,0.168938619840435,0.0090450580634899,0.151210306035995,0.186666933644875,5.10875231557184e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.0454102496239265,0.00242975044530965,0.0406479387511196,0.0501725604967335,5.96536809746313e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM5,Tripartite motif-containing protein 5,40341,0.148563703371095,0.0079673642291291,0.132947669482002,0.164179737260188,8.88002363290091e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.159013743542926,0.00852336121797009,0.142307955555704,0.175719531530147,1.03473961173682e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIT1,ARF GTPase-activating protein GIT1,37598,0.170721709210403,0.00915321387846157,0.152781410008618,0.188662008412188,1.19276036892631e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL13,C-C motif chemokine 13,40483,0.121469312249597,0.00652463302967893,0.108681031511426,0.134257592987768,1.49815306461451e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCC,Tubulin-specific chaperone C,40228,0.141368232367511,0.00760662019853354,0.126459256778385,0.156277207956636,2.77457683799512e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYTL4,Synaptotagmin-like protein 4,37990,0.127174723730995,0.0068557129281493,0.113737526391822,0.140611921070167,7.06743216789194e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.0915747704162243,0.00493731456850426,0.081897633861956,0.101251906970493,7.75736845239755e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.114004645065545,0.00614855609001442,0.101953475129117,0.126055815001973,8.28408155372562e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC13,Mucin-13,39961,0.087140973588449,0.00470605479228737,0.0779171061955658,0.0963648409813323,9.89513211607632e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP2,Methionine aminopeptidase 2,40453,0.101923363267194,0.00551163404186218,0.0911205605451443,0.112726165989244,1.45554136668565e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.1739207452282,0.00940709243601384,0.155482844053613,0.192358646402787,1.5892274400707e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGF,Placenta growth factor,40516,0.0453732739755418,0.00245898677335889,0.0405536598997583,0.0501928880513252,3.00704340055635e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNCG,Gamma-synuclein,40228,0.115534389979384,0.00626840616512584,0.103248313895738,0.127820466063031,4.52541987891407e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLG,Plasminogen,37705,0.0386978080606769,0.00209887195961179,0.0345840190198378,0.042811597101516,5.6818277649618e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYDGF,Myeloid-derived growth factor,37990,0.173035619974919,0.0094013013722345,0.154609069285339,0.191462170664498,9.66213251987951e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLK1,Protein delta homolog 1,40536,0.0911884644482625,0.00496210338452273,0.081462741814598,0.100914187081927,1.16588617814503e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESM1,Endothelial cell-specific molecule 1,40357,-0.058202904767947,0.00317275164065784,-0.0644214979836364,-0.0519843115522577,2.13103043948132e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.116185343691822,0.00633373034530372,0.103771232215026,0.128599455168617,2.25654755477177e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AZI2,5-azacytidine-induced protein 2,37959,0.094657117390307,0.00516057002100145,0.0845424001491442,0.10477183463147,3.01976938216209e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRAP,BRCA1-associated protein,37778,0.18789305959665,0.0102545210033495,0.167794198430085,0.207991920763215,4.39869189163115e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIAE,Sialate O-acetylesterase,40374,0.0802419691771114,0.004385844596796,0.0716457137673912,0.0888382245868316,5.13194706702877e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NIT2,Omega-amidase NIT2,37936,0.129560117693827,0.0070759127808742,0.115691328643313,0.14342890674434,5.41350320065257e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.19840323895373,0.0108472041588369,0.17714271880241,0.21966375910505,5.65097288565228e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.120115900793986,0.00656169914863823,0.107254970462655,0.132976831125317,6.14302922804814e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH2B3,SH2B adapter protein 3,39980,0.167172040372428,0.00914925803338694,0.149239494626989,0.185104586117866,8.25120929936827e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASHC3,WASH complex subunit 3,37942,0.128394886522212,0.00702548418857774,0.1146249375126,0.142164835531824,1.00180011156182e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.152874886328952,0.00837501795488337,0.136459851137381,0.169289921520524,1.49131849022673e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEFTY2,Left-right determination factor 2,40453,0.0887187790204953,0.00486521311867976,0.0791829613078829,0.0982545967331076,1.50262978577662e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F13B,Coagulation factor XIII B chain,37934,0.0441104142971473,0.00241801955747922,0.039371095964488,0.0488497326298066,1.81607672652714e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL3,C-X-C motif chemokine 3,40350,0.158746968407859,0.00871814596910383,0.141659402308415,0.175834534507302,2.44291383140156e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.183864568707077,0.0100925113711155,0.164083246419691,0.203645890994464,2.79923170516159e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAMP8,Vesicle-associated membrane protein 8,37598,0.151352564437289,0.0083097965257282,0.135065363246862,0.167639765627716,3.18405029232964e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE4,Ribonuclease 4,37575,0.0466306545937888,0.00256096241391623,0.041611168262513,0.0516501409250646,3.52418966209134e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.13496815931101,0.00742382877239553,0.120417454917115,0.149518863704905,5.46236994003796e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDHD2,Phospholipase DDHD2,37959,0.112717447721945,0.00620059134553681,0.100564288684693,0.124870606759197,5.65005080289568e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD1,Sushi domain-containing protein 1,40042,0.0835535091193278,0.00461460231814762,0.0745088885757585,0.0925981296628972,1.57080041435466e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.105756946222372,0.00584233146769325,0.0943059765456935,0.117207915899051,2.21040499310387e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAMBP,STAM-binding protein,40192,0.109474516312843,0.00605938167877469,0.0975981282224444,0.121350904403241,3.11258739456171e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D23,TBC1 domain family member 23,40305,0.151119042596256,0.0083892541407643,0.134676104480358,0.167561980712154,7.94828898482974e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAX1BP1,Tax1-binding protein 1,37942,0.108245454358464,0.00601113013251177,0.0964636392987409,0.120027269418187,1.1719372667821e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.045541848158248,0.00253128146861209,0.0405805364797683,0.0505031598367277,1.17259047528694e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTDH,Protein LYRIC,37598,0.154396035501965,0.00857483764817187,0.137589353711548,0.171202717292382,1.2712376934164e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QDPR,Dihydropteridine reductase,40290,0.0736787456745485,0.00409941442045721,0.0656438934104524,0.0817135979386447,1.6269377350552e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA5,Integrin alpha-5,40332,0.041905833426747,0.00233336007257467,0.0373324476845006,0.0464792191689933,2.05825720118676e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRKL,Crk-like protein,40374,0.178674476293983,0.00997385474320915,0.159125720997293,0.198223231590673,4.54453440446949e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL7,C-C motif chemokine 7,40341,0.102010515201105,0.00569810084898289,0.0908422375370986,0.113178792865112,5.60642729122862e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0333238529582913,0.00185992007653649,0.0296784096082798,0.0369692963083028,5.77363869829404e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.102486877012998,0.00572626821072283,0.091263391319981,0.113710362706014,6.11340312771525e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0891388781971995,0.0049804557267391,0.0793771849727909,0.0989005714216082,8.12472340706352e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.0842601937421363,0.00471449421742203,0.0750197850759891,0.0935006024082834,9.48146777634602e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISM1,Isthmin-1,40341,0.0652953297967113,0.0036539406527119,0.058133606117396,0.0724570534760266,9.96587938851641e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPHN1,Oligophrenin-1,37942,0.178900894365086,0.0100189409012166,0.159263770198702,0.198538018531471,1.67042619847782e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHRL,Appetite-regulating hormone,40359,0.131677863263567,0.00738343288102985,0.117206334816749,0.146149391710386,1.85872704139409e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDC4,Syndecan-4,40359,0.0754737793872645,0.00423546672154566,0.0671722646130351,0.083775294161494,2.40775298519251e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GASK1A,Golgi-associated kinase 1A,37562,0.0725473652242034,0.00406708095475974,0.0645758865528743,0.0805188438955325,2.43726355849913e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGLN1,Egl nine homolog 1,40341,0.0884866742888331,0.00497106905095152,0.0787433789489681,0.098229969628698,3.37273241000711e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5E,5'-nucleotidase,40411,0.0964964748983119,0.00542263968570952,0.0858681011143212,0.107124848682303,3.67044602581819e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F2,Prothrombin,38013,0.0245605340502288,0.00137953376700742,0.0218566478668943,0.0272644202335634,4.16022344847361e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDLIM5,PDZ and LIM domain protein 5,37959,0.197491232545958,0.0110948271605763,0.175745371311229,0.219237093780688,4.4314082451267e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.142620035120539,0.00801466463799755,0.126911292430064,0.158328777811014,5.08682413041032e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS1,Galectin-1,40359,0.0559629520985321,0.00315030367519743,0.0497883568951451,0.0621375473019191,6.3224148847975e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMN,Protein amnionless,40044,0.0793945353676272,0.00446907851226744,0.070635141483583,0.0881539292516714,6.40856054670147e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGA,Protein O-GlcNAcase,37901,0.116897491551916,0.0065821275757814,0.103996521503384,0.129798461600447,9.04021715834718e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.105432797365723,0.00594240053715536,0.0937856923128989,0.117079902418548,9.61039368270332e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSP1,Lymphocyte-specific protein 1,40341,0.0663783801742169,0.00374315961696531,0.0590417873249649,0.0737149730234689,1.08919364044339e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM13A,Protein FAM13A,37901,0.112047239635227,0.00631457844611574,0.0996706658808402,0.124423813389614,1.18632848465358e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.0820775654388786,0.00462984989790776,0.0730030596389794,0.0911520712387778,1.19443974414937e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAT2,Signal transducer and activator of transcription 2,37598,0.127776796804122,0.00720275452130787,0.113659397942359,0.141894195665886,1.33073286449542e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.103170046235322,0.00581747588667155,0.0917677934974454,0.114572298973198,1.47125722540382e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.0973340789430935,0.0054923775896834,0.086569018867314,0.108099139018873,1.81114203593976e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARSB,Arylsulfatase B,40305,0.0910324770905439,0.00514266243170961,0.080952858724393,0.101112095456695,1.90304226777223e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0778003165311209,0.00439327622764153,0.0691894951249435,0.0864111379372983,2.18939730070782e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.0519142211877621,0.00293255215585473,0.0461664189622869,0.0576620234132374,2.5301382371999e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYN,Tyrosine-protein kinase Lyn,40305,0.138918526373749,0.00785670860841633,0.123519377501253,0.154317675246245,2.69127353254321e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS1BP3,HCLS1-binding protein 3,37628,0.148211246483223,0.0083815016867468,0.131783503177199,0.164638989789246,3.55445867993178e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAO1,Hydroxyacid oxidase 1,40489,0.215779034250757,0.0122212701302686,0.19182534479543,0.239732723706083,4.12024183043358e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINC1,Antithrombin-III,37981,0.0243614655196736,0.00138040176457526,0.0216558780611061,0.0270670529782411,6.22100873953148e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.084258888184851,0.00477680429473025,0.0748963517671797,0.0936214246025223,7.3353074504408e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL7,Angiopoietin-related protein 7,40489,0.0611068093569474,0.00347017246323658,0.0543052713290037,0.0679083473848911,9.29222552205261e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH2D1A,SH2 domain-containing protein 1A,40341,0.0904015206497084,0.00513579061344406,0.0803353710473581,0.100467670252059,1.06158758164398e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.120018092856311,0.00681943696051341,0.106651996413705,0.133384189298918,1.10800644205512e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG4,BAG family molecular chaperone regulator 4,37598,0.0803462361047252,0.00456233613396037,0.0714040572821629,0.0892884149272876,1.24769950172588e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.0578850225183083,0.00328789233505295,0.0514407535416046,0.0643292914950121,1.4056776297531e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB27B,Ras-related protein Rab-27B,37990,0.135131683427199,0.00768905003516803,0.12006114535827,0.150202221496128,2.21290384263105e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.147868881842411,0.00842565725445475,0.131354593623679,0.164383170061142,3.5654102712644e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSIP1,PC4 and SFRS1-interacting protein,40341,0.101824877724897,0.0058099848845358,0.0904373073512065,0.113212448098587,3.97747158315726e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GTPBP2,GTP-binding protein 2,37572,0.131318069162979,0.00748922567146665,0.116639186846905,0.145996951479054,4.67612684308407e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.124017670113512,0.00709088114280445,0.110119543073615,0.137915797153409,7.45080947603585e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGKA,Diacylglycerol kinase alpha,37598,0.0891842624901952,0.00509491865330893,0.0791982219297097,0.0991703030506807,7.76278835674101e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.0521195291821573,0.0029854082633446,0.0462681289860019,0.0579709293783128,1.26812397032519e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBNL,Drebrin-like protein,40422,0.150864748743546,0.00864920901176269,0.133912299080491,0.167817198406601,1.65415595962547e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.0807415138929522,0.00462590709407555,0.0716747359885641,0.0898082917973403,1.84825232825852e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTBDN,Retbindin,40305,0.0477336722451033,0.0027420991161424,0.0423591579774642,0.0531081865127424,3.04149632175914e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOK1,Docking protein 1,37942,0.222700438265102,0.0127865235478012,0.197638852111412,0.247762024418792,3.33793641675262e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.130424446521436,0.00750904645200288,0.11570671547551,0.145142177567362,5.88427642749376e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.0435779705009194,0.00250978238674073,0.0386587970229076,0.0484971439789313,6.71696571968181e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS8,Galectin-8,40471,0.0983041733422163,0.0056641168212729,0.0872025043725214,0.109405842311911,7.31179148822333e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELE,E-selectin,40536,0.0812493107583849,0.0046835153580004,0.0720696206567042,0.0904290008600657,8.28936556666206e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX15,Sorting nexin-15,37671,0.0881813250095533,0.00508432767593542,0.0782160427647198,0.0981466072543867,1.20005018416291e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPHOSPH8,M-phase phosphoprotein 8,40042,0.121336605358299,0.00700818190429841,0.107600568825874,0.135072641890724,1.55658884793612e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDNF,Cerebral dopamine neurotrophic factor,40305,0.0524997074015226,0.00303540849006833,0.0465503067609887,0.0584491080420565,2.05927319115054e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.148803499488758,0.00860514890790338,0.131937407629267,0.165669591348249,2.23298405446958e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.135891281055509,0.00786279297466814,0.120480206825159,0.151302355285858,2.55470561265162e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IST1,IST1 homolog,37812,0.162426435992552,0.00939273116306735,0.14401668291294,0.180836189072164,2.80375468862706e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TWF2,Twinfilin-2,37998,0.134367159665166,0.00777286506633139,0.119132344135156,0.149601975195175,3.03968329445952e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.0711256564774433,0.00411802667929738,0.0630543241860204,0.0791969887688661,3.16960068357983e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RILPL2,RILP-like protein 2,37990,0.157506115086252,0.00912407461157172,0.139622928847571,0.175389301324932,4.57102232373308e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPC5,Glypican-5,40228,0.0904504244292476,0.00525299727406035,0.0801545497720893,0.100746299086406,7.66500354257166e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHMP1A,Charged multivesicular body protein 1a,40228,0.128032042707969,0.00745032911696727,0.113429397638713,0.142634687777225,1.36522448968988e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH2,Cadherin-2,40359,0.0567362172979661,0.0033021578903235,0.050263987832932,0.0632084467630002,1.42499448300431e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.0445397915909249,0.00259497509592687,0.0394536404029082,0.0496259427789415,1.93114433013155e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPART,Spartin,37671,0.124348271109532,0.00724039837497066,0.11015709029459,0.138539451924475,2.11834185778117e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTNB,Dystrobrevin beta,37878,0.0671392080097549,0.00391742834870783,0.0594610484462876,0.0748173675732223,3.76652494543351e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.193491827040148,0.0113063756708345,0.171331330725312,0.215652323354983,4.70511459047718e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.132395459685643,0.007734584716246,0.117235673641801,0.147555245729485,5.37173688667834e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.236748696693952,0.0138322496491434,0.209637487381631,0.263859906006273,5.52014010550107e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R2,Protein phosphatase inhibitor 2,40359,0.126994908473929,0.00742624581755172,0.112439466671528,0.14155035027633,5.5709841543192e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.125014214897387,0.00731355180442709,0.11067965336071,0.139348776434064,6.3714419117945e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDRKH,Tudor and KH domain-containing protein,39961,0.135985206636778,0.00798449762368699,0.120335591294352,0.151634821979205,1.85872962170274e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAVS,Mitochondrial antiviral-signaling protein,39980,0.148197012341978,0.00870269199213658,0.13113973603739,0.165254288646566,1.92816660105763e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT5,ADP-sugar pyrophosphatase,40332,0.0832990815935199,0.00489481309686352,0.0737052479236674,0.0928929152633724,2.25317389371574e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.071041071161944,0.00417523545139712,0.0628576096772057,0.0792245326466824,2.43850484588504e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APPL2,DCC-interacting protein 13-beta,37671,0.178227562430718,0.0104739918282456,0.157698538447357,0.198756586414079,3.00454257501343e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST3,Cystatin-C,40372,0.0446134707091305,0.00263019040122848,0.0394582975227227,0.0497686438955383,5.71293938956119e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD69,Early activation antigen CD69,40288,0.139678167582763,0.00823931843824206,0.123529103443809,0.155827231721717,6.73391276763385e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASC3,Protein CASC3,37572,0.065009238873202,0.00384638313479243,0.0574703279290088,0.0725481498173952,2.05660448741663e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICA1,Islet cell autoantigen 1,40044,0.12561665352632,0.00744419692589614,0.111026027551563,0.140207279501076,2.52914929946199e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOLGA3,Golgin subfamily A member 3,37959,0.124177602546326,0.00735389078330403,0.10976397661105,0.138591228481602,2.54330983106074e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0440725165780676,0.00261210640416532,0.0389527880259036,0.0491922451302317,2.55084050458724e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNPY4,Protein canopy homolog 4,40305,0.117959385727465,0.0070076314555552,0.104224428074577,0.131694343380354,4.93097273747528e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.106252604229563,0.00631350742494018,0.0938781296766798,0.118627078782445,6.70119669077796e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C3,Complement C3,37360,0.0742421900270513,0.00441377857231751,0.065591184025309,0.0828931960287936,8.03987532974115e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0771105781442451,0.0045900286468454,0.0681141219964281,0.0861070342920621,8.81768761393283e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COCH,Cochlin,37990,0.0735655761542802,0.00437627552878022,0.064988076117871,0.0821430761906894,8.90607233861594e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP3,Metalloproteinase inhibitor 3,40422,0.20726924665287,0.0123722084857967,0.183019718020709,0.231518775285032,1.8433439867524e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NSFL1C,NSFL1 cofactor p47,40471,0.104783180129838,0.00625548770329103,0.0925224242313875,0.117043936028288,1.90474186160861e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF2,TNF receptor-associated factor 2,40341,0.111827642442326,0.0066770479751615,0.0987406284110093,0.124914656473642,2.00592870730064e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSME1,Proteasome activator complex subunit 1,40216,0.0591042450908279,0.00353661357845701,0.0521724824770522,0.0660360077046036,3.66584757097582e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.136619228488061,0.00818475280399827,0.120577112992224,0.152661343983897,5.04195022625e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEP1A,Meprin A subunit alpha,37901,0.107332171988469,0.00642679691657536,0.0947356500319818,0.119928693944957,5.44661894531426e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.0747125135399477,0.00447702553248394,0.0659375434962791,0.0834874835836162,6.71470042734337e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.0690350666814826,0.00414529552857927,0.0609102874454672,0.0771598459174979,9.49651420679885e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA1,GDNF family receptor alpha-1,40453,0.0434340016080891,0.0026130653965604,0.0383123934308307,0.0485556097853474,1.5874835167666e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOLM2,Protein GOLM2,40471,0.0349947849923217,0.0021057958967112,0.0308674250347678,0.0391221449498757,1.68014612885674e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RWDD1,RWD domain-containing protein 1,40471,0.100434778757202,0.00604444689228488,0.0885876628483238,0.112281894666081,1.74403292842424e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.0497058472740221,0.00299094993617958,0.0438435853991101,0.0555681091489341,2.07728283926802e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSNK2A1,Casein kinase II subunit alpha,37959,-0.0705362745413872,0.00425401567396097,-0.0788741452623507,-0.0621984038204237,3.83414079234251e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.133157219052759,0.00803836610408877,0.117402021488745,0.148912416616773,4.15724407983862e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.104019699690216,0.00629001803546347,0.0916912643407071,0.116348135039724,6.32588639332595e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.105201292433378,0.00635639792166723,0.0927427525069101,0.117659832359846,6.58333717042735e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMOX2,Heme oxygenase 2,39961,0.0708481304973194,0.0042854005516503,0.0624487454160849,0.079247515578554,7.10729592226462e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAX,Protein max,39961,0.162111966162964,0.0098123935105315,0.142879674882323,0.181344257443606,8.54422632745132e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA11,Annexin A11,40312,0.104300860055262,0.00631845026283502,0.0919166975401054,0.116685022570419,1.04215835358954e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.111574993880043,0.0067533107203655,0.0983385048681263,0.124811482891959,1.05257711738967e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRADD,Death domain-containing protein CRADD,40192,0.118648582912388,0.00718796990915675,0.104560161890441,0.132737003934335,1.06511931513134e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM17,Splicing factor 45,37959,0.118340563056068,0.00716564516854221,0.104295898525725,0.132385227586411,1.12473508453516e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.111542569062125,0.0067614398958809,0.0982901468661986,0.124794991258052,1.23352380296149e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.105855192419974,0.0064139757630028,0.0932837999244882,0.118426584915459,1.34817095935821e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FIS1,Mitochondrial fission 1 protein,40354,0.118796932840916,0.00724515714871092,0.104596424829443,0.13299744085239,6.25979079635446e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NIT1,Deaminated glutathione amidase,37628,0.0762928401402621,0.00465753547230423,0.0671640706145458,0.0854216096659784,1.02440937633095e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPP,Lipoma-preferred partner,37562,0.103321422088323,0.00630860989229799,0.0909565466994188,0.115686297477227,1.07674613600542e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.0888394956350064,0.00542513263944183,0.0782062356617004,0.0994727556083124,1.0801240143007e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATOX1,Copper transport protein ATOX1,40411,0.11010062249797,0.00673135473025115,0.0969071672266782,0.123294077769263,1.19707690866999e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RL2,Interleukin-1 receptor-like 2,40044,0.0622371640283729,0.0038066963085632,0.054776039263589,0.0696982887931567,1.37538701454425e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGK,N-acetyl-D-glucosamine kinase,37608,0.0869230376855794,0.00531474955305009,0.0765061285616012,0.0973399468095575,1.54660092490612e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.0643688302685907,0.00393959780501325,0.0566472185707647,0.0720904419664166,1.58185338657411e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TALDO1,Transaldolase,37966,0.068517375171821,0.00419193590638692,0.0603011807953026,0.0767335695483394,1.75396220273096e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIFBP,KIF-binding protein,40305,0.126103328860871,0.00772431552528684,0.110963670431309,0.141242987290433,1.98455453667423e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.160060782394022,0.0098104733350548,0.140832254657314,0.179289310130729,2.33337206501828e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.0455007524027245,0.00279132158531087,0.0400297620955152,0.0509717427099338,2.93944056483143e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL11,Eotaxin,40516,0.0575703003962847,0.00353226829693736,0.0506470545342874,0.0644935462582819,3.02677160858817e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.0700308315110718,0.0042971730953258,0.0616083722442332,0.0784532907779103,3.13681972088134e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSZ,Cathepsin Z,40345,0.0474273214620815,0.00291460914377488,0.0417146875402827,0.0531399553838802,4.66031607473964e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMPR2,GMP reductase 2,37671,0.103647723835188,0.00636971375096202,0.091163084883302,0.116132362787073,5.83302777658409e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP10,Stromelysin-2,40341,-0.0914660061301898,0.00562602376359892,-0.102493012706844,-0.0804389995535359,5.89428379787763e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.136345239621101,0.00839072705668891,0.119899414589991,0.152791064652211,6.73440107424223e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS2,Trypsin-2,40403,0.0763077658562259,0.00470635915060174,0.0670833019210465,0.0855322297914053,1.18660669537912e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.134871768554818,0.00831809298248195,0.118568306309153,0.151175230800482,1.22273277812541e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT4,Vascular endothelial growth factor receptor 3,40411,0.050610147010745,0.00312197131588643,0.0444910832316076,0.0567292107898824,1.24032803813952e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.128654871070819,0.00794196769395445,0.113088614390669,0.14422112775097,1.53778463723302e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2,Microtubule-associated protein 2,37942,0.0696710939043858,0.00430783836023925,0.0612277307183169,0.0781144570904548,2.75612619568916e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL3,Angiopoietin-related protein 3,40355,0.0549278362415126,0.00340403504479125,0.0482559275537218,0.0615997449293035,4.11585131082022e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRP14,Signal recognition particle 14 kDa protein,40305,0.0897819694375849,0.00556510884859782,0.0788743560943332,0.100689582780837,4.33749587519468e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53,Cellular tumor antigen p53,39980,0.0652129247513659,0.00404678657940205,0.0572812230557379,0.0731446264469939,5.93086655903523e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.0440057715693449,0.00273154903652586,0.0386519354577542,0.0493596076809356,6.1529340688312e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUB1,NEDD8 ultimate buster 1,40341,0.126112461990108,0.00783559386232097,0.110754698019959,0.141470225960257,7.94687058253544e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.115714308413005,0.00718900891765963,0.101623850934392,0.129804765891618,7.9897521062756e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.166826043973021,0.0103723677788498,0.146496203126475,0.187155884819566,9.43305466419072e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLG4,Disks large homolog 4,37942,0.106003134219195,0.0065868651887347,0.0930928784492751,0.118913389989115,9.82289874691764e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.149122712247299,0.00928166525994013,0.130930648337816,0.167314776156782,1.2789303641416e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PXN,Paxillin,39961,0.0781096900240835,0.00486293606865013,0.0685783353295293,0.0876410447186378,1.36719697236009e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNLR1,Interferon lambda receptor 1,40341,0.0564072982177571,0.00351250342288974,0.0495227915088932,0.063291804926621,1.403512105411e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YJU2,Splicing factor YJU2,37900,0.04832059688546,0.0030074010932856,0.0424260907426202,0.0542151030282997,1.48561810503488e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.0744780236471189,0.00463510631376785,0.0653932152721339,0.0835628320221039,1.48705736646931e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.145900155148284,0.00908208327717175,0.128099271925027,0.16370103837154,1.5425053291637e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.084434199728773,0.00526560988204126,0.0741136043599722,0.0947547950975739,2.05719437741878e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD207,C-type lectin domain family 4 member K,40029,0.0578164496064746,0.00360631505870245,0.0507480720914178,0.0648848271215314,2.19783206199997e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDC,Nuclear migration protein nudC,40516,0.095121997499292,0.00593621689258064,0.0834870123898339,0.10675698260875,2.41653423135483e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.0865924377890218,0.00540710413424038,0.0759945136859107,0.097190361892133,3.50947058427174e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRY2,Protein sprouty homolog 2,40044,0.138445220288413,0.00865429422702944,0.121482803603436,0.155407636973391,3.80207027664057e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CETN3,Centrin-3,37901,0.115424912509465,0.0072128863008645,0.101287655359771,0.12956216965916,4.12293243447392e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKG1,cGMP-dependent protein kinase 1,37671,0.188196879428928,0.0117634577965222,0.165140502147744,0.211253256710111,4.49530941826439e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRAP2,GRB2-related adapter protein 2,40359,0.190127844242117,0.0118955956175562,0.166812476831706,0.213443211652527,4.66464950972891e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PF4,Platelet factor 4,37934,0.146013861773729,0.00913716299609748,0.128105022301378,0.16392270124608,5.84855970575716e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.116105819354973,0.0072728321643204,0.101851068312905,0.130360570397041,6.27932192163008e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTUD6B,Deubiquitinase OTUD6B,37901,0.0883590933992276,0.00553205629387862,0.0775162630632255,0.0992019237352297,6.65498940844419e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA4D,Semaphorin-4D,40471,0.0447064337522111,0.00280222546701871,0.0392140718368544,0.0501987956675678,7.33592874268965e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED8,Protein TMED8,37901,0.153973763300802,0.00964733267144241,0.135064991264775,0.172882535336829,8.03192324886056e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0847339945752641,0.00531411319099725,0.0743183327209095,0.0951496564296188,8.499058749611e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.0947515285497611,0.00593958413097621,0.0831099436530477,0.106393113446474,9.2524839487754e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACYBP,Calcyclin-binding protein,37642,0.153504661852629,0.00963099386097884,0.134627913885111,0.172381409820148,1.15478228118114e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.116891982107321,0.00735969520800328,0.102466979499635,0.131316984715007,2.31872808240478e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMOT,Angiomotin,37671,0.0623173559544796,0.00392241357245974,0.0546294253524585,0.0700052865565007,2.56613413718369e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRAS,Ras-related protein R-Ras,37572,0.194685822792304,0.0122540550097418,0.17066787497321,0.218703770611398,2.59084749166706e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGF,Pro-epidermal growth factor,40324,0.153056914855501,0.00964503051363723,0.134152655048772,0.17196117466223,2.81367999613456e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST13,Hsc70-interacting protein,37671,0.0850396989176456,0.0053551054277829,0.0745436922791911,0.0955357055561001,2.88052746671326e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPB1,Carboxypeptidase B,40536,0.0838289684034433,0.00528786509828026,0.0734647528108139,0.0941931839960726,3.56411548876019e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPARC,SPARC,40411,0.105365325383437,0.00664704020384691,0.0923371265838972,0.118393524182977,3.68352543713654e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MGLL,Monoglyceride lipase,40396,0.12835818072864,0.00809887753222251,0.112484380765484,0.144231980691796,3.83896743864637e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFB2,BPI fold-containing family B member 2,37951,0.101216876246281,0.00638235763686039,0.088707455278035,0.113726297214528,3.91965830604971e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GYS1,"Glycogen [starch] synthase, muscle",40042,0.138509850763936,0.00874036959097041,0.121378726365634,0.155640975162238,4.0338454711575e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD226,CD226 antigen,37598,0.062417453012745,0.00393915978303395,0.0546966998379984,0.0701382061874915,4.99012070365562e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.101438753795513,0.00640701039301084,0.0888810134252122,0.113996494165815,6.11792595419824e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMPR,GMP reductase 1,40516,0.0757809018139164,0.00479218563391517,0.0663882179714427,0.0851735856563901,6.6375187495036e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.124904572137797,0.00789533466791068,0.109429716188692,0.140379428086902,7.35957157712203e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBXN1,UBX domain-containing protein 1,37671,0.102617608516598,0.00649469273486886,0.089888010756255,0.115347206276941,1.00222056753183e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKD2,Polycystin-2,37562,0.0884683053417259,0.00560387054303674,0.0774847190773738,0.0994518916060779,1.24313920973294e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.154001395030371,0.00975932174070209,0.134873124418595,0.173129665642147,1.37441974834625e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.114945293040191,0.00728477658022007,0.10066713094296,0.129223455137422,1.40323228698949e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.142611358345384,0.00904575741865521,0.12488167380482,0.160341042885949,1.41626237970128e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PENK,Proenkephalin-A,37671,0.0457535421866133,0.00289990092588159,0.0400697363718854,0.0514373480013412,1.42458409359951e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F12,Coagulation factor XII,38013,0.0616729683128042,0.00392548291860225,0.0539790217923438,0.0693669148332646,3.89692356141429e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3GLB2,Endophilin-B2,37942,0.0988348005139716,0.00629510795297047,0.0864963889261495,0.111173212101794,4.62389566858263e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPBP,Platelet basic protein,37934,0.123650142236964,0.00788431520917539,0.10819688442698,0.139103400046948,6.03775854215128e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0568435299811743,0.00362777983662258,0.049733081501394,0.0639539784609546,7.52857029246845e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BIN2,Bridging integrator 2,40332,0.133382322928158,0.00852280162357744,0.116677631745946,0.15008701411037,8.51796235483613e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STIP1,Stress-induced-phosphoprotein 1,40307,0.0961946951620214,0.00614917613566478,0.0841423099361185,0.108247080387924,9.43976969169199e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17RB,Interleukin-17 receptor B,40126,-0.0784532602611235,0.00502189815457664,-0.0882961806440937,-0.0686103398781532,1.32572660673055e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCB,Tubulin-folding cofactor B,40228,0.148336396199274,0.00949773650640896,0.129720832646712,0.166951959751835,1.40501426884314e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0793257729011778,0.00508331802185229,0.0693624695783473,0.0892890762240083,1.70493810384159e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD5,T-cell surface glycoprotein CD5,40470,0.0489280579274221,0.00313979720139461,0.0427740554126886,0.0550820604421555,2.37332274099496e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK10,Kallikrein-10,40354,0.0574329503897861,0.00369162963391212,0.0501973563073184,0.0646685444722539,3.54231234033482e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.117179391917245,0.00752842716080986,0.102423674682058,0.131935109152433,3.71983442310132e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DFFA,DNA fragmentation factor subunit alpha,40516,0.0990711374248001,0.00637646062789752,0.086573274594121,0.111569000255479,4.81857460071426e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0886878445361077,0.00570845636242411,0.0774992700657564,0.0998764190064589,4.92573336761846e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.107203781950253,0.0069008982532812,0.0936780213738219,0.120729542526684,6.06813602568619e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.063358677391789,0.00407893818066209,0.0553639585576913,0.0713533962258867,6.10389941794021e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMA,Granzyme A,40516,0.0512026853295106,0.00330645187457857,0.0447220396553366,0.0576833310036846,1.05913111831166e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.0837229858375177,0.00540618334716455,0.0731268664770752,0.0943191051979602,1.06270178781287e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINE2,Glia-derived nexin,37990,0.0934503607767784,0.006035754355875,0.0816202822392634,0.105280439314293,1.30527839501097e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA1,Carboxypeptidase A1,40536,0.0829215492408374,0.00537252807092011,0.072391394221834,0.0934517042598408,2.31978015001571e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0656157532893902,0.00425262325275402,-0.0739508948647881,-0.0572806117139923,2.5083285680342e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.14477513204576,0.00937603183534988,0.126398109648474,0.163152154443046,2.5595946322096e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.084402948521621,0.00547232359524579,0.0736771942749393,0.0951287027683028,2.75217907598167e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.0510922014500541,0.00331474548986364,0.0445953002899213,0.0575891026101868,3.21503270870892e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RFC4,Replication factor C subunit 4,37900,0.0297801416425542,0.00193111881653777,0.0259951487621402,0.0335651345229682,3.36258811400179e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YWHAQ,14-3-3 protein theta,37671,0.106923446238869,0.00693727449637513,0.0933263882259736,0.120520504251764,3.88379855155055e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0870995273252783,0.00565852200146261,0.0760088242024115,0.098190230448145,4.50529108215945e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.134403097115885,0.00872767101944802,0.117296861917767,0.151509332314003,4.64436607997321e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.0668183537215902,0.00434130407724212,0.0583093977301957,0.0753273097129848,5.40926271200689e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.123567682748067,0.00803480681707217,0.107819461386605,0.139315904109528,6.35075194623978e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF3,Immunoglobulin superfamily member 3,40305,0.0498034837989122,0.00324169859883354,0.0434497545451984,0.0561572130526259,6.92726069791198e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM172A,Cotranscriptional regulator FAM172A,37628,0.0892897036197404,0.00580819722165588,0.0779056370652949,0.100673770174186,7.13625967107287e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2,Complement C2,40372,0.0345018541553887,0.00225076897441189,0.0300903469655414,0.038913361345236,1.16501047127156e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1R2,Interleukin-1 receptor type 2,40330,0.0280839117727214,0.00183440154532021,0.0244884847438938,0.031679338801549,1.56551209231842e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESYT2,Extended synaptotagmin-2,37942,0.117290976100319,0.00767098516212004,0.102255845182564,0.132326107018074,2.43970922495606e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.0295640870432223,0.0019367959623454,-0.0333602071294193,-0.0257679669570253,3.08445379976114e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP7,Caspase-7,37942,0.120243491512336,0.00787492422755583,0.104808640026326,0.135678342998345,3.35135687696482e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEXN,Nexilin,37987,0.0979360901369484,0.00641942301588169,0.0853540210258202,0.110518159248076,4.05993235910374e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.0953765177238545,0.00625206049279464,0.083122479157977,0.107630556289732,4.20607915480241e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF19,Fibroblast growth factor 19,40422,0.109676422097984,0.00719846691512989,0.0955674269443295,0.123785417251639,4.73189709368924e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX8,Syntaxin-8,40341,0.0699112297618195,0.00458928887401431,0.0609162235687515,0.0789062359548876,4.93581178469297e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.111354883486251,0.00731957524283067,0.0970085160103024,0.125701250962199,6.83124746430163e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFA,Platelet-derived growth factor subunit A,40536,0.102591819130454,0.00674968876784439,0.0893624291454794,0.115821209115429,8.16373441696202e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.101769741476853,0.00669597389667312,0.0886456326393742,0.114893850314333,8.32592341180519e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN2L,Ataxin-2-like protein,37959,0.0690213853694195,0.00453941275568044,0.0601241363682858,0.0779186343705531,8.7987669171938e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.109310365561288,0.00719694587139058,0.0952043516533621,0.123416379469213,9.70976361991762e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.0780992456448771,0.0051435883254879,0.0680178125269208,0.0881806787628333,1.06056557960272e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.114901931638107,0.00756482386085235,0.100074876870836,0.129728986405377,1.14695025885515e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERP29,Endoplasmic reticulum resident protein 29,37671,0.169150873255263,0.0111415595555787,0.147313416526329,0.190988329984198,1.26783374157823e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK24,Serine/threonine-protein kinase 24,39961,0.0880672091762053,0.00581061291967898,0.0766784078536345,0.0994560104987761,1.61078208314358e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JAM3,Junctional adhesion molecule C,37671,0.0722315237015474,0.00476305548958074,0.0628959349419691,0.0815671124611256,1.6359473035219e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EHD3,EH domain-containing protein 3,37628,0.166903975964095,0.0110129389226517,0.145318615675698,0.188489336252492,1.89741730022164e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.0895112573835727,0.00592865785221195,0.0778910879932373,0.101131426773908,3.74659716440838e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4G,C-type lectin domain family 4 member G,40341,0.0467096143720614,0.0030941918529463,0.0406449983402867,0.0527742304038362,3.89873372879778e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL3,C-C motif chemokine 3,40341,0.0872383390636107,0.00578189016827745,0.0759058343337869,0.0985708437934345,4.37397678117433e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.14257841634594,0.00945103228250971,0.124054393072221,0.161102439619659,4.51937173373525e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB6,Serpin B6,40433,0.0846961977901664,0.00561565198977629,0.0736895198902049,0.0957028756901279,4.76462179786987e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPI,Glucose-6-phosphate isomerase,37987,0.0663856093022288,0.00440151239554297,0.0577586450069645,0.075012573597493,5.48216620588433e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F2R,Proteinase-activated receptor 1,40396,0.0812551161497841,0.00539861201416446,0.0706738366020218,0.0918363956975465,7.58675453555827e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.10377513173699,0.00689130986594339,0.0902681643997413,0.117282099074239,7.94328627460641e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.0910215652025415,0.0060459970750092,0.0791714109355234,0.10287171946956,8.31783878971401e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASP,Vasodilator-stimulated phosphoprotein,37987,0.101950377113124,0.00678199051057732,0.0886576757123927,0.115243078513856,1.15224534439915e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.0817811192546912,0.00544677325623505,0.0711054436724705,0.0924567948369119,1.33448791750769e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.0864805423367439,0.00576958270314305,0.0751721602385835,0.0977889244349042,1.90856434538275e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LACTB2,Endoribonuclease LACTB2,40359,0.0927927400818447,0.0061983609135475,0.0806439526912916,0.104941527472398,2.5184665009103e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPI,Mannose-6-phosphate isomerase,40305,0.12061599906613,0.00806166573848,0.10481513421871,0.136416863913551,2.87943545891514e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX4,Syntaxin-4,40305,0.08386017196702,0.00560961389793008,0.072865328727077,0.094855015206963,3.45519774017188e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANG,Angiogenin,40309,0.0483282287301135,0.00323763700172979,0.0419824602067231,0.0546739972535039,4.80915852808151e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUS,RNA-binding protein FUS,39960,0.0552335522442155,0.00370803622579432,0.0479658012416587,0.0625013032467724,7.77727841424946e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPACT,Protein IMPACT,37942,0.0797019029347866,0.00535304652839525,0.0692099317391319,0.0901938741304413,9.63252293533512e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.121357239942444,0.00815324513674761,0.105376879474418,0.137337600410469,1.03269731889641e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.128418309354849,0.00863462613079426,0.111494442138492,0.145342176571206,1.07377543727128e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.15693606778572,0.0105677684376736,0.136223241647879,0.17764889392356,1.51314074475442e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.0805383381190014,0.00542076176075916,0.0699136450679134,0.0911630311700893,1.53901878218402e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP2B1,AP-2 complex subunit beta,37572,0.0682690395495046,0.00460300832345561,0.0592471432355316,0.0772909358634776,2.30390685446355e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.0758606783272078,0.00511919506636397,0.0658270559971344,0.0858943006572812,2.36655867618462e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELOA,Elongin-A,40305,0.0709317066001387,0.00479071166791382,0.0615419117310276,0.0803215014692498,2.85474215489668e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THTPA,Thiamine-triphosphatase,37884,0.123386233912789,0.00833054375167847,0.107058368159499,0.139714099666079,3.02754849036137e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP2,Caspase-2,40341,0.0939711938203153,0.00635182534565617,0.0815216161428292,0.106420771497801,3.38478066280387e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.0532677801701799,0.00360084748148908,0.0462101191064613,0.0603254412338985,3.43370504128642e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JPT2,Jupiter microtubule associated homolog 2,37901,0.122059309307067,0.00825032002695174,0.105888682054242,0.138229936559893,3.86755557883257e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG6,Large proline-rich protein BAG6,40042,0.0499239114106578,0.00337707257435146,0.0433048491649289,0.0565429736563866,4.04400703944981e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MESD,LRP chaperone MESD,40332,0.16805779381931,0.0113754738458084,0.145761865081525,0.190353722557094,4.58336428579323e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.152739499717377,0.0103496699024638,0.132454146708548,0.173024852726206,5.7568768780498e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP5,Platelet glycoprotein V,37671,0.0498873541436736,0.00337900070816294,0.0432645127556742,0.056510195531673,6.13617980412133e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.130448331063085,0.00884518808959221,0.113111762407485,0.147784899718686,6.67820919795682e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.0657063908501689,0.00445612250376943,0.0569723907427808,0.074440390957557,7.91436080047351e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.0650533004965226,0.00442150685791393,0.0563871470550113,0.0737194539380339,1.26369645303929e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REEP4,Receptor expression-enhancing protein 4,37959,0.0860294124630865,0.00584795029245895,0.0745674298898669,0.097491395036306,1.3014435664797e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB33A,Ras-related protein Rab-33A,37562,0.0923919501631925,0.00628057366100462,0.0800820257876235,0.104701874538762,1.34120984722292e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGBP1,Immunoglobulin-binding protein 1,37959,0.0847078713390075,0.00576227989200596,0.0734138027506758,0.0960019399273391,1.51893027539837e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.0936902022865666,0.006377521364294,0.0811902604125504,0.106190144160583,1.53797496162217e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F11,Coagulation factor XI,37810,0.041847869537797,0.00284689586182207,0.0362679536486258,0.0474277854269683,1.55446490150421e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.0798107992451769,0.00544006026738471,0.0691482811211028,0.0904733173692509,2.09059316996204e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB9,Serpin B9,40228,0.0462894570440481,0.00315603759832952,0.0401036233513222,0.052475290736774,2.18546707675848e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLOD4,Glyoxalase domain-containing protein 4,40328,0.0501005250605997,0.00341709289531662,0.0434030229857791,0.0567980271354202,2.34677331811871e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB1,Leukocyte elastase inhibitor,40287,0.122584027076261,0.00836122043793464,0.106196035017909,0.138972019134613,2.3758351998097e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OCLN,Occludin,37959,0.0601894331646002,0.00410390767166951,0.052145774128128,0.0682330922010724,2.48980815781907e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.0852479401062087,0.00581319824630501,0.0738540715434509,0.0966418086689666,2.55147078063845e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.0366878416239573,0.002506453435081,0.0317751928911986,0.0416004903567161,3.3363204896026e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNM3,Dynamin-3,37959,0.0755822080370702,0.00516107067026961,0.0654665095233418,0.0856979065507986,3.40970525789239e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNLT1,Dynein light chain Tctex-type 1,37572,0.111665299530537,0.00762579445890454,0.0967187423910842,0.12661185666999,3.57582704938533e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.129629983624934,0.00887552147443655,0.112233961535038,0.147026005714829,5.32396127382724e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIAPIN1,Anamorsin,40411,0.0876091197400377,0.00599891983880899,0.0758512368559721,0.0993670026241034,5.39079810382048e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CETN2,Centrin-2,39961,0.0923476695062603,0.0063236605606325,0.0799532948074206,0.1047420442051,5.55320165437216e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.128196983627198,0.0087738218525903,0.111000292796121,0.145393674458275,5.64256285844943e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.0697069499909078,0.00477144348443463,0.060354920761416,0.0790589792203997,5.71748748566575e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.148389561322728,0.0101579944518677,0.128479892197068,0.168299230448389,5.80403973572527e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADD1,Alpha-adducin,37671,0.09648450059618,0.00660661759436485,0.0835355301112249,0.109433471081135,6.23307457039293e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA4,Protein disulfide-isomerase A4,37998,0.0829772656508251,0.00568980718293855,0.0718252435722655,0.0941292877293847,8.23617587136938e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.14038193069091,0.00963780597050548,0.12149183098872,0.159272030393101,1.08841338703427e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMSB10,Thymosin beta-10,40332,0.103793628174975,0.00713808446101167,0.0898029826313922,0.117784273718558,1.35053639138996e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.120158996903749,0.00826960818246492,0.103950564866118,0.13636742894138,1.56874570995765e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLMAP,Sarcolemmal membrane-associated protein,37901,0.113817447337523,0.00783503321831774,0.0984607822296201,0.129174112445426,1.8757853104007e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMVK,Phosphomevalonate kinase,39951,0.151306513257204,0.0104259090637433,0.130871731492267,0.171741295022141,2.06428754951258e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.0650899063786307,0.00448294321354878,0.056303337680075,0.0738764750771863,2.07518764039456e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXJ3,Forkhead box protein J3,37598,0.0597008135293025,0.00411251222241188,0.0516402895733752,0.0677613374852298,2.20231736054252e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.0430671594213247,0.00297043466007137,-0.0488892113550646,-0.0372451074875848,2.45852332403619e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPT1,Angiopoietin-1,40263,0.115595323457855,0.00797404317497753,0.0999661988348993,0.131224448080811,2.56586801563791e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL7,Interleukin-7,40341,0.0877904642482143,0.00605686980345244,0.0759189994334476,0.0996619290629811,2.63508785708995e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRGN,Neurogranin,37987,0.123557722899041,0.00852002034747912,0.106858483017982,0.1402569627801,2.6600344777755e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM24,Transcription intermediary factor 1-alpha,37687,0.087734654622162,0.00605260901859355,0.0758715409457186,0.0995977682986053,2.98241200484087e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MIF,Macrophage migration inhibitory factor,40307,0.0937978202826806,0.00647948287618798,0.0810980338453522,0.106497606720009,3.4291331275539e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TADA3,Transcriptional adapter 3,37900,0.0529681860832602,0.00366306524812904,0.0457885781969272,0.0601477939695931,4.87873334307828e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIABLO,"Diablo homolog, mitochondrial",40314,0.1485848861897,0.0102843156239345,0.128427627566788,0.168742144812612,5.15229455130126e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MICALL2,MICAL-like protein 2,37572,0.0930813902969731,0.0064429360274268,0.0804532356832165,0.10570954491073,5.99651426087637e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP170,Centrosomal protein of 170 kDa,37628,0.105080999401734,0.00727412457673509,0.0908237152313335,0.119338283572135,6.07755678154756e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D5,TBC1 domain family member 5,40341,0.10630317718522,0.00736690611567849,0.0918640411984899,0.12074231317195,6.6490452651502e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTF1,Cardiotrophin-1,40042,0.114602746188679,0.00795285099779112,0.099015158233008,0.130190334144349,8.90883576739671e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOD,Apolipoprotein D,37345,-0.060374829347633,0.00419249781373349,-0.0685921250625507,-0.0521575336327154,1.17855382958501e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYO9B,Unconventional myosin-IXb,40044,0.0898444578991942,0.00624392626218268,0.0776063624253161,0.102082553373072,1.20529699835522e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARF1,Scavenger receptor class F member 1,40536,0.0572400971641459,0.00398032531684677,0.0494386595431262,0.0650415347851656,1.32955922631046e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L1,Bcl-2-like protein 1,37942,0.135044310674722,0.00939297915766023,0.116634071525708,0.153454549823736,1.58854032033235e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.11809014764931,0.00821975919182504,0.101979419633333,0.134200875665287,1.87511944021799e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP7,Matrilysin,40015,0.0652004176429089,0.00454133344365251,0.05629940409335,0.0741014311924678,1.90391915772236e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.0712517549246197,0.00497061581992551,0.0615093479175657,0.0809941619316737,2.62677104261457e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0832632546175506,0.00580824206944849,0.0718791001614315,0.0946474090736696,2.87377932928368e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUGT1,Protein SGT1 homolog,39980,0.109735533432221,0.00765951874655223,0.0947228766889783,0.124748190175463,2.9391004513095e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIP,Gastric inhibitory polypeptide,37628,0.0697087987782218,0.00486610147513037,0.0601712398869663,0.0792463576694773,3.37520508560484e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.122982822778678,0.0085862709558708,0.106153731705171,0.139811913852185,3.48817059207787e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.124564523655949,0.00869987093731134,0.107512776618819,0.141616270693079,3.755940095658e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRB1,Chymotrypsinogen B,40332,0.0716412305075126,0.00500847196062814,0.0618246254646815,0.0814578355503438,3.9957949389969e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UROD,Uroporphyrinogen decarboxylase,37671,0.0947814149428935,0.00662439102334933,0.0817976085371288,0.107765221348658,4.31036391326733e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP6,Platelet glycoprotein VI,40311,0.11826987354874,0.00827397644135222,0.102052879723689,0.13448686737379,4.59634825013339e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.0999848431900776,0.00699409847145198,0.0862764101860317,0.113693276194123,5.03934889588307e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMTN,Smoothelin,37905,0.129606256408091,0.009067815301617,0.111833338416922,0.147379174399261,5.25378182901362e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN3,Ataxin-3,37942,0.0838752051569614,0.00586898365056603,0.072371997201852,0.0953784131120708,5.37271887125262e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPB1,Heat shock protein beta-1,40116,0.0908808334883436,0.00636718167471513,0.078401157405902,0.103360509570785,6.22893989943357e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.126837022042469,0.00888269761938586,0.109426934708473,0.144247109376465,6.39551293598111e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP3,Caspase-3,40536,0.118058849810165,0.0082743719401968,0.101841080807379,0.134276618812951,6.60089182703648e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.101193142339581,0.00709516246650348,0.0872866239052343,0.115099660773928,7.33119103506233e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM2,Paralemmin-2,37942,0.049575690525084,0.00348057317254013,0.0427537671069054,0.0563976139432627,1.05420116377653e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH1A1,Retinal dehydrogenase 1,40332,0.0707223792617985,0.00496808749298129,0.0609849277755552,0.0804598307480418,1.0564865274358e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP10,Caspase-10,39961,0.0961411152770404,0.00675731029756678,0.0828967870938095,0.109385443460271,1.19456054817661e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APP,Amyloid-beta precursor protein,40309,0.0895670956266288,0.00630090517061808,0.0772173214922174,0.10191686976104,1.40984399345064e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18,Interleukin-18,40292,0.063301072214433,0.0044537436422294,0.0545717346756633,0.0720304097532026,1.4502288402018e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMT,Catechol O-methyltransferase,39877,0.113714190375029,0.00800076814297838,0.0980326848147915,0.129395695935267,1.47734909490327e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMFG,Glia maturation factor gamma,37990,0.0958994052042464,0.00675100010380401,0.0826674450007905,0.109131365407702,1.80379268919087e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBI,Acyl-CoA-binding protein,40270,0.10523760214002,0.00742120460135827,0.0906920411213576,0.119783163158682,2.28916576621102e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM106A,Transmembrane protein 106A,37900,0.0935403945058537,0.00659617755169564,0.0806118865045303,0.106468902507177,2.54758343426955e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.132201049248814,0.00932316995096047,0.113927636144931,0.150474462352696,2.58104935827593e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CERT,Ceramide transfer protein,39961,0.0819900749518235,0.00579322112989793,0.0706353615372235,0.0933447883664234,3.43145696430805e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTD,Deoxycytidylate deaminase,37671,0.125916363050608,0.00889427508070674,0.108483583892422,0.143349142208793,3.61281303371909e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.0704879445643345,0.00500461136845017,0.0606789062821722,0.0802969828464968,9.79645754380737e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6AP2,Renin receptor,39980,0.0552343762211518,0.0039254941167801,0.0475404077522628,0.0629283446900408,1.08212087659644e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.129586994720226,0.00921851102622383,0.111518713108827,0.147655276331625,1.43036333853396e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.105475596608504,0.00750685504980853,0.0907621607108794,0.120189032506129,1.60366981515561e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53I3,Quinone oxidoreductase PIG3,37419,0.070998805618459,0.00505381586121632,0.061093326530475,0.080904284706443,1.66607488314487e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.0622732361934518,0.00443951619358346,0.0535717844540282,0.0709746879328754,1.95130988239755e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSNL1,Visinin-like protein 1,37942,0.049417150760338,0.00352900543135453,0.0425003001148831,0.0563340014057929,3.04236615228464e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.118242750376127,0.00845427285756263,0.101672375575305,0.13481312517695,3.84061946365806e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH9,Protocadherin-9,37901,0.0445479043341102,0.00318594722798288,0.0383034477672638,0.0507923609009567,4.05172517486729e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.124639989101498,0.0089281988610033,0.107140719333931,0.142139258869064,4.9794804823282e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSC22D1,TSC22 domain family protein 1,37959,0.0883194533728181,0.00633829552066971,0.0758963941523054,0.100742512593331,7.88533870332034e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL16,C-X-C motif chemokine 16,40517,0.031114149425872,0.00223448273400619,0.0267345632672198,0.0354937355845241,8.07782449538378e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD244,Natural killer cell receptor 2B4,40516,0.034869306781845,0.00250520642348611,0.0299591021918122,0.0397795113718777,8.75335503068337e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK13,Kallikrein-13,40032,0.0567697826697635,0.00408110015604088,0.0487708263639234,0.0647687389756036,9.99883806511807e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.10590209057723,0.00761789595988841,0.0909710144958482,0.120833166658611,1.11390140548838e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.11086541021602,0.00797759957287369,-0.126501505378853,-0.095229315053188,1.18554471888016e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPSE,Heparanase,37848,0.121505447389834,0.00875071006587263,0.104354055660724,0.138656839118945,1.55914853146467e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP3R1,Calcineurin subunit B type 1,40228,0.0539531479567118,0.00388808971276976,0.0463324921196831,0.0615738037937405,1.58415746451433e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SULT2A1,Bile salt sulfotransferase,40341,0.069386342379291,0.00500954149641343,0.0595676410463207,0.0792050437122613,2.24676635421616e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.0761509237477651,0.00550373400816554,0.0653636050917606,0.0869382424037695,2.74742781908727e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.0522109194409502,0.00377332945616586,0.0448151937068651,0.0596066451750353,3.00879852031945e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTX3,Pentraxin-related protein PTX3,40341,-0.063906979625072,0.00462496658923721,-0.072971914139977,-0.0548420451101671,3.53631757982219e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NACC1,Nucleus accumbens-associated protein 1,37900,0.0715593617603796,0.00517596341376531,0.0614144734693995,0.0817042500513596,3.53878253482294e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARK7,Parkinson disease protein 7,40332,0.0695845425845706,0.00503698072936916,0.0597120603550071,0.0794570248141342,3.69081083517298e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0584886806102276,0.00423682063582002,0.0501845121640204,0.0667928490564348,4.24240363403075e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.153894046233295,0.0111716286268426,0.131997654124683,0.175790438341906,6.30376527336918e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.0869953542884311,0.00632341445064171,0.0746014619651734,0.0993892466116889,9.07763649801616e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOC1,Apolipoprotein C-I,37981,0.0469031067152127,0.00341131979495015,0.0402169199171104,0.0535892935133149,9.96779174675682e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STXBP1,Syntaxin-binding protein 1,37959,0.0999818244603474,0.00728639211190214,0.0857004959210192,0.114263152999676,1.45181238411328e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.0746994092106925,0.0054463647794601,0.0640245342429507,0.0853742841784343,1.45242479931898e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.0849793753736041,0.00620628601983396,0.0728150547747296,0.0971436959724787,1.95219759910365e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.0738035187000016,0.00539184798245711,0.0632354966543856,0.0843715407456175,2.07504880810982e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.0787546870994082,0.00576338224019853,0.0674584579086191,0.0900509162901973,3.2101528424072e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0786264336029375,0.00575638716860635,0.0673439147524691,0.089908952453406,3.44954214410819e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POSTN,Periostin,37998,-0.0487519494122007,0.00357001444942796,-0.0557491777330795,-0.0417547210913219,3.53814592980064e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD22,B-cell receptor CD22,40516,0.0525529651068188,0.00385611509172903,0.0449949795270299,0.0601109506866077,4.64671695215137e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.0391490458187164,0.00287783819272509,-0.0447896086764576,-0.0335084829609753,6.53232210152661e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.0413259170933388,0.00303894466222762,0.0353695855553727,0.0472822486313049,6.99420727669907e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALB2,Calretinin,39961,0.0403724699672333,0.0029687235127562,0.0345537718822311,0.0461911680522354,7.03063139495983e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS3BP,Galectin-3-binding protein,38013,0.0379457195367788,0.00278999358374662,0.0324773321126355,0.0434141069609222,7.46625621712724e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FMNL1,Formin-like protein 1,39961,0.0767544998665675,0.00564601414402888,0.0656883121442709,0.0878206875888641,7.50277790240419e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0523707231860349,0.00385752805132758,0.0448099682054329,0.059931478166637,9.52120740253375e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCT5,T-complex protein 1 subunit epsilon,39980,0.0580464210352811,0.00428089935286231,0.049655858303671,0.0664369837668913,1.20315920912509e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.0443682191506117,0.00327244381479774,0.0379542292736081,0.0507822090276152,1.20375097241484e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAP3,Cytosol aminopeptidase,40044,0.0627687148342379,0.00462956043688363,0.053694776377946,0.0718426532905298,1.21929222738097e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.0465454489817605,0.00343319152324433,0.0398163935962016,0.0532745043673194,1.35679707602807e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.137428444838176,0.0101597819984505,0.117515272121213,0.157341617555139,2.09663839042205e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGCT,Gamma-glutamylcyclotransferase,37978,0.0615942015552505,0.00455546175811406,0.0526654965093469,0.070522906601154,2.18439813227836e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MZT1,Mitotic-spindle organizing protein 1,39980,0.0671033113469116,0.00496651317961763,0.057368945514861,0.0768376771789621,2.30219167351932e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UMOD,Uromodulin,40502,-0.0688744901180807,0.00510090849813244,-0.0788722707744203,-0.0588767094617411,2.54477228264692e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC37,Hsp90 co-chaperone Cdc37,40411,0.106308224146529,0.00787542921319668,0.090872382888663,0.121744065404394,2.68131385197802e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCG2,Secretogranin-2,40392,0.0409494343498803,0.00303707523417574,0.0349967668908959,0.0469021018088648,3.3046840127728e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.159278033630155,0.0118318843389452,0.136087540325822,0.182468526934487,4.82812960031196e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFB,Complement factor B,37770,0.0415751495400486,0.0030899987434521,0.0355187520028825,0.0476315470772148,5.34793560097787e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCA,Calcitonin,40192,0.0695595821705168,0.00518067808165586,0.0594054531304713,0.0797137112105623,7.07710888152095e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BDNF,Brain-derived neurotrophic factor,37998,0.104682279926115,0.00779327264208746,0.089407465547624,0.119957094304607,7.13233674018335e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP25,Rho GTPase-activating protein 25,39980,0.0749900324295371,0.00559095949163608,0.0640317518259304,0.0859483130331438,8.59054315517769e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.036366849222723,0.00271155042993555,0.0310522103800494,0.0416814880653967,9.51783953597406e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYBB1,Beta-crystallin B1,37990,0.0818365922694604,0.00610609380375862,0.0698686484140935,0.0938045361248273,1.06299243014683e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.139362000545452,0.010407001794021,0.118964277029171,0.159759724061733,1.14242937511685e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPA,Inosine triphosphate pyrophosphatase,37562,0.085699868459664,0.00640755979009787,0.0731410512710721,0.0982586856482558,1.56438627554623e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCN1,Ficolin-1,37967,0.0708430283830626,0.00531464618526741,0.0604263218599384,0.0812597349061867,2.79011138212774e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.0441147188989014,0.00331040049012553,0.0376263339382554,0.0506031038595475,2.93761016931839e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.111115479346852,0.00834385160079814,0.0947615302092878,0.127469428484417,3.29816259640156e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G4A,Cytosolic phospholipase A2,40422,0.108978296816357,0.00819223430921086,0.0929215175703035,0.12503507606241,3.65521629641044e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL8,C-C motif chemokine 8,40470,0.0755995063521905,0.00568357334919822,0.064459702587762,0.086739310116619,3.70975361241281e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.0530044207303712,0.00398275743459796,0.0451982161585592,0.0608106253021832,3.73809448566164e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1RL,Complement C1r subcomponent-like protein,37993,0.0243111762516652,0.00182737356077254,0.020729524072551,0.0278928284307794,3.92393617907443e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LARP1,La-related protein 1,37900,0.0795499258316131,0.00598203153143573,0.0678251440299991,0.0912747076332272,4.24993233813858e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RILP,Rab-interacting lysosomal protein,40434,0.0753412029438651,0.00567155791400666,0.064224949432412,0.0864574564553182,4.67220636790314e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.0681629477811737,0.0051375529538682,0.0580933439915921,0.0782325515707554,6.42162240834907e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.0529914472918029,0.00399697360626626,0.0451573790235211,0.0608255155600848,6.67402883854266e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.0812181019772434,0.00612636744491079,0.0692104217852183,0.0932257821692686,7.29584927223976e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA2,Integrin alpha-2,37671,0.0423113889441687,0.0031920162963205,0.0360550370033805,0.0485677408849569,7.54111615566991e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSAP,Prosaposin,37901,0.0354795101395334,0.00268108085955468,0.0302245916548062,0.0407344286242605,9.98341788430719e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPC3,PDZ domain-containing protein GIPC3,37901,0.121988491774684,0.00922094282203112,0.103915443843503,0.140061539705865,1.04920296114089e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.12165901879296,0.00919554172990996,0.103635757002337,0.139682280583584,1.05166552849598e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPON2,Spondin-2,40267,-0.0428926805493149,0.00324887293832284,-0.0492604715084277,-0.0365248895902021,1.37780139164953e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0397934640351824,0.00301593974980625,0.0338822221255621,0.0457047059448026,1.51912252464373e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0759649676242851,0.00575765057988681,0.064679972487707,0.0872499627608633,1.53281906961364e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA3,Annexin A3,40442,0.086839019355264,0.00658849408001524,0.0739255709584342,0.0997524677520939,1.82747466068639e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDCP1,CUB domain-containing protein 1,40228,0.0601859764291059,0.00457199611257597,0.051224864048457,0.0691470888097547,2.27878503379102e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DXO,Decapping and exoribonuclease protein,37942,0.0568378483365705,0.00431914160660792,0.048372330787619,0.0653033658855221,2.61970294523861e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.0873263212664004,0.00664293373753063,0.0743061711408403,0.10034647139196,3.14428773248117e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSS,Cathepsin S,37057,0.0305779318818112,0.00232834960717414,0.0260143666517499,0.0351414971118725,3.85501573306224e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.0441756786696095,0.00336617655340243,0.0375779726249408,0.0507733847142783,4.26211336743161e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP5,Microfibrillar-associated protein 5,40536,0.0505735141108853,0.00385950456360772,0.0430088851662142,0.0581381430555565,4.9737578145304e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3C,Protein FAM3C,40330,0.0365408953355955,0.00279168154480967,0.0310691995077685,0.0420125911634224,6.03783084843731e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGL1,Fibrinogen-like protein 1,37987,-0.077435113132418,0.00591695393510858,-0.0890323428452308,-0.0658378834196052,6.72984298720459e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARB2,Lysosome membrane protein 2,40011,0.0380279755916958,0.00290753184533249,0.0323292131748441,0.0437267380085475,6.94971789534299e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.083604586906476,0.00639386656424463,0.0710726084405566,0.0961365653723955,7.26876967221421e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS3,Galectin-3,40374,0.0364055821145023,0.00278447876496715,0.0309480037351667,0.0418631604938379,7.30535971389531e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FADD,FAS-associated death domain protein,40359,0.0937547362196532,0.00718070224492548,0.0796805598195993,0.107828912619707,9.23365872807061e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.049970175331833,0.00383546422629731,0.0424526654482903,0.0574876852153758,1.44119130107303e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.0804424751521194,0.00617966745218257,0.0683303269458415,0.0925546233583972,1.55252977978816e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBN1,Drebrin,37598,0.0634682548822329,0.00488009596177391,0.0539032667971561,0.0730332429673098,1.96424405556504e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRMD4B,FERM domain-containing protein 4B,37562,0.0863787265530367,0.00664729459444611,0.0733500291479223,0.0994074239581511,2.26631190258677e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0852415978583279,0.00656323411152054,0.0723776589997476,0.0981055367169081,2.47493414930624e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD84,SLAM family member 5,40341,0.0376008985789664,0.00290003676155735,0.031916826526314,0.0432849706316188,2.99474681282804e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.0903893046925295,0.00697831727820308,0.0767118028272515,0.104066806557808,3.812960534851e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.0698917577147135,0.00539818868450054,0.0593113078930925,0.0804722075363346,3.84532557996067e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.0781102358171738,0.00603343490729669,0.0662847033988723,0.0899357682354753,3.88945615803175e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASSF2,Ras association domain-containing protein 2,39980,0.0670540741430838,0.0051810140779947,0.0568992865502141,0.0772088617359534,4.0908369205409e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNMA1,Paraneoplastic antigen Ma1,37628,0.0682381743152022,0.00527192677726385,0.057905197831765,0.0785711507986393,4.3528759481483e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RP2,Protein XRP2,40305,0.0502639913444014,0.00388740852056536,0.0426446706440933,0.0578833120447095,4.75002004810784e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.149073344674247,0.0115359195291157,0.126462942397181,0.171683746951314,5.22011439607043e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH7,Protocadherin-7,37901,0.0425154134038888,0.00328992113596596,0.0360671679773956,0.0489636588303821,5.62286452381821e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCA,Tubulin-specific chaperone A,37671,0.106065485771403,0.00821530804375993,0.0899634820056333,0.122167489537172,6.63627126852946e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEMIP2,Cell surface hyaluronidase,37598,0.0411436793588957,0.00318709528174711,0.0348969726066713,0.04739038611112,6.76338590023939e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3B,Protein FAM3B,40305,0.043843299334785,0.00339820415798868,0.0371828191851271,0.0505037794844428,6.81234133827055e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.0444336485049842,0.00344329594466934,0.0376847884534323,0.0511825085565361,7.19635198854125e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD274,Programmed cell death 1 ligand 1,40228,0.0421772225744182,0.00327332502008761,0.0357615055350465,0.0485929396137899,8.46655619066061e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1R,Complement C1r subcomponent,38013,0.0241724285627374,0.00187733861501976,0.0204928448772987,0.0278520122481761,1.02306343006498e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGH,Gamma-glutamyl hydrolase,40077,0.0414714122919139,0.00322486100000267,0.0351506847319087,0.0477921398519191,1.17463932111804e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL4,C-C motif chemokine 4,40376,0.0818338478111982,0.00637091583098784,0.069346852782462,0.0943208428399343,1.41150163190318e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOM,Apolipoprotein M,40372,0.0323062559833312,0.00251627769649157,0.0273743516982077,0.0372381602684547,1.52429118622375e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10RB,Interleukin-10 receptor subunit beta,40422,0.0343682481462849,0.00268141467602105,0.0291126753812837,0.0396238209112862,2.00847866606506e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXO3,Forkhead box protein O3,39980,0.117060569773227,0.00913687722076169,0.0991522904205337,0.134968849125919,2.17569897474982e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0799857769706411,0.0062449504842453,0.0677456740215203,0.0922258799197618,2.2798873215019e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFT20,Intraflagellar transport protein 20 homolog,37572,0.0521079476165868,0.0040678962020443,0.04413487106058,0.0600810241725937,2.42607924350211e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C19orf12,Protein C19orf12,39961,0.0750027915976541,0.00585900805372773,0.0635191358123477,0.0864864473829605,2.49187683671785e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT16,U8 snoRNA-decapping enzyme,37880,0.105615090318543,0.00825381638864718,0.0894376101967941,0.121792570440291,2.85254472243076e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.0571104193626615,0.00446340480033503,0.0483621459540048,0.0658586927713181,2.90373057295676e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.0646863618500269,0.00506462271275456,0.054759701333028,0.0746130223670259,3.57488432794757e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.0852803141714656,0.0066791187630927,0.0721892413958039,0.0983713869471273,4.04011178195051e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MENT,Protein MENT,37671,-0.0260625999915574,0.00204518191053452,-0.0300711565362051,-0.0220540434469098,5.59720136401864e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA6,Integrin alpha-6,40341,0.0637286605068936,0.00500531909217814,0.0539182350862245,0.0735390859275628,5.93638486605809e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFAT5,Nuclear factor of activated T-cells 5,37598,0.10523129716325,0.00826374330366589,0.0890343602880645,0.121428234038435,6.31544100360146e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATG4A,Cysteine protease ATG4A,39980,0.0711266409156734,0.00561008152044714,0.060130881135597,0.0821224006957498,1.18423132492852e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL18,C-C motif chemokine 18,40172,0.0838841511078016,0.00661711399059448,0.0709146076862364,0.0968536945293667,1.20096198787035e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.0827480256100224,0.00652995510639802,0.0699493136014823,0.0955467376185625,1.26454688855028e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIF1,Allograft inflammatory factor 1,39980,0.0629829868975564,0.00497222610086267,0.0532374237398656,0.0727285500552472,1.36750240880006e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.0911915685282106,0.00719724120644194,0.0770849757635844,0.105298161292837,1.39478967192871e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL11,C-X-C motif chemokine 11,40471,0.094762827530975,0.00748754977474143,0.0800872299724818,0.109438425089468,1.54939075314628e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP25,Synaptosomal-associated protein 25,37541,0.0558694352257659,0.00441763783363951,0.0472108650718324,0.0645280053796993,1.90096045108957e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.0582331382656553,0.00460944135287959,0.0491986332140113,0.0672676433172993,2.24636058159751e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD40LG,CD40 ligand,40516,0.0909657270944512,0.00720797141311795,0.07683810312474,0.105093351064162,2.43200972427761e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.142148668889123,0.0112740445684087,0.120051541535042,0.164245796243204,2.82521841175604e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTC,Probetacellulin,39980,0.0895145268990468,0.00710358644294298,0.0755914974708786,0.103437556327215,3.12362898631791e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREML2,Trem-like transcript 2 protein,40332,0.0397973297974633,0.00315898203660367,0.0336057250057201,0.0459889345892065,3.22111235607348e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.0355106028067349,0.00281796357762476,0.0299873941945904,0.0410338114188794,3.3070898740175e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB10,Ras-related protein Rab-10,37990,0.0637620297661505,0.00506037561925805,0.0538436935524047,0.0736803659798963,3.35955901785872e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA13,Carbonic anhydrase 13,40173,0.12277012202137,0.00974836698511362,0.103663322730547,0.141876921312193,3.41048211219422e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.0487209331815968,0.00387757358545066,0.0411208889541135,0.0563209774090801,5.25203555715069e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.046567563959316,0.00370662637547219,0.0393025762633905,0.0538325516552415,5.33867927489618e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBKS,Ribokinase,39991,0.0587737899304464,0.00468187556939622,0.0495973138144298,0.067950266046463,5.68657270316883e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.0671289532791369,0.0053470567857031,0.0566487219791589,0.077609184579115,6.04609897732317e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.0425419648811718,0.00339090125604564,0.0358957984193223,0.0491881313430212,6.2515696507604e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.0658838550068465,0.00525163958743356,0.0555906414154767,0.0761770685982163,6.72835924279496e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BGLAP,Osteocalcin,37998,0.107803118083322,0.00860889032492319,0.0909296930464727,0.124676543120172,8.89539906568394e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0797996710743569,0.00637978582398746,0.0672952908593414,0.0923040512893723,1.07619033478778e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.0456225963546845,0.00364986422979599,0.0384688624642844,0.0527763302450847,1.17914409904283e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.0487349050041898,0.00390444130857854,0.0410822000393759,0.0563876099690038,1.48632513615213e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOL1,Apolipoprotein L1,37987,0.0765003680933554,0.00613548024471103,0.0644748268137218,0.088525909372989,1.73646832310248e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMMT,MICOS complex subunit MIC60,37900,0.0521991283522931,0.00419223329696129,0.0439823510902489,0.0604159056143372,2.15353229464354e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.0349188399586726,0.00281060830189043,0.0294100476869674,0.0404276322303779,2.83647236907327e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.0442619718427454,0.00356424747925502,0.0372760467834055,0.0512478969020852,3.051256398514e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MIA,Melanoma-derived growth regulatory protein,40411,0.0431501138012854,0.00348540164074038,0.0363187265854343,0.0499815010171365,4.84236028261584e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTF2,Transcription termination factor 2,37572,0.0568580125929238,0.00459081032296263,0.0478600243599171,0.0658560008259306,4.93377761118228e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.0361038326077017,0.00291796535917277,0.0303846205037231,0.0418230447116804,5.30469902497105e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTRK3,NT-3 growth factor receptor,40471,-0.0254369006130357,0.0020568700031133,-0.0294683658191378,-0.0214054354069336,5.70775155041114e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0577481732517397,0.00466866314654563,0.0485975934845103,0.0668987530189692,5.92204796355196e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPXM1,Probable carboxypeptidase X1,40411,0.0799628734203806,0.00647593623106073,0.0672700384075016,0.0926557084332596,7.23249591130554e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDT,D-dopachrome decarboxylase,37998,0.047654744947681,0.00385999521951987,0.040089154317422,0.05522033557794,7.89803662858346e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.120106145153927,0.00972970627297221,0.101035920858902,0.139176369448953,8.07294588122579e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.0638706033714418,0.00517666735054831,0.0537243353643671,0.0740168713785165,8.16600144924531e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFL7,Epidermal growth factor-like protein 7,39980,0.0469364531313831,0.00380553965538395,0.0394775954068305,0.0543953108559356,8.67623739525113e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRG1,Scrapie-responsive protein 1,37990,0.0319534369437203,0.00258993060366475,0.0268771729605374,0.0370297009269032,8.74142574548458e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.0772908256592155,0.00627261634281037,0.0649964976273072,0.0895851536911239,1.00314104870407e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.0363365152403887,0.00294931486894233,0.0305558580972617,0.0421171723835156,1.08438310667497e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.0533193959262726,0.00432938603964386,0.0448337992885706,0.0618049925639745,1.14490898814624e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSR1,Macrophage scavenger receptor types I and II,40471,0.0517977208492617,0.00421362666692814,0.0435390125820825,0.0600564291164408,1.41570638363198e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF2,Fibroblast growth factor 2,40341,0.0765463644278231,0.00623720485802034,0.0643214429061032,0.0887712859495429,1.82201149990352e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.0888011477893957,0.00726482288392159,0.0745620949369094,0.103040200641882,3.53714181740303e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD164,Sialomucin core protein 24,40332,0.0305343838756345,0.00250144444716373,0.0256315527591936,0.0354372149920754,4.07045500938431e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNRD2,Protein ZNRD2,37901,0.0783729269442991,0.00642084224513522,0.0657880761438341,0.0909577777447642,4.37189271613895e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.100970992458695,0.00827974058278573,0.0847427009164351,0.117199284000955,4.72685555986703e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LONP1,"Lon protease homolog, mitochondrial",37628,0.0997249858156006,0.00817794120098859,0.0836962210616629,0.115753750569538,5.07836804800128e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERMAP,Erythroid membrane-associated protein,37598,0.0516693694670826,0.00423808464186553,0.0433627235690261,0.059976015365139,5.25308418155028e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APLP1,Amyloid-like protein 1,40359,-0.0596781933854719,0.00489833369763834,-0.0692789274328431,-0.0500774593381008,5.40303842301649e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF6,SLAM family member 6,39980,0.0436459974683168,0.00358445655989472,0.0366204626109231,0.0506715323257104,5.92557131399593e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.0605200838945551,0.00497870206894395,0.0507618278394249,0.0702783399496852,8.10693982198321e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.0440026469101314,0.00363159410728924,0.0368847224598445,0.0511205713604183,1.21459221947524e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL2,C-C motif chemokine 2,40203,0.0603793117386166,0.00498555852099971,0.0506076170374571,0.070151006439776,1.3052945645864e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKN3,Serine/threonine-protein kinase N3,37714,0.0882013585719954,0.00728682219510879,0.0739191870695822,0.102483530074409,1.50719301215044e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARD3,Partitioning defective 3 homolog,37714,0.0845698214944698,0.00700999369148541,0.0708302338591584,0.0983094091297813,2.44041944711501e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12A_IL12B,Interleukin-12,40305,0.0889913981376443,0.00738197724572142,0.0745227227360304,0.103460073539258,2.54623697747547e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPLAH,5-oxoprolinase,37628,0.0774574145431457,0.00642431242236311,0.0648657621953141,0.0900490668909774,2.66970900216843e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL1,Growth-regulated alpha protein,40329,0.110376022418596,0.00916283360925264,0.0924168685444608,0.128335176292731,2.84149118996963e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACRBP,Acrosin-binding protein,37900,0.0429669311109496,0.00357285591270262,0.0359641335220525,0.0499697286998467,3.84008976606904e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPP1,Tripeptidyl-peptidase 1,40255,0.050592631275449,0.00421152785260451,0.0423380366843441,0.0588472258665538,4.23726977530263e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABHD14B,Protein ABHD14B,40171,0.0662536457901524,0.00551545142236613,0.0554433610023148,0.07706393057799,4.27138733253677e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.0675293647941537,0.00562588293798616,0.0565026342357008,0.0785560953526065,5.01981231208654e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWC2,Brorin,40167,0.0439054070076153,0.00366599251756752,0.0367200616731829,0.0510907523420476,6.56950147240416e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.100193626563757,0.00836937189799847,0.0837896576436803,0.116597595483834,6.94814481495678e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0759132936444953,0.00634526070044972,0.0634765826716139,0.0883500046173767,8.11368843234404e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPB6,Heat shock protein beta-6,40489,0.0411008930303127,0.00343885674430456,0.0343607338114757,0.0478410522491496,8.74391464228867e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLNK,B-cell linker protein,37598,0.0432346811489508,0.00361993224715549,0.0361396139445261,0.0503297483533756,1.03640446571521e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.134097379236416,0.0112391040208171,0.112068735355614,0.156126023117217,1.12079412912037e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CORO1A,Coronin-1A,39990,0.101196931250523,0.00848444994555127,0.0845674093572427,0.117826453143804,1.18370084087837e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.0303687409077376,0.00254610976124588,0.0253783657756956,0.0353591160397795,1.23886832168654e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDZD2,PDZ domain-containing protein 2,37562,0.0691982387245221,0.00580320963786549,0.0578239478343058,0.0805725296147385,1.30619486258191e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AK2,"Adenylate kinase 2, mitochondrial",37942,0.118488433764977,0.00995830204510683,0.0989701617565674,0.138006705773386,1.7524242423474e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGS10,Regulator of G-protein signaling 10,37959,0.0672670820728413,0.00565573487416927,0.0561818417194695,0.078352322426213,1.85529969621947e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIPF,Gastric triacylglycerol lipase,37628,0.0670408444708991,0.00564053997853779,0.055985386112965,0.0780963028288331,2.06047208079589e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB2B,Ras-related protein Rab-2B,37900,0.0688436343214186,0.00579382997047829,0.0574877275792812,0.0801995410635561,2.12634975817975e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.0426635630257469,0.00359497129697758,0.0356174192836708,0.0497097067678229,2.38172382298007e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARSA,Arylsulfatase A,40332,0.0498225549290958,0.00420108239969883,0.0415884334256861,0.0580566764325055,2.63122670890568e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNMT,Histamine N-methyltransferase,40147,0.0518373640301903,0.00437316092291977,0.0432659686212675,0.060408759439113,2.83302746212048e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSL,Cathepsin L1,40359,0.0270504187337807,0.00228242904545477,0.0225768578046894,0.0315239796628721,2.88633586960204e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN9,Septin-9,40305,0.0314244174995693,0.00265186974203889,0.0262267528051731,0.0366220821939656,2.94747594354803e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.0329871021635568,0.00278446653770721,0.0275295477496507,0.0384446565774629,3.06109759746549e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.0688176345484736,0.00580948843599027,0.0574310372139327,0.0802042318830145,3.11705755245962e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSTB,Cystatin-B,40097,0.0467549216849813,0.00394744581077859,0.0390179278958553,0.0544919154741073,3.16090644124784e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT2,Kunitz-type protease inhibitor 2,40422,0.0467742989252315,0.00395286814745611,0.0390266773562175,0.0545219204942454,3.59134279516287e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4A,C-type lectin domain family 4 member A,40341,-0.0383542131869999,0.0032424395427428,-0.0447093946907758,-0.031999031683224,3.77940443370392e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD72,B-cell differentiation antigen CD72,37671,0.0472773018772147,0.00399923098012641,0.0394388091561669,0.0551157945982625,4.37932055656088e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA2,Carboxypeptidase A2,40398,0.0713570307876083,0.00604343460682307,0.0595118989582351,0.0832021626169815,4.862401978191e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TST,Thiosulfate sulfurtransferase,39923,0.0844957798446102,0.00715582869286939,0.0704703556065863,0.0985212040826342,4.87352372591025e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNA4,Ephrin-A4,40203,0.0327741962103413,0.00277670855074476,0.0273318474508816,0.0382165449698011,5.1230341010615e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRD1,Natural killer cells antigen CD94,40516,0.0507311813813725,0.00429828416311976,0.0423065444216578,0.0591558183410873,5.12813651774531e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.0856805259450147,0.00726416214739408,0.0714427681361223,0.0999182837539071,5.95399061636312e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.0679504506726781,0.00576339687355394,0.0566541928005124,0.0792467085448439,5.97243114653241e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSNAX,Translin-associated protein X,37562,0.0439809131697852,0.00372896714457269,0.0366721375664228,0.0512896887731477,6.04990444915506e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLMH,Bleomycin hydrolase,40536,0.0357942386138512,0.00304319147152283,0.0298295833296665,0.041758893898036,8.26346405187249e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.0957797518272076,0.0081424708236318,0.0798205090128893,0.111738994641526,8.6578712347502e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.0413391408851586,0.00351782560158779,0.0344442027060465,0.0482340790642707,9.37727454976404e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG3,BAG family molecular chaperone regulator 3,40203,0.0438538990449337,0.00373995004260991,0.0365235969614183,0.0511842011284491,1.27238210209763e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPING1,Plasma protease C1 inhibitor,37981,0.0205832855665212,0.00175601548080891,0.0171414952241358,0.0240250759089067,1.40425456750916e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDF2,Growth/differentiation factor 2,40359,0.039360923482395,0.00336501530255522,0.0327654934893867,0.0459563534754032,1.77455057021424e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0480548116539465,0.00410867384357735,0.0400018109205349,0.0561078123873581,1.89831819917212e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRN1,Secernin-1,40341,0.0618801164960636,0.00530035229451853,0.0514914259988073,0.07226880699332,2.30502852360255e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.0585649225724766,0.00501511167233768,0.0487353036946948,0.0683945414502585,2.36694355928721e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.0400424475898353,0.00343054852622749,-0.0467663227012412,-0.0333185724784295,2.51769848443435e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0843795399617512,0.00724349251505354,0.0701822946322462,0.0985767852912561,3.13059191169559e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAM2,Neural cell adhesion molecule 2,40332,-0.0296732853292726,0.00254753439122188,-0.0346664527360674,-0.0246801179224777,3.15258277441799e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDHB,Succinate dehydrogenase,37901,0.0782693113109674,0.00671826411438276,0.0651015136467772,0.0914371089751576,3.23177789603961e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEPR,Leptin receptor,40359,-0.0336284947798944,0.00288836570772369,-0.0392896915670328,-0.027967297992756,3.34372849044886e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.0500140055538126,0.0042997954950237,0.0415864063835661,0.058441604724059,4.00651513829195e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.0956956921557663,0.00824147953077919,0.079542392275439,0.111848992036093,5.0661853870728e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WDR46,WD repeat-containing protein 46,37900,0.039000425075677,0.00335935600910069,0.0324160872978397,0.0455847628535143,5.18353930508503e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPC2,NPC intracellular cholesterol transporter 2,37815,0.033955319834607,0.00292573699248771,0.0282208753293311,0.0396897643398829,5.42594129886002e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DMD,Dystrophin,37628,0.0569487852352654,0.004910211020775,0.0473247716345464,0.0665727988359844,5.96013468842729e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREH,Trehalase,37998,0.0814738683436061,0.00702754239862458,0.0676998852423019,0.0952478514449103,6.22161602157014e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.0446382330329058,0.00385567255678421,0.0370811148216087,0.0521953512442028,7.58751875544404e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAL,Integrin alpha-L,37598,0.047657860072952,0.00411952348619125,0.0395835940400171,0.0557321261058869,8.36251608800644e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POMC,Pro-opiomelanocortin,37628,0.0741560921252492,0.00643993700299734,0.0615338155993744,0.086778368651124,1.55125241628052e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX9,Sorting nexin-9,40359,0.0743631344195315,0.0064676359171895,0.0616865680218401,0.0870397008172229,1.7870328904929e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARFIP1,Arfaptin-1,37959,0.0744688511402625,0.00648651730084542,0.0617552772306054,0.0871824250499195,2.2849156923509e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NID1,Nidogen-1,40355,0.0427599331012429,0.0037259583269502,0.0354570547804205,0.0500628114220653,2.28751123210917e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ING1,Inhibitor of growth protein 1,39925,0.0483575232083702,0.00421474931249926,0.0400966145558716,0.0566184318608687,2.38070332670134e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.0407694237418123,0.00355291919170855,0.0338057021260635,0.047733145357561,2.4386661743723e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.0401545967480744,0.00349912830557465,0.0332963052691481,0.0470128882270008,2.44213151911304e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.0800227062410301,0.00699063086621834,0.0663210697432421,0.0937243427388181,3.20083801918714e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESAM,Endothelial cell-selective adhesion molecule,40536,0.0337130605734066,0.00294983311574342,0.0279313876665495,0.0394947334802637,3.92408130484965e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDK,Midkine,40352,0.0546099680687745,0.0047786658845426,0.045243782935071,0.063976153202478,3.97838791264022e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.0520975366356344,0.00455977940335623,0.0431603690050562,0.0610347042662126,4.08159811493728e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFRP1,Secreted frizzled-related protein 1,40178,0.0469546692074121,0.00411046078487569,0.0388981660690558,0.0550111723457685,4.20811283290671e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.0464040917103899,0.00406435762490656,0.0384379507655731,0.0543702326552068,4.49188761627315e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC134,Coiled-coil domain-containing protein 134,37900,0.0528927180035317,0.00463893340636475,0.0438004085270568,0.0619850274800066,5.61581546116644e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACYP1,Acylphosphatase-1,37622,0.0711786933460707,0.00624602221142821,0.0589364898116714,0.08342089688047,6.05731749558498e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NBN,Nibrin,40044,0.054730475299232,0.00480835423945511,0.0453061009899,0.064154849608564,6.71741125158939e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGXT,Serine--pyruvate aminotransferase,40359,0.0823162617863188,0.00723713092007648,0.0681314851829689,0.0965010383896687,7.33584298675988e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0482152357051322,0.00423864823276713,0.0399074851689086,0.0565229862413558,7.66755258300698e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.0533529775962883,0.0046931863815474,0.0441543322884554,0.0625516229041212,7.90235017821521e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN2,Dynactin subunit 2,40305,0.100559162822918,0.00886058380236211,0.0831924185702886,0.117925907075548,9.76533982062221e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1F,Protein phosphatase 1F,37990,0.0559257836081853,0.00493913336865493,0.0462450822056216,0.0656064850107489,1.37152043840627e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C7,Complement component C7,37678,-0.0336637388151221,0.00297441704358749,-0.0394935962205536,-0.0278338814096906,1.46557169168677e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOLA2_BOLA2B,BolA-like protein 2,37628,0.0598792889398583,0.00529222206462747,0.0495065336931885,0.0702520441865281,1.52089674459969e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.124582917900511,0.0110221995318591,-0.146186428982955,-0.102979406818067,1.64845038862963e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFP,Alpha-fetoprotein,40182,0.0740724340983559,0.00655849395089915,0.0612177859545935,0.0869270822421182,1.82180936812544e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPA1,Inositol monophosphatase 1,40228,0.0648596860088769,0.00574636005828318,0.0535968202946419,0.0761225517231119,1.97080110444559e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.0679895303712269,0.00603051368838193,0.0561697235419983,0.0798093372004555,2.27300361035043e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.0297977471100061,0.00264669104576937,0.0246102326602981,0.0349852615597141,2.86542361196104e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNAS,Neuroendocrine secretory protein 55,37959,0.0959195337454063,0.00852404065067551,0.0792124140700823,0.11262665342073,3.02636248077273e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WAS,Wiskott-Aldrich syndrome protein,40044,0.072421092095718,0.00644355399322782,0.0597917262689915,0.0850504579224445,3.38538170722169e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPPK1,Epiplakin,37628,0.0780933316502446,0.00694628000143237,0.0644786228474371,0.091708040453052,3.42504571395011e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX6,Peroxiredoxin-6,40489,-0.0633726080970121,0.00564123868265893,-0.0744294359150236,-0.0523157802790006,3.57549309570938e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.0674559955394071,0.00600274717797947,-0.0792213800082469,-0.0556906110705673,3.62054824575847e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD83,CD83 antigen,40341,0.0356063920619518,0.00317063565769564,0.0293919461728684,0.0418208379510353,3.73848548218808e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN4,CCN family member 4,40489,0.04333561656655,0.00386034639133618,0.0357693376395311,0.0509018954935689,3.91044317576956e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.0472291628114874,0.00421092744455346,0.0389757450201626,0.0554825806028122,4.61543885959449e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GET3,ATPase GET3,37990,0.0594075053449123,0.00530436028887105,0.049010959178725,0.0698040515110995,5.48289829324583e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.0478552290264135,0.00427265828328327,0.0394808187911783,0.0562296392616487,5.49055171419301e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP1,Interstitial collagenase,39757,0.0978452300327227,0.00876753200458594,0.0806608673037343,0.115029592761711,8.27100026802194e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.0708725539504364,0.00636706859816661,0.0583930994980298,0.0833520084028429,1.18682677985184e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PQBP1,Polyglutamine-binding protein 1,39980,0.0578240963024755,0.00520711867901409,0.0476181436916079,0.0680300489133431,1.5223777413094e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XCL1,Lymphotactin,40489,0.0589809461461213,0.00531774881045403,0.0485581584776314,0.0694037338146112,1.75434305934219e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP1,Metalloproteinase inhibitor 1,40167,0.0294128109560098,0.00265194374754629,0.0242150012108191,0.0346106207012005,1.76874246405286e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.0498657953266447,0.00449656593790598,0.041052526088349,0.0586790645649405,1.79943103154669e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.0625853467773918,0.00565184562621768,0.0515077293500051,0.0736629642047784,2.14534209714732e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMPER,BMP-binding endothelial regulator protein,37671,0.0234458069694167,0.00212302008284625,0.019284687607038,0.0276069263317953,3.12739631904997e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0403031696060813,0.00365443565579443,0.0331404757207242,0.0474658634914384,3.69780325934787e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM,Paralemmin-1,37824,0.0304612565463838,0.00276923251291239,0.0250335608210756,0.0358889522716921,5.04481981857108e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL26,C-C motif chemokine 26,40341,0.092099021202053,0.00837853316090582,0.0756770962066776,0.108520946197428,5.25259082993117e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.0310417399935924,0.00282400172794514,0.0255066966068199,0.0365767833803649,5.26194754297879e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARA5,Scavenger receptor class A member 5,40471,0.0303571568156012,0.00276478578159204,0.0249381766836808,0.0357761369475216,6.00375708110271e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G15,Phospholipase A2 group XV,40411,0.0265794598524749,0.00242670057967426,0.0218231267163134,0.0313357929886365,8.0819648108067e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL24,C-C motif chemokine 24,40396,0.0856074508014389,0.00781657325453569,0.0702869672225489,0.100927934380329,8.16180697592074e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.0938968723289453,0.00857853230761143,0.0770829490060269,0.110710795651864,9.12754341962653e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF23,Fibroblast growth factor 23,40469,0.0636006647549409,0.0058171552612033,0.0521990404429824,0.0750022890668994,1.00117475426739e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNDP1,Beta-Ala-His dipeptidase,40403,0.0470891784215453,0.00430715516529219,0.0386471542975726,0.055531202545518,1.00775279450825e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPCAL1,Hippocalcin-like protein 1,40516,0.075481852408488,0.00691477922441536,0.0619288851286339,0.0890348196883421,1.20852394847802e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL4,Angiopoietin-related protein 4,40396,-0.0469461642582642,0.00430352419069859,-0.0553810716720334,-0.038511256844495,1.31023181129801e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL25,C-C motif chemokine 25,40516,0.0501363484537118,0.00460887907092986,0.0411029454746892,0.0591697514327343,1.8253529546542e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA4,Annexin A4,40279,0.0734558157256961,0.00675974192217164,0.0602067215582397,0.0867049098931525,2.07659668962971e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.0552431403442967,0.00509564584507758,0.0452556744879447,0.0652306062006488,2.72907221185775e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NID2,Nidogen-2,40332,0.0754564488817598,0.00696177706174982,0.0618113658407302,0.0891015319227895,2.81219679048191e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASGR2,Asialoglycoprotein receptor 2,37987,0.0264506067339619,0.0024411998166758,0.0216658550932773,0.0312353583746464,3.0366455662563e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASAH1,Acid ceramidase,37882,0.0471755128356899,0.00435957356255564,0.0386307486530809,0.055720277018299,3.53885946099303e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.0293107431552486,0.00270897688436195,0.0240011484618992,0.034620337848598,3.60620626534241e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNC79,Protein unc-79 homolog,37482,0.0577513124256351,0.00534636383510517,0.047272439308829,0.0682301855424412,4.38686362557054e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO2,Gamma-enolase,40471,0.0669281204242259,0.00620399869512892,0.0547682829817732,0.0790879578666786,4.86335363991208e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN6,Dynactin subunit 6,39961,0.071927332251486,0.0066840734976217,0.0588265481961475,0.0850281163068246,6.5457934179385e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.0579389231593568,0.00538374654019429,0.047386779940576,0.0684910663781376,6.74310445616048e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN2,Nectin-2,40330,0.0292658912568204,0.00272397388934356,0.0239269024337071,0.0346048800799338,7.8359105674654e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0228790049948814,0.00213011454255613,0.0187039804914714,0.0270540294982915,8.09505128193158e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.0593773748609019,0.00553043689299632,0.0485377185506292,0.0702170311711747,8.49207127162273e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0902026433608673,0.008402872752759,0.0737330127654597,0.106672273956275,9.01349956846093e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.0833474694788181,0.00776744862070293,0.0681232701822403,0.0985716687753958,9.05546663011571e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPPB,Natriuretic peptides B,40042,-0.129934861741251,0.0121232980126407,-0.153696525846026,-0.106173197636475,1.04059397928428e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.0399816090399904,0.003734577721974,0.0326618367049214,0.0473013813750595,1.22311512925224e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLO1,Lactoylglutathione lyase,40042,0.0597958534620654,0.00558958296910941,0.0488402708426109,0.0707514360815198,1.29014276021113e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12B,Interleukin-12 subunit beta,40516,0.0547355293343534,0.00511844789037776,0.044703371469213,0.0647676871994939,1.3376052619447e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.0696450568194719,0.00651021704566495,0.0568850314099686,0.0824050822289752,1.34140857371184e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL32,Interleukin-32,40341,-0.0430638268325111,0.00402839649738332,-0.0509594839673824,-0.0351681696976398,1.39492925683652e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA4,Carbonic anhydrase 4,40536,-0.0235513054681675,0.00220323044993828,-0.0278696371500466,-0.0192329737862885,1.40075736414929e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFCAB2,Dynein regulatory complex protein 8,37714,0.0350580369897059,0.00328651023760541,0.0286164769239993,0.0414995970554125,1.85418596378271e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREML1,Trem-like transcript 1 protein,37987,0.053102531952132,0.00498067697454927,0.0433404050820155,0.0628646588222486,1.95741671328548e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0435462070258855,0.00408744588813876,0.0355348130851335,0.0515576009666375,2.1482598353268e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLN4,Cerebellin-4,40489,0.0316348545280313,0.00297257207823912,0.0258086132546827,0.03746109580138,2.32039545590285e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD46,Membrane cofactor protein,40250,0.0287406934014322,0.00270333422387718,0.0234421583226329,0.0340392284802315,2.60787030830973e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TF,Serotransferrin,38013,0.0218777387367696,0.00206064959997314,0.0178388655208222,0.0259166119527169,3.15164264515103e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.0695658747707711,0.00656311433671086,0.0567021706708178,0.0824295788707243,3.66417805612832e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.0585589031284617,0.00552301547781266,0.0477337927919489,0.0693840134649745,3.66811319224275e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPK1,Thiamin pyrophosphokinase 1,37990,0.0271042209335417,0.00256033834176613,0.0220859577836801,0.0321224840834033,4.36760491978728e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCAM1,Vascular cell adhesion protein 1,40372,-0.0269559468759613,0.00254890384690549,-0.0319517984158961,-0.0219600953360266,4.7231186587329e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX16,Syntaxin-16,39980,0.0588167064554157,0.00557940037821032,0.0478810817141235,0.0697523311967079,6.78247470163279e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMOTL2,Angiomotin-like protein 2,37855,0.04794779906623,0.00454749053446141,0.0390347176186857,0.0568608805137744,6.85289648779591e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNM1,Dynamin-1,37901,0.113033766960475,0.010721623142078,0.0920193856020023,0.134048148318948,6.93429997544181e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3BP1,SH3 domain-binding protein 1,37901,0.0464839979429322,0.00441703269297234,0.0378266138647064,0.055141382021158,8.45312939794427e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGES2,Prostaglandin E synthase 2,37484,0.054305362388071,0.0051672861861788,0.0441774814631606,0.0644332433129815,9.9033252836031e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFA,Protransforming growth factor alpha,40341,0.0473633709378972,0.00452060761003424,0.0385029800222301,0.0562237618535643,1.33225773842234e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGRN,Neugrin,37942,0.021795467766475,0.00208232143043626,0.0177141177628199,0.0258768177701301,1.53551689577676e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLF4,Krueppel-like factor 4,37541,0.0386877508846285,0.00369915058436591,0.0314374157392714,0.0459380860299857,1.68748065729733e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGR1,Prostaglandin reductase 1,37990,0.0783674624939447,0.00750630673651608,0.0636551012903732,0.0930798236975162,2.02862745357416e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD1,Superoxide dismutase [Cu-Zn],39978,0.0481739328014406,0.00462323206968883,0.0391123979448505,0.0572354676580307,2.43669664154797e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRK5,G protein-coupled receptor kinase 5,40042,0.0517713608656994,0.0049688587704411,0.0420323976756348,0.061510324055764,2.4552877921787e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.0367839586603857,0.00353238125271416,0.0298604914050659,0.0437074259157054,2.59933443169826e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOLA1,BolA-like protein 1,37541,0.0539843101716138,0.00518622356560589,0.0438193119830263,0.0641493083602014,2.82572452514579e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSE,Cathepsin E,37671,0.050719831895809,0.00487345232008996,0.0411678653484327,0.0602717984431853,2.87291531279436e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH5,Cadherin-5,40536,-0.0298003477192881,0.00286548884514869,-0.0354167058557795,-0.0241839895827966,2.98926898802378e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0318121112232606,0.00305863897973286,0.0258171788229842,0.037807043623537,3.06217807863075e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK4,Serine/threonine-protein kinase 4,40359,0.0842066730125697,0.00810167601121301,0.0683273880305922,0.100085957994547,3.18890590334539e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.0485361844908541,0.00466795256894723,0.0393869974557175,0.0576853715259907,3.19416497641924e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.0267118229266085,0.00258053158686082,0.0216539810163613,0.0317696648368557,4.95954499524007e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF22,Kinesin-like protein KIF22,37562,0.119795578187123,0.0115692502250448,0.097119847746035,0.142471308628211,4.97757368169307e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.0930599569691978,0.00899282901409582,0.07543401210157,0.110685901836826,5.12710608408266e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAP,Prolyl endopeptidase FAP,40536,0.0263832360652988,0.00255138209843974,0.0213825271523569,0.0313839449782407,5.51879356593402e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADM,Pro-adrenomedullin,40489,0.0262162422767368,0.00254176577603491,0.0212343813557084,0.0311981031977653,7.27075523113109e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.0395796458090053,0.00384102133094707,0.032051244000349,0.0471080476176615,8.35940052133492e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.023397603345714,0.00227806103696906,0.0189326037132546,0.0278626029781734,1.13917284259058e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DENR,Density-regulated protein,37598,0.0558815599382496,0.00544597217672406,0.0452074544718705,0.0665556654046288,1.30655994324196e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK4,Dickkopf-related protein 4,40203,0.044077884601854,0.00430350085669835,0.0356430229227253,0.0525127462809828,1.52948328620957e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.0596967431973072,0.00586778200511464,0.0481958904672825,0.0711975959273319,3.17708699747811e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIP,Pancreatic triacylglycerol lipase,37987,0.0578716987121495,0.00570009788658646,0.04669950685444,0.0690438905698589,3.93082239611065e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX7,Syntaxin-7,37598,0.0483326987305233,0.00476053211774587,0.0390020557797414,0.0576633416813052,3.95239063564638e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS27,Serine protease 27,40314,0.038681189060637,0.00381616976663853,0.0312014963180255,0.0461608818032485,4.52197568200731e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPQ,Carboxypeptidase Q,37986,0.0350216650166899,0.00345429307354208,0.0282512505925474,0.0417920794408324,4.53961858728535e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FXN,"Frataxin, mitochondrial",40489,0.0707112868355651,0.00697935378528578,0.057031753416405,0.0843908202547252,4.7314085229782e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAA10,N-alpha-acetyltransferase 10,37562,0.0492362338371388,0.00485810214802235,0.039714353627015,0.0587581140472626,4.7445464682253e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGMN,Legumain,40422,0.0339243838328679,0.00334916455977002,0.0273600212957187,0.0404887463700171,4.84603083804116e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.0289724888473475,0.00286687875887826,0.0233534064799461,0.0345915712147488,6.13545311093098e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FEN1,Flap endonuclease 1,39980,0.0591273449929865,0.00585345585877645,0.0476545715097847,0.0706001184761883,6.46452047945856e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.0232157655460576,0.00229864299780157,-0.0277211058217486,-0.0187104252703665,6.53364218691912e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERI1,3'-5' exoribonuclease 1,37714,0.0321075578605314,0.00317990435404728,0.0258749453265988,0.0383401703944641,6.94671887983531e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.02804048213365,0.00278052074314415,0.0225906614770875,0.0334903027902126,7.63163582669614e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCS,Copper chaperone for superoxide dismutase,40228,0.0459294260672056,0.00455804827148106,0.0369956514551027,0.0548632006793085,8.27972877033442e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PVR,Poliovirus receptor,40471,0.0348277367157257,0.00346897043100762,0.0280285546709508,0.0416269187605006,1.19691708157085e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMG3,Proteasome assembly chaperone 3,40341,0.0484790630904173,0.00483553402038002,0.0390014164104725,0.0579567097703621,1.38271986961446e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.0226192460508269,0.00225785795936785,0.0181938444504659,0.0270446476511879,1.49270897667959e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.024216322662939,0.00241723232478962,-0.0289540980195266,-0.0194785473063513,1.5308181321093e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMM2,Phosphomannomutase 2,37562,0.0572702526298406,0.00572288897998593,0.0460533902290682,0.068487115030613,1.72008387959996e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR3,Toll-like receptor 3,40516,0.057321953410442,0.00574739686936228,0.0460570555464919,0.068586851274392,2.32678682082863e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAGED1,Melanoma-associated antigen D1,39980,0.0457188825104528,0.00459214260532624,0.0367182830040134,0.0547194820168923,2.79106192590716e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGR,Tyrosine-protein kinase Fgr,39961,0.0519949178100645,0.00522399382125331,0.041755889920408,0.062233945699721,2.87068693645445e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BGN,Biglycan,39956,-0.114237238105675,0.0114842335228035,-0.13674633581037,-0.0917281404009802,3.04159186606707e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100P,Protein S100-P,40042,0.0501981410296763,0.00506317879225349,0.0402743105968594,0.0601219714624931,4.22058836888189e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX6,Syntaxin-6,39980,0.0643495859619154,0.00650590959785978,0.0515980031501102,0.0771011687737205,5.32951741712134e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.0227166161666803,0.00229955667888377,0.0182094850760681,0.0272237472572925,5.99806544710664e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SWAP70,Switch-associated protein 70,37901,0.0328187788982726,0.00332591833900738,0.0262999789538181,0.039337578842727,6.88099349406978e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0349345793476213,0.00355131869591155,0.0279739947036347,0.0418951639916079,9.08531344874346e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,0.0297075488759496,0.00302096110701561,0.023786465106199,0.0356286326457002,9.36054830219095e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPMT,Thiopurine S-methyltransferase,39980,0.0686559905154326,0.00699105955292318,0.0549535137917032,0.082358467239162,1.06949591848874e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFASC,Neurofascin,40516,0.0252321396868485,0.00256970236862868,0.0201955230443363,0.0302687563293607,1.07943518393151e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPAG1,Sperm-associated antigen 1,37959,0.0534726847790678,0.00544535472561775,0.042799789516857,0.0641455800412786,1.10125747456706e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRG2,Bone marrow proteoglycan,37998,-0.0484491558838022,0.00493803028490922,-0.0581276952422242,-0.0387706165253801,1.19605611145418e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAP18,Chromatin complexes subunit BAP18,37942,0.0599311555508651,0.00612676778048198,0.0479226907011204,0.0719396204006098,1.6006444903347e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRG,Histidine-rich glycoprotein,37934,0.0291149056063695,0.0029789092384474,0.0232762434990126,0.0349535677137264,1.73445748171773e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRL,Prolactin,40471,-0.070757495408852,0.00724518558674394,-0.0849580591588701,-0.0565569316588339,1.81767026082621e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COLEC12,Collectin-12,40357,0.0235261629243596,0.00241205517760088,0.0187985347762618,0.0282537910724573,2.05799762699745e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1F,V-type proton ATPase subunit F,39925,0.0608189227749886,0.00624912204826213,0.0485706435603949,0.0730672019895824,2.54207513994249e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PZP,Pregnancy zone protein,38013,0.0599848587916818,0.00616375931948414,0.0479038905254929,0.0720658270578708,2.60873308477722e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRPX,Sushi repeat-containing protein SRPX,37990,-0.0300908508149651,0.00309224964189116,-0.0361516601130718,-0.0240300415168585,2.6301366913287e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.0661935612588145,0.00680668208371509,0.0528524643747329,0.0795346581428961,2.735046003512e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP3,Stromelysin-1,40332,-0.0442768581463551,0.0045652719629648,-0.0532247911937661,-0.0353289250989441,3.52105444147468e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6R,Interleukin-6 receptor subunit alpha,40273,0.030671345892802,0.00317710545367428,0.0244442192036005,0.0368984725820036,5.44310811679607e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL2,ADAMTS-like protein 2,37998,0.0281778478487045,0.00292265522851659,0.022449443600812,0.033906252096597,6.29971858185648e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.0612387476558663,0.00635606357049015,0.0487808630577056,0.073696632254027,6.74348348218189e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.0452574282965348,0.00471105752760089,0.0360237555424371,0.0544911010506326,8.7948685393419e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD276,CD276 antigen,40357,-0.0326298274186545,0.00339777058303426,-0.0392894577614017,-0.0259701970759074,8.87043924301062e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.105652340757903,0.0110084814834839,0.0840757170502749,0.127228964465532,9.62882937496431e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.0273455623501709,0.0028518804244034,0.0217558767183403,0.0329352479820016,1.04702684240052e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD302,CD302 antigen,40305,0.0271430646835201,0.0028387948864848,0.0215790267060099,0.0327071026610303,1.32758682150773e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.0470396702262647,0.00491903413182572,0.0373983633278863,0.0566809771246431,1.34174523537128e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMS,Spermine synthase,37541,0.0574675233045707,0.00605218642866746,0.0456052379043825,0.0693298087047589,2.57074495351204e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.031152440358012,0.00328267853632143,0.024718390426822,0.037586490289202,2.63475832748047e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.0455648950348517,0.00480258552520393,0.036151827405452,0.0549779626642514,2.68899336500889e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM1,Intercellular adhesion molecule 1,40291,0.0255217246935082,0.00269146911673814,0.0202464452247015,0.030797004162315,2.82845872302286e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.0429109263453482,0.00452751622658864,0.0340369945412345,0.0517848581494619,3.02366705769673e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNGR2,Interferon gamma receptor 2,40228,0.0461587872471174,0.0048742008884617,0.0366053535057324,0.0557122209885023,3.18561700492103e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.048199130459231,0.00508995915909093,0.0382228105074128,0.0581754504110493,3.2877553108934e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPT,Dermatopontin,40536,0.0236223671765518,0.00249934048370096,0.018723659828498,0.0285210745246057,3.79202799328889e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNF,Tumor necrosis factor,40014,0.0355372130854839,0.00376044381501792,0.0281667432080488,0.0429076829629191,3.85060412635764e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.0610277570708668,0.00646252860791369,0.048361200999356,0.0736943131423776,4.19502474598648e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.0708336306322462,0.00750687740627401,0.0561201509159491,0.0855471103485432,4.50677769561122e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.100992357587073,0.0107158675688048,0.0799892571522159,0.121995458021931,5.01443465487535e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.0254634118425247,0.002702282527644,0.0201669380883424,0.0307598855967069,5.11209673809507e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLRX,Glutaredoxin-1,40260,0.0502948274828067,0.00534159700897867,0.0398252973452085,0.0607643576204049,5.33420422504056e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNAR1,Interferon alpha/beta receptor 1,37901,0.0235187097314401,0.00249980963923843,0.0186190828385328,0.0284183366243475,5.8536667995836e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK3,Dickkopf-related protein 3,40536,-0.0261256073796514,0.0027799302237247,-0.0315742706181518,-0.020676944141151,6.29599152475329e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SF3B4,Splicing factor 3B subunit 4,40305,0.0650329164271323,0.0069214713529011,0.0514668325754462,0.0785990002788185,6.434531624095e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBD,Thrombomodulin,40359,0.0245780990877761,0.00261812518374479,0.0194465737276363,0.0297096244479159,6.94644837994763e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.0277072014934918,0.00295616169381853,-0.0335012784133761,-0.0219131245736075,8.13307883988775e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPE,Ribulose-phosphate 3-epimerase,37714,0.0619889559549989,0.00661523995570891,0.0490230856418094,0.0749548262681884,8.36023215738405e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.0773455454214713,0.00825603107037488,0.0611637245235365,0.0935273663194061,8.53992062007695e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMB1,Laminin subunit beta-1,37628,0.0261432578490853,0.00279129329514212,0.0206723229906067,0.0316141927075638,8.74066130817586e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.0370087223369228,0.00396071962139988,0.029245711878979,0.0447717327948666,1.05126031264584e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.0370291441489577,0.00396706135650857,0.0292537038902009,0.0448045844077145,1.14967206333976e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.0291037697182827,0.00312189475026619,-0.0352226834288044,-0.022984856007761,1.31003283830601e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP8,Caspase-8,40434,0.0544647417064515,0.00584377421327705,0.0430109442484285,0.0659185391644745,1.31050826680447e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSR,"Glutathione reductase, mitochondrial",37944,0.019487792159784,0.00209359965093038,0.0153843368439605,0.0235912474756076,1.49709276197138e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.0481028958455847,0.00517748278854565,0.0379550295800352,0.0582507621111341,1.76359328749203e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STXBP3,Syntaxin-binding protein 3,39980,0.0387295062926661,0.00417625467661149,0.0305440471265076,0.0469149654588246,2.02924938286856e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.0799959865512855,0.0086376159100173,0.0630662593676516,0.0969257137349194,2.32712371608291e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.0473840419398199,0.00512184715689973,0.0373452215122964,0.0574228623673433,2.49978435108305e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.0453778485658429,0.00492027158716084,0.0357341162550077,0.0550215808766782,3.25442142569501e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSB,Cathepsin B,40353,-0.0470097823991438,0.0050992885824782,-0.0570043880208011,-0.0370151767774866,3.37048396704006e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.0325901504224082,0.0035412302991507,0.0256493390360729,0.0395309618087436,3.9066754087678e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C5,Complement C5,38013,0.0133145931682856,0.00144651558979446,0.0104794226122885,0.0161497637242828,3.92478602244194e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA9,Serpin A9,40228,0.0625859106641618,0.00680606688537032,0.049246019568836,0.0759258017594877,4.1856716381156e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASS1,Argininosuccinate synthase,37562,0.0699250788156622,0.00760444060463467,0.0550203752305782,0.0848297824007461,4.29709311941878e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FST,Follistatin,40396,0.0449815949118572,0.00490577055834264,0.0353662846175056,0.0545969052062088,5.33982155657571e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG4,Regenerating islet-derived protein 4,40379,0.0421087963141416,0.00459356728485896,0.033105404435818,0.0511121881924651,5.45066452772821e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF1R,Insulin-like growth factor 1 receptor,40305,0.0189739849084159,0.00207331534261669,0.0149102868368872,0.0230376829799446,6.28446405240245e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMA4,Laminin subunit alpha-4,40422,0.0283274711710776,0.0030968342254429,0.0222576760892095,0.0343972662529457,6.53192650218083e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXN,Thioredoxin,37819,0.0384972030873076,0.00421304212182583,0.030239640528529,0.0467547656460862,7.29152553472937e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELOB,Elongin-B,37562,0.0347422183689296,0.00380233528653721,0.0272896412073167,0.0421947955305426,7.34764239473994e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.0560137000415013,0.00613256992915303,0.0439938629803613,0.0680335371026412,7.56643751059539e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C4BPB,C4b-binding protein beta chain,40411,0.0355671011023084,0.00389599904091013,0.0279309429821246,0.0432032592224923,7.71562090054744e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.021690551413316,0.00237842565290098,0.0170288371336301,0.026352265693002,8.58054902470891e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEP1B,Meprin A subunit beta,40359,0.101807927358947,0.0111697556738654,0.0799152062381704,0.123700648479723,8.81975742898497e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.0493273473366735,0.00542017225822893,0.0387038097105448,0.0599508849628022,1.00415380235152e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.0531643672757101,0.00584330403667994,0.0417114913638174,0.0646172431876027,1.04786645746693e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.0196444114083205,0.00216087488684396,0.0154090966301063,0.0238797261865347,1.09410074627331e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA2,Apolipoprotein A-II,37987,-0.0407982632443091,0.00449737306763445,-0.0496131144568726,-0.0319834120317456,1.33272274566939e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.0566825011250959,0.00625108589161812,0.0444303727775244,0.0689346294726674,1.35487066830044e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XRCC4,DNA repair protein XRCC4,39961,0.0319461683708072,0.00352330658807468,0.0250404874581808,0.0388518492834336,1.3660397781167e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APRT,Adenine phosphoribosyltransferase,40216,0.0413730498001378,0.0045784173755866,0.032399351743988,0.0503467478562875,1.80144470982239e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRK1,Protein BRICK1,39961,0.0376790966350847,0.0041798839737136,0.0294865240466061,0.0458716692235634,2.20697889047143e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0647345494717876,0.00718058243476371,0.0506606078996507,0.0788084910439245,2.2308774043428e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANSC1,MANSC domain-containing protein 1,40411,-0.0233379553458423,0.00259033937602414,-0.0284150205228497,-0.018260890168835,2.29768350214498e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB8,Serpin B8,40516,0.0463421543392738,0.00514931344386258,0.0362494999893032,0.0564348086892444,2.51258982172894e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA2,Annexin A2,37441,0.0608389100402374,0.00676816497891857,0.047573306681557,0.0741045133989178,2.83670715706383e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAM,Signal transducing adapter molecule 1,37900,0.0319166890044439,0.0035526450899715,0.0249535046280998,0.0388798733807881,2.95654219968882e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLIF,Cobalamin binding intrinsic factor,40330,0.0618123101602825,0.00688922095240499,0.0483094370935687,0.0753151832269963,3.22215097034641e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.0798425508962394,0.00890130982029684,0.0623959836484576,0.0972891181440212,3.30030876185221e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP1,Guanylate-binding protein 1,37931,0.0546184438857467,0.00609196041265414,0.0426782014769446,0.0665586862945489,3.48561990147396e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLB,Beta-klotho,39961,-0.0623771544560663,0.00695881547086904,-0.0760164327789697,-0.048737876133163,3.48976400495294e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADA,Adenosine deaminase,40516,0.0287758050306525,0.00321115896589668,0.022481933457495,0.03506967660381,3.55863501559971e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFRP4,Secreted frizzled-related protein 4,37671,0.035425517170783,0.00395876343005641,0.0276663408478725,0.0431846934936936,4.07343376567094e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR2,Folate receptor beta,40471,-0.0248960569822442,0.00278326233920505,-0.0303512511670862,-0.0194408627974023,4.12215143907984e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMOX1,Heme oxygenase 1,40184,-0.0395454735238216,0.00442820477961511,-0.0482247548918672,-0.030866192155776,4.70798343752788e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTN,Pleiotrophin,40042,0.0423386053760322,0.00474509505669346,0.033038219064913,0.0516389916871514,5.05279671375301e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS7_LGALS7B,Galectin-7,40270,0.0338401430130236,0.00379590850156238,0.0264001623499613,0.0412801236760858,5.40682444234276e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRZB,Secreted frizzled-related protein 3,40176,0.0224294228832761,0.00251749195073084,0.0174951386598437,0.0273637071067086,5.68226521857691e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRIB,Protein scribble homolog,37628,0.0783926506839266,0.00880296593858312,0.0611388374443037,0.0956464639235495,6.01650051171917e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MARCO,Macrophage receptor MARCO,40359,0.0223074424583915,0.00250694121074836,0.0173938376853247,0.0272210472314583,6.27312514269466e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDGF,Hepatoma-derived growth factor,40471,0.0801995270564281,0.00901961207500154,0.0625210873894251,0.0978779667234311,6.64995082786562e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENAH,Protein enabled homolog,40044,0.0397662577115263,0.00447517368665494,0.0309949172856826,0.04853759813737,7.01800301200352e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP6,Gastrotropin,40017,0.0469232862236361,0.00528091498174989,0.0365726928594064,0.0572738795878659,7.05220339032116e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL19,C-C motif chemokine 19,40471,0.109949529816049,0.0123748568384937,0.0856948104126019,0.134204249219497,7.06548008610973e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFA2,BPI fold-containing family A member 2,37150,-0.0928799713485982,0.0105073149858648,-0.113474308720893,-0.0722856339763031,1.08654689397165e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PER3,Period circadian protein homolog 3,37598,0.0986444942223027,0.0111778072896305,0.076735991934627,0.120552996509978,1.23114239138481e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD93,Complement component C1q receptor,39725,-0.0263016398005578,0.00298177092195328,-0.0321459108075863,-0.0204573687935294,1.25745365700316e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL2A1,Collagen alpha-1(II) chain,37628,0.068676254265307,0.00778542349666229,0.0534168242118489,0.0839356843187651,1.27417000945792e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP6,Bone morphogenetic protein 6,40024,0.0352757523364202,0.00400014778837307,0.027435462671209,0.0431160420016314,1.27978792608708e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0585019729514639,0.00663751066988296,0.0454924520384933,0.0715114938644344,1.35970593465439e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C7orf50,Uncharacterized protein C7orf50,37942,0.0183019490305515,0.00207770778650954,0.0142296417689928,0.0223742562921102,1.41866774606456e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSCAM,Down syndrome cell adhesion molecule,37959,0.0293333279498609,0.00333339240893418,0.0227998788283499,0.0358667770713718,1.53461630384176e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEPH,Hephaestin,37990,0.0208695950985712,0.00237161309502906,0.0162212334323143,0.0255179567648282,1.53551774023493e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD2,Sushi domain-containing protein 2,40332,-0.0238128585994861,0.00270692446038914,-0.0291184305418488,-0.0185072866571234,1.54719658339867e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.023625989454143,0.00268801424551875,-0.0288944973753598,-0.0183574815329262,1.65518324968639e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0254010977840387,0.00288952007091001,0.0197376384450551,0.0310645571230223,1.66261207503692e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC1,WAP four-disulfide core domain protein 1,37653,0.0453617809698518,0.00516131695673142,0.0352455997346582,0.0554779622050453,1.69666474556765e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMD,Osteomodulin,40422,-0.0367288859740768,0.00418670527276449,-0.0449348283086952,-0.0285229436394584,1.91708396660722e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.0315540744092996,0.00360009286027898,0.0244978924031528,0.0386102564154464,2.09725152984157e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC3B,Tetranectin,37681,0.0174591449705121,0.00199354033797144,0.0135518059080881,0.0213664840329361,2.22938286982101e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP12,Macrophage metalloelastase,40346,0.0427772247683495,0.00489276468068017,0.0331874059942163,0.0523670435424826,2.49470745820503e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.0463789168439431,0.00530572493952257,0.0359796959624788,0.0567781377254073,2.57723994593668e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL20,C-C motif chemokine 20,40516,0.0731072317184309,0.00837635975079065,0.0566895666068812,0.0895248968299806,2.84791613916292e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.0340552284779271,0.00390244389129377,0.0264064384509913,0.0417040185048628,2.87908616636876e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXADR,Coxsackievirus and adenovirus receptor,40341,0.0436242956451977,0.00501322752077808,0.0337983697044727,0.0534502215859228,3.58123738499786e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC80,Coiled-coil domain-containing protein 80,40359,0.0288334485537911,0.00331620387342418,0.0223336889618797,0.0353332081457025,3.81165767407516e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOF,Apolipoprotein F,37987,-0.0198536711674098,0.00228299800921707,-0.0243283472654753,-0.0153789950693444,3.81939712076638e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDF1,Endothelial differentiation-related factor 1,37959,0.0572637182620585,0.00658705977552416,0.0443530811020311,0.0701743554220859,3.92023778459463e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPR,Nucleoprotein TPR,37562,0.038659424390392,0.00444800659158032,0.0299413314708946,0.0473775173098895,4.00114395740882e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL8,Interleukin-8,40209,0.0556323404629498,0.0064068101564823,0.0430749925562445,0.0681896883696552,4.21566926188274e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYGD,Gamma-crystallin D,37942,0.0787015792858124,0.00908252740742348,0.0608998255672623,0.0965033330043624,5.01712584107068e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.0270786178198442,0.00312634491154122,0.0209509817932234,0.033206253846465,5.09960586574566e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANBP1,Ran-specific GTPase-activating protein,37628,0.0434170649651799,0.0050270436242162,0.0335640594617161,0.0532700704686437,6.44579177031769e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSTN,Growth/differentiation factor 8,40042,0.0416956710192333,0.00483418460330522,0.032220669196755,0.0511706728417115,7.00819567212921e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL1,Fc receptor-like protein 1,40359,0.0366328960576907,0.00424979370334206,0.0283033003991403,0.0449624917162412,7.32217517217271e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NADK,NAD kinase,40359,0.0434906020430707,0.00505213080195063,0.0335884256712474,0.0533927784148939,8.09530771804642e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRP2,Neuropilin-2,40332,-0.0236341575822185,0.0027465749134689,-0.0290174444126175,-0.0182508707518194,8.33985599933191e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRDT,Bromodomain testis-specific protein,37562,0.0303631017751598,0.00352779789091373,0.0234486179089689,0.0372775856413507,8.3606570121812e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRSF1,G-rich sequence factor 1,37402,0.06429238625551,0.00747735560866398,0.0496367692625286,0.0789480032484914,9.01445336238494e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD1C,T-cell surface glycoprotein CD1c,40411,0.0194342060546393,0.00226162890278396,0.0150014134051827,0.0238669987040958,9.24596485269652e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX5,Sorting nexin-5,37628,0.0243450516851984,0.00283740769646074,0.0187837326001353,0.0299063707702614,1.05369077437533e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMARCA2,Probable global transcription activator SNF2L2,39961,0.0593511405303056,0.00692659059000325,0.0457750229738992,0.072927258086712,1.1450362807852e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK7,Kallikrein-7,37352,0.0314137960386534,0.00367231639677477,0.0242160559009749,0.038611536176332,1.31965151910778e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.0584035794336339,0.00683396652082606,0.0450090050528149,0.071798153814453,1.38763389337779e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.0265837736251191,0.00311193473702751,0.0204843815405452,0.032683165709693,1.42955904739841e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.040598635162838,0.00475195062693644,0.0312848119340426,0.0499124583916334,1.44320262998634e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.032048844257585,0.00375750050200879,0.0246841432736477,0.0394135452415222,1.62767475820797e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0233229271269545,0.00273933095526506,0.017953838454635,0.0286920157992741,1.82781969778149e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QA,Complement C1q subcomponent subunit A,40442,-0.0182847843347434,0.00214798782157777,-0.0224948404650359,-0.014074728204451,1.85128676629669e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHCHD6,MICOS complex subunit MIC25,37900,0.0233668151939985,0.00274497561050746,0.0179866629974038,0.0287469673905931,1.87989330029566e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.0674344788562089,0.00792510738955186,0.0519012683726873,0.0829676893397306,1.91355420633052e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.0383299526454403,0.00451389996043111,0.0294827087229953,0.0471771965678853,2.22246202351868e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP1,Rho GTPase-activating protein 1,39980,0.0368240390160456,0.00433667566149432,0.0283241547195168,0.0453239233125745,2.22620965438271e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLIT2,Slit homolog 2 protein,39961,0.0421279351413694,0.00496305571422529,0.0324003459414879,0.051855524341251,2.28438767566607e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPL14,60S ribosomal protein L14,37628,0.0331551688923624,0.00391356827383897,0.0254845750756381,0.0408257627090868,2.66947022564126e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.0534551700317485,0.00631757696426808,0.0410727191817831,0.065837620881714,2.91293152922623e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.0332446238160419,0.00392890206142065,0.0255439757756574,0.0409452718564264,2.9146691820809e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.0441123715979157,0.00521835204214036,0.0338844015953206,0.0543403416005108,3.07162181784257e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.0242489276855468,0.00286802791373307,0.01862759297463,0.0298702623964636,3.08451928123392e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP9,Caspase-9,37598,0.0499170336181557,0.00591508481861832,0.0383234673736638,0.0615105998626476,3.53484113790487e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDA,Cytidine deaminase,37970,0.0366050039585842,0.0043389990301026,0.0281005658595831,0.0451094420575853,3.60595533736823e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECI2,Enoyl-CoA delta isomerase 2,37562,0.0501630279851955,0.00594709266805933,0.0385067263557992,0.0618193296145918,3.6598949115383e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VGF,Neurosecretory protein VGF,37959,0.0243407298030138,0.00288701458599646,0.0186821812144608,0.0299992783915669,3.76836641751677e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSF,Cathepsin F,40411,0.0317636786098147,0.00378072357824132,0.0243534603964618,0.0391738968231677,4.77605907357858e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RARRES1,Retinoic acid receptor responder protein 1,39980,0.0278383789064379,0.00331664436560863,0.021337755949845,0.0343390018630308,5.1199940663331e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.0350847778079053,0.00418306028096881,-0.0432835759586042,-0.0268859796572065,5.38391443151256e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.0283229684829691,0.00337874047534014,0.0217006371513024,0.0349452998146357,5.68124498866129e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCT,Secretin,37572,0.0364594603158591,0.00435328728906784,0.0279270172292862,0.0449919034024321,6.07117884946845e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL14,C-C motif chemokine 14,40309,0.0308134546872513,0.00368201091617498,0.0235967132915483,0.0380301960829542,6.30923417617275e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPG,Macrophage-capping protein,40185,0.0458632064449125,0.0054807790929855,0.0351208794226609,0.0566055334671641,6.34737822140108e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_E,,40341,0.0227005559403982,0.00272269733127046,0.0173640691711081,0.0280370427096884,8.20142585102761e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIT,Mast/stem cell growth factor receptor Kit,40372,-0.0233349078311465,0.00279897839807826,-0.0288209054913799,-0.0178489101709131,8.24081003429319e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LBP,Lipopolysaccharide-binding protein,40403,-0.0458243249292005,0.00549756441391114,-0.0565995511804663,-0.0350490986779346,8.34781546546005e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.0414733762896078,0.00498569744559077,0.0317014092962499,0.0512453432829657,9.64467970146394e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.0448188774466292,0.00540974581992997,0.0342157756395665,0.055421979253692,1.27839269701564e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSNK1D,Casein kinase I isoform delta,37598,0.0500026758735803,0.00603519172848173,0.0381737000857561,0.0618316516614045,1.29275516084583e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.0546549508240329,0.00660846481655852,0.0417023597835782,0.0676075418644876,1.44008179044944e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL15,C-C motif chemokine 15,40536,0.0347439744245671,0.00420142551565276,0.0265091804138876,0.0429787684352465,1.44857270337553e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL6A3,Collagen alpha-3(VI) chain,40536,0.026760668554109,0.00323984046305326,0.0204105812465246,0.0331107558616934,1.57068042939814e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLTA,Clathrin light chain A,40042,0.0370020146864682,0.00448107273991397,0.0282191121162368,0.0457849172566996,1.60715429880281e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPCAM,Epithelial cell adhesion molecule,40358,-0.0778482627041793,0.00942874924154115,-0.0963286112176,-0.0593679141907587,1.61711693366591e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYM,Ketimine reductase mu-crystallin,37541,0.0602191861490323,0.00730355305214796,0.0459042221668223,0.0745341501312423,1.80524474759006e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPOCK1,Testican-1,40228,0.0195779907635201,0.00237824250052772,0.0149166354624857,0.0242393460645544,1.98184974879667e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASET2,Ribonuclease T2,40465,0.0205071272443639,0.00249368377477881,0.0156195070457975,0.0253947474429304,2.12453256443589e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.029365927642438,0.00358113340660161,0.0223469061654988,0.0363849491193771,2.58232561299964e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIGR,Polymeric immunoglobulin receptor,40154,0.0271526807307132,0.00332532646914179,0.0206350408511953,0.0336703206102311,3.44472976790178e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC5A,C-type lectin domain family 5 member A,40314,-0.021762501529106,0.00266815325837061,-0.0269920819155124,-0.0165329211426996,3.70819303979269e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL5,Insulin-like peptide INSL5,37901,0.0724882070545717,0.00889522953735578,0.0550535571613543,0.089922856947789,3.98798518229603e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN2,Calsyntenin-2,40516,-0.0300524682211684,0.00368958258727638,-0.0372840500922301,-0.0228208863501067,4.06184460670616e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AK1,Adenylate kinase isoenzyme 1,40359,0.0491329248591976,0.00603457263855682,0.0373051624876263,0.060960687230769,4.17707451771848e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LACRT,Extracellular glycoprotein lacritin,37863,0.0409505856072868,0.00504300295689783,0.0310662998117671,0.0508348714028066,5.05482005048274e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRH,Corticoliberin,39947,0.0665964580578657,0.00822027589073134,0.0504847173120323,0.0827081988036991,5.83100198602077e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA7,Thyroxine-binding globulin,38013,0.0142921444544988,0.00177032821308924,0.0108223011568439,0.0177619877521537,7.42393248235064e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.0299270788894023,0.00371069431480243,0.0226541180323895,0.037200039746415,7.94880001123618e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.0491528789505441,0.00610273798485825,0.0371915125002219,0.0611142454008662,8.57531437505993e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.0259965091614711,0.00322972012687017,-0.0323267606101366,-0.0196662577128055,8.9341645005102e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MET,Hepatocyte growth factor receptor,40375,-0.0152757271015408,0.00189795037054624,-0.0189957098278115,-0.0115557443752702,8.96592836653855e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAX,Apoptosis regulator BAX,39934,0.0679720844022812,0.00844938553504691,0.0514112887535892,0.0845328800509731,9.27422086482457e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.024605274430068,0.00306783753941704,0.0185923128528106,0.0306182360073254,1.12631707553755e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSDE1,Cold shock domain-containing protein E1,37562,0.0889403881337955,0.0110945929509488,0.0671949859499358,0.110685790317655,1.17921609795709e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA3,Protein disulfide-isomerase A3,37671,0.0193596035525806,0.00241976288635011,0.0146168682953344,0.0241023388098268,1.34056048221869e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.0361755650241307,0.00452764287838089,0.0273013849825041,0.0450497450657572,1.4443552090318e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRN,Progranulin,40262,0.0182276980977541,0.00229413688900739,0.0137311897952996,0.0227242064002086,2.06628956750791e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST5,Cystatin-D,40070,0.0414162752214994,0.00521667080150269,0.0311916004505541,0.0516409499924446,2.1722009202421e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAPK2,Death-associated protein kinase 2,37598,0.0393568793209595,0.00496121011915299,0.0296329074874197,0.0490808511544994,2.31290016310389e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COPB2,Coatomer subunit beta',37562,0.0324184165563107,0.00409663022375409,0.0243890213177527,0.0404478117948688,2.70399772815681e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.0355498826778071,0.00449302481289767,0.0267435540445277,0.0443562113110866,2.72385740975839e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.0208752682622723,0.00264090694396042,0.0156990906521099,0.0260514458724347,2.86271905451112e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0404339732013327,0.00512466168273753,0.0303896363031671,0.0504783100994982,3.25075113589777e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCOF1,Treacle protein,37990,0.0225665515239853,0.00286198479546389,0.0169570613248761,0.0281760417230946,3.38691460038427e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIT,Citron Rho-interacting kinase,37572,0.0336243551190677,0.00426894671709979,0.0252572195535521,0.0419914906845833,3.63067158272175e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE6,Ribonuclease K6,37917,0.0219731445796318,0.00279181614067616,0.0165011849439065,0.027445104215357,3.79923619295465e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINI2,Serpin I2,37901,0.0417021785035423,0.00529990848518667,0.0313143578725764,0.0520899991345082,3.86310048829033e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0325235653567915,0.00414169960724591,0.0244058341265895,0.0406412965869934,4.33629784214712e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTA,Lymphotoxin-alpha,40341,0.0297999634544599,0.00380467966979798,0.0223427913016559,0.0372571356072639,5.08535405846794e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.0304536935564064,0.00388834534288203,0.0228325366843576,0.0380748504284552,5.15804881950148e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHCY,Adenosylhomocysteinase,40359,0.0501104913058745,0.00639950228913686,0.0375674668191663,0.0626535157925828,5.16938666926339e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA14,Carbonic anhydrase 14,40489,-0.0255342345045826,0.00326336017519997,-0.0319304204479746,-0.0191380485611907,5.4119389088834e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PVALB,Parvalbumin alpha,40417,0.0834697990837358,0.0106822112773896,0.0625326649800522,0.104406933187419,5.88779081920094e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.0263125624473986,0.00336902725647261,0.0197092690247122,0.0329158558700849,6.14423979699149e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CX3CL1,Fractalkine,40228,-0.0251601193078711,0.0032322324023704,-0.0314952948165171,-0.0188249437992251,7.45299516627896e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.0463774510874305,0.00595998903736001,0.0346958725742049,0.0580590296006561,7.60874500454917e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD248,Endosialin,37998,-0.029490508777052,0.00379453803742294,-0.0369278033304009,-0.022053214223703,8.2914083191256e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAM,Basal cell adhesion molecule,40332,-0.0174010761640234,0.00224056984122929,-0.0217925930528328,-0.013009559275214,8.56825257034728e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLGN,Calmegin,37572,0.0326966155021798,0.00421076378373481,0.0244435184860596,0.0409497125183,8.76767789570243e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPTLC1,Serine palmitoyltransferase 1,37942,0.0263989586263818,0.00340199585627622,0.0197310467480804,0.0330668705046832,9.11269371204323e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTX2,Neuronal pentraxin-2,37998,-0.0239244250420147,0.00309474687583745,-0.0299901289186561,-0.0178587211653733,1.14511468040203e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR2,TGF-beta receptor type-2,40411,0.0230398121255644,0.00298360308276069,0.0171919500833534,0.0288876741677753,1.21149257433765e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAEP,Glycodelin,40228,-0.0959829190182859,0.0124370585396237,-0.120359553755948,-0.0716062842806234,1.2571699531618e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2orf69,UPF0565 protein C2orf69,37572,0.0440848952701222,0.00571312784932104,0.032887164685453,0.0552826258547915,1.28266196533986e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPME1,Protein phosphatase methylesterase 1,40305,0.0446345172835845,0.00578912559951922,0.0332878311085269,0.0559812034586422,1.33192225343998e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0227173281169446,0.00294897681229781,0.0169373335648409,0.0284973226690483,1.40140644695033e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAST,Gastrin,37942,0.0949239962567837,0.0123286111726646,0.0707599183583611,0.119088074155206,1.46095714198507e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX2,Sorting nexin-2,37900,0.0568007097720884,0.00738654328220573,0.0423230849389652,0.0712783346052116,1.57630574513145e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GC,Vitamin D-binding protein,38013,0.0189011393439258,0.00246074845632082,0.014078072369537,0.0237242063183146,1.68574781442319e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.0299875793595873,0.00390554268805499,0.0223327156909996,0.0376424430281751,1.72751692580466e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.0250444822502895,0.00326319387344047,0.0186486222583462,0.0314403422422329,1.75250826342756e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR2,Complement factor H-related protein 2,37911,0.0414887394444398,0.00541187738862198,0.0308814597627407,0.0520960191261389,1.89224043570962e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHL1,Neural cell adhesion molecule L1-like protein,40379,-0.0228661897298169,0.00299174062588426,-0.0287300013565501,-0.0170023781030838,2.24089308360846e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ULBP2,UL16-binding protein 2,40228,0.0268785441121781,0.00352491753536677,0.0199697057428592,0.033787382481497,2.57308251846669e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.0416863360768314,0.00548868056332953,0.0309285221727055,0.0524441499809572,3.25300321901802e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.029924198775202,0.00394681140141597,0.0221884484284267,0.0376599491219773,3.62938021185757e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.0349031901531955,0.00460976499166177,0.0258680507695384,0.0439383295368525,3.88912260958401e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.0398108600047667,0.00526112397566309,0.029499057012467,0.0501226629970663,4.02917581453637e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSHB,Follitropin subunit beta,37628,0.0500440158974298,0.00661833967734944,0.0370720701298249,0.0630159616650347,4.250557983581e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGT,Angiotensinogen,37987,0.0173022087277851,0.00229324283072839,0.0128074527795574,0.0217969646760127,4.81602117653938e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.0319624631056648,0.00423776213208112,0.0236564493267859,0.0402684768845438,4.92038301194516e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.039699773949921,0.00527298237864824,0.0293647284877705,0.0500348194120716,5.45085106863779e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0726145053981123,0.00965531467421464,0.0536900886366516,0.091538922159573,5.79429808375552e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARF2,Scavenger receptor class F member 2,40471,-0.021092399424265,0.0028109792090113,-0.0266019186739272,-0.0155828801746029,6.53550951821399e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAFA5,Chemokine-like protein TAFA-5,40305,0.0254082417760624,0.00339026150327393,0.0187633292296455,0.0320531543224794,7.00723932866119e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN1,Contactin-1,40536,-0.019550769547536,0.00260926437919044,-0.0246649277307493,-0.0144366113643228,7.09041295916097e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBS,Cystathionine beta-synthase,37628,0.0360095460248318,0.00480856471391361,0.0265847591855611,0.0454343328641025,7.40207269006962e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.0319202996147521,0.00426842626165158,0.023554184141915,0.0402864150875892,7.92550868775871e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPD,Pulmonary surfactant-associated protein D,40359,0.0467776694602308,0.00627334613840052,0.0344819110289658,0.0590734278914958,9.33732172283421e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.0342668333119418,0.00459611664729535,0.025258444683243,0.0432752219406407,9.40671922860346e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCF2,Neutrophil cytosol factor 2,40324,0.0583830543426392,0.00785644062033807,0.0429844307267766,0.0737816779585018,1.13064763575009e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGMB,RGM domain family member B,40471,0.0181346917554507,0.00245461345709752,0.0133236493795395,0.0229457341313618,1.56391331204324e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRR3,Small proline-rich protein 3,37942,0.0497840081647273,0.00674531594510838,0.0365631889123149,0.0630048274171398,1.66881465126742e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.0366503464260238,0.00498524326134829,-0.0464214232182664,-0.0268792696337811,2.05133512948893e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SBSN,Suprabasin,37977,-0.0233997376123143,0.00318309922957049,-0.0296386121022725,-0.0171608631223561,2.07643585297301e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSR,Insulin receptor,37598,0.0117623280502097,0.00160136780563297,0.00862364715116909,0.0149010089492503,2.17593087880019e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.0385052479358177,0.00524968198268765,0.0282158712497499,0.0487946246218855,2.34981434812218e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR5,Complement factor H-related protein 5,37785,0.0289923817843598,0.00395765370556348,0.0212353805214554,0.0367493830472643,2.51400738792755e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL15A1,Collagen alpha-1(XV) chain,37998,0.0179872796555516,0.00245568656255176,0.0131741339929502,0.0228004253181531,2.5287145533346e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOBR,Apolipoprotein B receptor,37628,-0.0293750794409128,0.00401679628022468,-0.0372480001501531,-0.0215021587316724,2.76199275844141e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL4,ADAMTS-like protein 4,37628,0.0162627286108302,0.00222591185084127,0.0118999413831813,0.0206255158384791,2.90830511453176e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RHOC,Rho-related GTP-binding protein RhoC,40152,0.080140490078572,0.0109767585929419,0.0586260432364058,0.101654936920738,2.99495957479259e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALCAM,CD166 antigen,40536,0.0133774217267498,0.00183282053337456,0.00978509348133569,0.016969749972164,3.03869909593451e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.0255219280803161,0.00350255993842348,0.0186569106010061,0.0323869455596261,3.35717509500041e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.0393021757748227,0.00539583775502718,0.0287263337749694,0.049878017774676,3.39818044004977e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS22,Brain-specific serine protease 4,37598,0.0243937957672465,0.00335201644877026,0.0178238435276568,0.0309637480068362,3.59758929559313e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGKZ,Diacylglycerol kinase zeta,40044,0.0240079844441331,0.00331938437922647,0.0175019910608492,0.030513977827417,4.95635305436023e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0376603402971569,0.00521328136948404,-0.0478783717813456,-0.0274423088129682,5.28011886999141e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEPACAM2,HEPACAM family member 2,37942,-0.0277920625010681,0.00385875041163155,-0.035355213307866,-0.0202289116942703,6.23213053470355e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYZL2,Lysozyme-like protein 2,37482,0.0244867098191065,0.0034020002356292,0.0178187893572732,0.0311546302809397,6.45724997640825e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,-0.0164422112092709,0.0022882585523949,-0.0209271979719649,-0.0119572244465769,6.99151116857815e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSTL1,Follistatin-related protein 1,37628,-0.0153095293666352,0.00213157036914843,-0.0194874072901661,-0.0111316514431042,7.22405052822517e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.015216151370015,0.00212045412926203,0.0110600612766614,0.0193722414633686,7.55724439442535e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP2,Retinol-binding protein 2,40305,-0.0513689281483559,0.00719296068776824,-0.0654671310963817,-0.0372707252003301,9.62894500564574e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.0368954039784491,0.00516925924117273,0.0267636558657505,0.0470271520911476,1.00067003769843e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM3,Myomesin-3,37671,-0.060841518167191,0.00854244022721275,-0.077584701012528,-0.044098335321854,1.116605054554e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.031731864513921,0.00445939077485467,0.0229914585952058,0.0404722704326362,1.1619953333158e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNA1,Ephrin-A1,40303,0.0183388860573734,0.00258251879550529,0.013277149218183,0.0234006228965637,1.28965952992152e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0307608159668527,0.00433224406324318,0.0222696176028961,0.0392520143308094,1.30774032346191e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.0385907204029988,0.00543895083653977,0.0279303767633808,0.0492510640426168,1.3558097085801e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0337848591389677,0.00477042075589813,0.0244348344574073,0.043134883820528,1.49131434140727e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNC,Tenascin,40403,-0.031534213891844,0.00446589492483248,-0.0402873679445156,-0.0227810598391723,1.71981771901558e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP4,Dipeptidyl peptidase 4,40068,0.0199534867026459,0.00282591590169464,0.0144146915353244,0.0254922818699674,1.72410918710451e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFD,Vascular endothelial growth factor D,40483,-0.0222207914514302,0.00314851671109942,-0.0283918842051851,-0.0160496986976753,1.76414858083189e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MATN2,Matrilin-2,40379,0.0197879252102376,0.00280496035952499,0.0142902029055686,0.0252856475149066,1.80200089114611e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPL,Periplakin,37598,0.0220510569937147,0.00312858047341035,0.0159190392658305,0.028183074721599,1.90203525868382e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,0.0225306581301125,0.00319793677627236,0.0162627020486187,0.0287986142116064,1.92549584141911e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFR,Epidermal growth factor receptor,40536,0.0108958292235356,0.00154690238310955,0.00786390055264091,0.0139277578944303,1.9486251492363e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK2,SLIT and NTRK-like protein 2,40489,0.0252328851177684,0.00358385954833687,0.0182085204030282,0.0322572498325087,1.99032374078403e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0287711812830211,0.00408591875489482,0.0207627805234272,0.0367795820426149,1.99568223282292e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.0280943157273486,0.00399006731915918,0.0202737837817966,0.0359148476729006,2.00039215348281e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A14,Protein S100-A14,37959,0.0357056989741447,0.00509859086063878,0.0257124608872927,0.0456989370609968,2.62288760061454e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFIC,Nuclear factor 1 C-type,37959,0.0289489554526554,0.00413596430607655,0.0208424654127454,0.0370554454925654,2.69337062116941e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNB2,Plexin-B2,40472,0.0153916280208388,0.00220352124938742,0.0110727263720395,0.0197105296696382,2.96029994271982e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.0434736595007283,0.00622511910675568,0.0312724260514872,0.0556748929499694,3.01254079353952e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.0362803893926899,0.00521251266272605,0.0260638645737469,0.046496914211633,3.55412542315586e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MST1,Hepatocyte growth factor-like protein,37787,0.040548320899203,0.00583230881534663,0.0291169956211236,0.0519796461772823,3.75938187213289e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.0399328632026294,0.00575034512193882,0.0286621867636294,0.0512035396416295,3.97856056727395e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECE1,Endothelin-converting enzyme 1,39961,0.0231705355333842,0.00334038125856812,0.0166233882665907,0.0297176828001777,4.17841516899595e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.0171154827983824,0.00246732322668371,0.0122795292740824,0.0219514363226825,4.19234012898579e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGA4,Pepsin A-4,37987,0.0446489236637823,0.00644191109367266,0.0320227779201839,0.0572750694073807,4.36777361957281e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.0217212605199092,0.00314878232967834,0.0155496471537397,0.0278928738860788,5.49801394344871e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.0501416448317291,0.00730278518512224,-0.0644551037945687,-0.0358281858688895,6.84223320979377e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0381808458584578,0.00556226456286809,0.0272788073152363,0.0490828844016793,6.97802498549381e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPHS1,Nephrin,37598,0.0225836648593753,0.00329046463678217,0.0161343541712822,0.0290329755474683,7.02725754547957e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.0167464040752868,0.00244328786037404,0.0119575598689537,0.0215352482816199,7.44174214967202e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLU,Clusterin,38013,0.0214479219980219,0.00313526274079856,0.0153028070260567,0.0275930369699871,8.20895215052273e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD101,Immunoglobulin superfamily member 2,37901,0.0275687373602352,0.00403084778998458,0.0196682756918654,0.035469199028605,8.29392185438434e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,40305,0.0136187698615208,0.00199862660818261,0.00970146170948289,0.0175360780135587,9.82963646584678e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MILR1,Allergin-1,40044,-0.0321161751649639,0.00473153868371411,-0.0413899909850436,-0.0228423593448842,1.18059845736002e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.0621508471820264,0.00916022195780739,0.0441968121447239,0.0801048822193288,1.20303425970962e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF7,SLAM family member 7,40341,-0.0367772758057143,0.00545821804151449,-0.0474753831670827,-0.0260791684443459,1.66140409490343e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY75,Lymphocyte antigen 75,40341,0.024766198650599,0.0036795525031122,0.0175542757444991,0.0319781215566989,1.7454920539368e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMOD1,Leiomodin-1,37959,-0.0231278027285426,0.0034367676415285,-0.0298638673059385,-0.0163917381511467,1.77085669409248e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC2,WAP four-disulfide core domain protein 2,39535,0.0242273086597243,0.00360140271919656,0.0171685593300991,0.0312860579893496,1.79200838172736e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.0209923467365331,0.00312102489800416,-0.0271095555366212,-0.0148751379364449,1.8130628845906e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.0192354268949484,0.00286697120003144,-0.0248546904470101,-0.0136161633428868,2.03614708267757e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHPS,Deoxyhypusine synthase,37900,0.0261558688122994,0.00390220959357798,0.0185075380088866,0.0338041996157123,2.12563035414881e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP7,Dipeptidyl peptidase 2,40251,0.0366580261056856,0.00547794777292099,0.0259212484707605,0.0473948037406107,2.27657550514236e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.0234341703281999,0.00350158670367686,0.0165710603889932,0.0302972802674065,2.28170761763941e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.0164237144423296,0.00245471521924263,-0.0212349562720451,-0.011612472612614,2.30863059719821e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM4,Intercellular adhesion molecule 4,40341,-0.0333839478179805,0.00499074685832227,-0.0431658116602922,-0.0236020839756689,2.31933772853541e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4D,C-type lectin domain family 4 member D,40341,0.0386982055664314,0.00578707068940461,0.0273555470151984,0.0500408641176645,2.35368148965277e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCAN,Versican core protein,40471,-0.0190142322825931,0.00284421891921268,-0.02458890136425,-0.0134395632009363,2.38191723745647e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTT2B,Glutathione S-transferase theta-2B,37942,0.150830809797539,0.0226303110955353,0.10647540005029,0.195186219544789,2.74966317901813e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL2,Fc receptor-like protein 2,40442,0.0306585648321057,0.00460390382240054,0.0216349133402007,0.0396822163240108,2.84187866365565e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGA,Glycoprotein hormones alpha chain,40332,0.0564531149299151,0.00847784027261219,0.0398365479955952,0.073069681864235,2.84928751296654e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENSA,Alpha-endosulfine,37900,0.0332777273451362,0.00500324788511813,0.0234713614903047,0.0430840931999677,3.01899877317424e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDM1,Nuclear protein MDM1,37572,0.0197253517080041,0.00296621183595114,0.0139115765095398,0.0255391269064683,3.04672973230094e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.0151857932074112,0.00228943912491501,0.0106984925225778,0.0196730938922446,3.39700735758424e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFAP1,Actin filament-associated protein 1,37671,0.0531533709575676,0.00802951755652553,0.0374155165467775,0.0688912253683576,3.73704853002894e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CR1,Complement receptor type 1,37959,0.0227078516811129,0.00343177369711401,0.0159815752347694,0.0294341281274564,3.80527529591321e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CABP2,Calcium-binding protein 2,37572,0.0410358446241992,0.00620193142728511,0.0288800590267204,0.053191630221678,3.81764159009087e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.0238344392569943,0.00360387282993606,0.0167708485103196,0.030898030003669,3.8738038556785e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.0189846306947501,0.00287088023661884,-0.024611555958523,-0.0133577054309772,3.89310984125886e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.0454200155130411,0.00688214405271917,0.0319310131697115,0.0589090178563707,4.27853286312535e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.0319146790464522,0.00484291159620388,0.0224225723178926,0.0414067857750118,4.54056507623712e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.0255666789029203,0.00388529927906294,0.017951492315957,0.0331818654898837,4.86685996096394e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK6,Kallikrein-6,40387,0.0188746025287449,0.00288051056408028,0.0132288018231476,0.0245204032343423,5.83089224638488e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.046070230234689,0.00703138304569101,0.0322887194651346,0.0598517410042433,5.88341406511642e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGR2,Anterior gradient protein 2 homolog,39839,0.062864554094436,0.00959712017128939,0.0440541985587088,0.0816749096301632,5.92212618343137e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN3,Calsyntenin-3,37942,0.0189797249538985,0.00289767100157052,0.0133002897908203,0.0246591601169767,5.9625705092155e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.0177290102133018,0.00270799972238423,0.0124213307574287,0.0230366896691749,6.09197114630132e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A13,Protein S100-A13,37598,0.0216165713859392,0.00330519427044512,0.0151383906158668,0.0280947521560116,6.37172195663095e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300A,CMRF35-like molecule 8,37671,0.0183038496487747,0.00280421968072368,0.0128075790745562,0.0238001202229931,6.94320666037889e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGER,Advanced glycosylation end product-specific receptor,40311,0.0250072090374957,0.00383257950448265,0.0174953532087097,0.0325190648662817,7.01073563321756e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.0270524261479899,0.00414950289962055,0.0189194004647336,0.0351854518312462,7.27564470673026e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABEPK,Rab9 effector protein with kelch motifs,39980,0.0370242354123892,0.00569319344638582,0.025865576257473,0.0481828945673054,8.1006553302812e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0366688458717587,0.00564200136093713,0.0256105232043219,0.0477271685391955,8.36343128069779e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6L2,Seizure 6-like protein 2,40305,-0.014572154186398,0.00224542107342289,-0.0189731794903069,-0.0101711288824892,8.85473455304282e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.0335657487282796,0.00519183313330592,0.023389755787,0.0437417416695592,1.04186529663347e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.0121542306142865,0.001880272310699,-0.0158395643432565,-0.00846889688531646,1.04893554197996e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BST2,Bone marrow stromal antigen 2,40471,0.0326787098094664,0.00506420556545397,0.0227528669011766,0.0426045527177562,1.12894258419149e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGFAC,Hepatocyte growth factor activator,37849,0.0176855176053097,0.00274360761892004,0.0123080466722264,0.023062988538393,1.18711410688778e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.0235703146410211,0.00367131266057269,0.0163745418262986,0.0307660874557436,1.40026097352208e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,-0.0234729785801601,0.00366314411723926,-0.0306527410499491,-0.0162932161103712,1.51712986983941e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSME2,Proteasome activator complex subunit 2,40152,0.0224393804160176,0.00350485639815381,0.0155698618756361,0.029308898956399,1.57329325495429e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17D,Interleukin-17D,40044,0.0206985696903929,0.00324651529087903,0.01433539972027,0.0270617396605157,1.87340806121987e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XG,Glycoprotein Xg,40458,0.0180360955569372,0.00283189341775452,0.0124855844581384,0.0235866066557361,1.95558963201935e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.0483587253737583,0.00759352233891378,0.0334754215894873,0.0632420291580293,1.96357230949603e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIMAP8,GTPase IMAP family member 8,37482,0.0312579671344594,0.00490978710253313,0.0216347844134944,0.0408811498554243,1.99928075993527e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR15L,Protein GPR15L,37901,0.0363816837266886,0.00571628268959449,0.0251777696550834,0.0475855977982938,2.02190825451277e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.0262423811557315,0.00413772515836604,0.0181324398453341,0.034352322466129,2.32709356627192e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C8B,Complement component C8 beta chain,38013,0.0183525711045536,0.00289436574363262,0.0126796142470337,0.0240255279620735,2.3583287674009e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN5,CCN family member 5,40332,0.0235340992441548,0.00371301732413373,0.0162565852888527,0.0308116131994569,2.38629727531842e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFC1,Cryptic protein,39980,0.0276904959914667,0.00437021551581076,0.0191248735804776,0.0362561184024558,2.4201329780738e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.0241874377746692,0.00382630924723618,0.0166878716500863,0.0316870038992522,2.67477748727281e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD59,CD59 glycoprotein,39665,0.0134653790943701,0.00213386278457658,0.00928300803660002,0.0176477501521402,2.86148204154782e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRK1,NKG2-D type II integral membrane protein,37942,0.0275825132736357,0.00437206672365406,0.0190132624952737,0.0361517640519976,2.89982761672594e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.0288506903757599,0.00459420842959707,-0.0378553388977702,-0.0198460418537497,3.47834586121975e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAG3,Lymphocyte activation gene 3 protein,40305,-0.024344744401235,0.00388891185069449,-0.0319670116285962,-0.0167224771738738,3.947792330912e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BSG,Basigin,40502,0.0119484855061847,0.00190957267375664,0.00820572306562172,0.0156912479467477,4.02015203549067e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO2,Roundabout homolog 2,40471,0.0137178089826599,0.00220298529446212,0.0093999578055141,0.0180356601598056,4.87557634484176e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300E,CMRF35-like molecule 2,40436,0.0235063304505896,0.00377836818865027,0.016100728800835,0.0309119321003441,5.05353133405757e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA2,Carbonic anhydrase 2,40291,0.0415417934123695,0.00668561380041686,0.0284379903635524,0.0546455964611865,5.3075733923444e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.0238510863474979,0.00385680372150203,0.0162917510533539,0.0314104216416419,6.39912236853862e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.0495587373010476,0.0080253659134933,0.0338290201106007,0.0652884544914944,6.80051550101007e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.0195413862314708,0.00316512541489327,0.01333774041828,0.0257450320446616,6.84994173917388e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.0343079166378587,0.00556040172307396,0.0234095292606338,0.0452063040150837,6.9958454195991e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN4B,Sodium channel subunit beta-4,37628,0.0244792216733325,0.0039749290968948,0.0166883606434187,0.0322700827032463,7.56179341918631e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMIGO2,Amphoterin-induced protein 2,40305,0.0131247321528913,0.00213164697876826,0.00894670407450552,0.0173027602312771,7.58812759067616e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG4,Desmoglein-4,40250,0.0295465033327666,0.00481169683449453,0.0201155775371573,0.0389774291283759,8.41994577554614e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICOSLG,ICOS ligand,40305,0.0110626516269499,0.00180769261767048,0.00751957409631575,0.014605729157584,9.59187290134565e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FES,Tyrosine-protein kinase Fes/Fps,39980,0.0275113860184169,0.00450037951509388,0.0186906421688329,0.0363321298680009,1.00035095513298e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB6A,Ras-related protein Rab-6A,40341,0.0275808922878328,0.00451713793163344,0.0187273019418312,0.0364344826338343,1.04644227269941e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.045072745165368,0.00738451592615242,0.0305990939501093,0.0595463963806268,1.06560961766674e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDNF,Glial cell line-derived neurotrophic factor,39961,0.0220907183278551,0.00362802152135509,0.0149797961459991,0.0292016405097111,1.16357826986145e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,-0.0197585787492329,0.00324560436926042,-0.0261199633129833,-0.0133971941854825,1.17100747766299e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A12,Protein S100-A12,40139,0.0440263602063027,0.00723300333783763,0.029849673664141,0.0582030467484645,1.17818345262042e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.0395313935389431,0.00650008163108162,0.0267912335420232,0.0522715535358631,1.22223242456662e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH1,Cadherin-1,39806,0.0230439348056172,0.00379079876425046,0.0156139692276863,0.0304739003835481,1.23863403303829e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSHB,Thyrotropin subunit beta,40359,0.0479834460812693,0.00792541688980048,0.0324496289772604,0.0635172631852783,1.44131488007304e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN10,Ataxin-10,39961,0.041513112645756,0.00686349806030519,0.0280606564475578,0.0549655688439541,1.49660138257659e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP4,Guanylate-binding protein 4,39961,0.0282411241532426,0.00467263812068359,0.0190827534367028,0.0373994948697824,1.53843258792728e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0381977691024977,0.0063201641132615,0.0258102474405052,0.0505852907644903,1.54641626082138e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.0581023414495249,0.00961703444214653,0.0392529539429177,0.0769517289561321,1.56721171921098e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RSPO3,R-spondin-3,40489,0.0162774202405997,0.00270432030146221,0.0109769524497338,0.0215778880314656,1.79272483067563e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSC,Dipeptidyl peptidase 1,40349,0.0242119758751488,0.00402665315884887,0.016319735683805,0.0321042160664926,1.86189436481467e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.0504051928437922,0.00838702393117494,0.0339666259386893,0.0668437597488951,1.89677973987314e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.0148521566750696,0.00247234918844838,-0.0196979610844284,-0.0100063522657108,1.93604052386103e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSBP1,Heat shock factor-binding protein 1,37628,0.0543972083410235,0.00905572909977393,0.0366479793054666,0.0721464373765804,1.9404124596873e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYTL1,Cytokine-like protein 1,37998,0.0130801500215967,0.00218016442717089,0.0088070277443417,0.0173532722988516,2.02828162255165e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPE,Carboxypeptidase E,40360,-0.0217058104283922,0.00361889483411374,-0.0287988443032552,-0.0146127765535293,2.04199968540094e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD28,T-cell-specific surface glycoprotein CD28,39980,0.0203504847584565,0.0034070639756697,0.0136726393661438,0.0270283301507691,2.37975682264721e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPO,Myeloperoxidase,40332,0.0263927550650307,0.00442486088573221,0.0177200277289956,0.0350654824010658,2.50359479005758e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA12,Serpin A12,39903,0.0644357941993785,0.0108049066949808,0.043258177077216,0.0856134113215409,2.52169926323166e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCP1,Plastin-2,37998,0.0265913238548328,0.00446458896350905,0.0178407294863551,0.0353419182233106,2.64807357155704e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP3,"Fatty acid-binding protein, heart",37990,0.026746245652547,0.00450534540488626,0.0179157686589699,0.0355767226461241,2.98191693956997e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEL1L,Protein sel-1 homolog 1,37628,0.0182705774098903,0.00307783192751698,0.012238026831957,0.0243031279878235,2.99068909237301e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.014077819533366,0.00237254710792743,-0.0187280118649038,-0.00942762720182826,3.03721973975392e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA12,Carbonic anhydrase 12,40305,-0.0181069451864703,0.00305436758315243,-0.024093505649449,-0.0121203847234915,3.12603121357355e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALPP,"Alkaline phosphatase, placental type",40305,0.0576662917407545,0.00974293341805753,0.0385701422413617,0.0767624412401472,3.31025617743681e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB6,Integrin beta-6,40044,0.0168839508163105,0.00285964385422017,0.0112790488620389,0.022488852770582,3.61690907164803e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA1,Apolipoprotein A-I,38013,-0.0154155077715827,0.00261335763534836,-0.0205376887368654,-0.0102933268062999,3.75023689320281e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EBI3_IL27,Interleukin-27,40453,-0.017391928943714,0.0029513532937158,-0.023176581399397,-0.011607276488031,3.87177529040297e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSLN,Mesothelin,40271,0.0301705220300349,0.00512435337120719,0.0201267894224688,0.040214254637601,3.99598752547092e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MBL2,Mannose-binding protein C,37810,-0.0594131593634268,0.0101043641599973,-0.0792177131170215,-0.0396086056098322,4.20194266672864e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RCOR1,REST corepressor 1,40042,0.0249257815125726,0.00424095463467669,0.0166135104286063,0.033238052596539,4.25267964363138e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMNB2,Lamin-B2,37942,0.0152098161218264,0.00259341219905685,0.010126728211675,0.0202929040319778,4.60233573874132e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PI3,Elafin,40074,0.0296949928137502,0.00506562348356746,0.019766370785958,0.0396236148415424,4.66372036069304e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1R1,Interleukin-1 receptor type 1,40303,-0.0123604153772913,0.00211338898352443,-0.0165026577849992,-0.00821817296958341,5.05415717455024e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1A,Protein phosphatase 1A,39980,0.0171807163326557,0.00294034938658133,0.0114176315349563,0.0229438011303551,5.2268333318133e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.0199864084485146,0.00342507643300159,0.0132732586398314,0.0266995582571977,5.47531736026904e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGA,Fibrinogen alpha chain,37698,0.0169601076504059,0.00291637787119018,0.0112440070228731,0.0226762082779387,6.18588424391267e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1B,Interleukin-1 beta,39946,0.0309979853056016,0.00533972262037377,0.020532128969669,0.0414638416415341,6.55593683453156e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,-0.0229897612865819,0.00396410149053105,-0.0307594002080227,-0.015220122365141,6.77839957734211e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAS2,Growth arrest-specific protein 2,37714,0.0294398611450882,0.00507681137895131,0.0194893108423437,0.0393904114478328,6.82772214903243e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.0194916609389222,0.00336269003868518,0.0129007884630992,0.0260825334147451,6.90208481843047e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,0.0158293616661036,0.0027372035535731,0.0104644427011003,0.0211942806311069,7.4740968589501e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITM2A,Integral membrane protein 2A,40341,-0.0323131548433458,0.00559519073907846,-0.0432797286919396,-0.0213465809947521,7.83138473273799e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300LF,CMRF35-like molecule 1,40489,0.0330564138491859,0.00574663069152039,0.0217930176938059,0.0443198100045658,8.96355670053508e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC16A1,Monocarboxylate transporter 1,39961,0.0327111412610852,0.00569451250228482,0.021549896756607,0.0438723857655635,9.40177376739453e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAMP5,Vesicle-associated membrane protein 5,40042,0.0304510884535866,0.00530328259073424,0.0200566545757475,0.0408455223314257,9.53453612235757e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.0178099017787753,0.00310243683856574,-0.0238906779823642,-0.0117291255751865,9.60578671500073e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD1,Programmed cell death protein 1,40455,0.0237604233020277,0.00414105800749923,0.0156439496073292,0.0318768969967262,9.76683378441432e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL3,Fc receptor-like protein 3,40044,0.0297264478900984,0.00518818386215098,0.0195576075202825,0.0398952882599143,1.02499625267448e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA6,Carbonic anhydrase 6,40295,-0.0345664537712385,0.00603561503414785,-0.0463962592381683,-0.0227366483043087,1.04026708565898e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPARCL1,SPARC-like protein 1,40346,-0.0149118650399268,0.00260945505121481,-0.0200263969403078,-0.00979733313954573,1.11965254962221e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGCR6,Protein DGCR6,37541,0.0246008053258823,0.0043148267181035,0.0161437449583995,0.0330578656933652,1.21352975745489e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRISP3,Cysteine-rich secretory protein 3,37875,-0.0145792989897423,0.00256057077723663,-0.019598017713126,-0.00956058026635846,1.26868485789114e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA5,Protein disulfide-isomerase A5,37482,0.0331416960628643,0.00582802898635919,0.0217187592496002,0.0445646328761283,1.32373914755906e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN2,Prefoldin subunit 2,39961,0.0302432540201009,0.00532361096482832,0.0198089765290374,0.0406775315111644,1.36340390190945e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBP1,Z-DNA-binding protein 1,37598,0.0216867955195701,0.00382039633070909,0.0141988187113803,0.02917477232776,1.40317596139547e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0193019026942549,0.00340894128768795,0.0126203777703865,0.0259834276181233,1.52083602754613e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR4,Complement factor H-related protein 4,37973,0.0393280613969004,0.0069557694239084,0.0256947533260399,0.0529613694677609,1.59909112402456e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE3,Eosinophil cationic protein,40288,0.0579598314653905,0.0102685407936999,0.0378334915097387,0.0780861714210423,1.68591769186225e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.0256713237368491,0.00455117084697642,0.0167510288767753,0.0345916185969228,1.72876283777252e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS4,Galectin-4,40357,0.0281386967390484,0.00499470060133768,0.0183490835604266,0.0379283099176703,1.79360656312498e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF1C,Kinesin-like protein KIF1C,37562,0.020094255826472,0.00357034382863303,0.0130963819223513,0.0270921297305927,1.85939732736956e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2,Apoptosis regulator Bcl-2,37901,0.0287960909161008,0.00512787963176117,0.0187454468378489,0.0388467349943527,1.99767809511263e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN1,Tetraspanin-1,40042,0.0162134380250333,0.0028906558727197,0.0105477525145027,0.0218791235355639,2.07059759965189e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSH,Pro-cathepsin H,40013,0.0383446477992336,0.0068536713395915,0.0249114519736342,0.0517778436248329,2.24649980034938e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.0204579004929461,0.00365778306663227,0.0132886456823468,0.0276271553035453,2.27660247159562e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A11,Protein S100-A11,40207,0.0237525566596419,0.00424897461012493,0.015424566423797,0.0320805468954867,2.30590114430669e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTPN,Myotrophin,40042,0.0175350301784599,0.00313798629456865,0.0113845770411054,0.0236854833158145,2.33561026326678e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPC1,Glypican-1,40489,0.015515804462649,0.00277851957700741,0.0100699060917145,0.0209617028335835,2.38590685513616e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOC,Brother of CDO,40042,-0.0124435915702525,0.00223559176023272,-0.0168253514203086,-0.00806183172019632,2.64754897469685e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBA,Lysosomal acid glucosylceramidase,37572,0.0278464437531673,0.00501373103821302,0.0180195309182698,0.0376733565880648,2.84576825543705e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIMAP7,GTPase IMAP family member 7,37671,-0.0170226079336507,0.00307708425978667,-0.0230536930828326,-0.0109915227844688,3.2251064560332e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO1,Roundabout homolog 1,40379,0.0125854498285331,0.00227754386767878,0.00812146384788272,0.0170494358091835,3.32966896018308e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300C,CMRF35-like molecule 6,40471,0.0178196265889204,0.00322675149059457,0.0114951936673551,0.0241440595104858,3.39473658681659e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LXN,Latexin,40183,-0.0346738672886965,0.0062793117686225,-0.0469813183551966,-0.0223664162221965,3.40622201107509e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKD2,Serine/threonine-protein kinase D2,37562,0.0248575625926186,0.00450641434452936,0.016024990477341,0.0336901347078961,3.53292798671983e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0201235515644441,0.00365261583644772,0.0129644245250065,0.0272826786038816,3.65857816933919e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OBP2B,Odorant-binding protein 2b,40184,-0.0345128706305549,0.00626950194460114,-0.0468010944419731,-0.0222246468191366,3.7519443993859e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.0200678044729958,0.00365005560649163,0.0129136954842722,0.0272219134617195,3.91430743364667e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.0188766914276618,0.00346681097438826,0.0120817419178608,0.0256716409374628,5.2741821304767e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JAM2,Junctional adhesion molecule B,40471,0.0134510358094484,0.00247072609520573,0.00860841266284521,0.0182936589560517,5.28152703333979e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.0222287726037814,0.00408406999189718,0.0142239954196629,0.0302335497878999,5.33821064347523e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.0251609067415198,0.00462451784110497,0.016096851772954,0.0342249617100855,5.3852951657018e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.0207371228817278,0.00381556739275077,0.0132586107919363,0.0282156349715193,5.57843159657008e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PREB,Prolactin regulatory element-binding protein,40044,0.0152501055009237,0.00281086164035835,0.00974081668582132,0.0207593943160261,5.86807413563127e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD209,CD209 antigen,40382,-0.019916630771058,0.00367539659690917,-0.0271204081009999,-0.012712853441116,6.08358517096976e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL21,C-C motif chemokine 21,40422,0.0217281847226189,0.00402103345024455,0.0138469591601396,0.0296094102850982,6.62409277029449e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0190061068858663,0.00351756374167921,0.0121116819521751,0.0259005318195576,6.64066910961e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.0155045151155009,0.00287253662357731,0.00987434333328937,0.0211346868977124,6.85692010396691e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,-0.0134777361640514,0.00249805193870375,-0.0183739179639108,-0.00858155436419208,6.93915808781496e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GM2A,Ganglioside GM2 activator,37714,0.0196760524340839,0.00364715580196083,0.0125276270622407,0.0268244778059272,6.97378582504106e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.0135654714367747,0.00251659447599157,0.00863294626383122,0.0184979966097182,7.12999597886252e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL5,Fc receptor-like protein 5,40332,-0.0285367714318098,0.00529891180840149,-0.0389226385762767,-0.0181509042873429,7.33111485956418e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK8,Kallikrein-8,39801,0.018088749967337,0.00336277076194521,0.0114977192739244,0.0246797806607496,7.59474122941702e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.0148470958002098,0.00276012540357179,-0.0202569415912105,-0.00943725000920911,7.61139060876031e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.0182402479987244,0.00339357070186462,0.0115888494230698,0.0248916465743791,7.79188137397798e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB37,Ras-related protein Rab-37,40044,0.0424384997929914,0.00790120118829039,0.0269521454639423,0.0579248541220406,7.93602014240568e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL28,C-C motif chemokine 28,40278,0.0302854937003017,0.00564365281987203,0.0192239341733525,0.0413470532272509,8.15029497616968e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG3,Desmoglein-3,40419,0.0170048021653319,0.00316902986729872,0.0107935036254264,0.0232161007052374,8.16552315648798e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18BP,Interleukin-18-binding protein,40403,0.0154578109055156,0.00288275261952067,0.0098076157712551,0.0211080060397761,8.33730053067545e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAM,Integrin alpha-M,40332,-0.0160548566485051,0.00299912615178732,-0.0219331439060082,-0.0101765693910019,8.7623735352051e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL1,Angiopoietin-related protein 1,40136,0.0148853068133384,0.0027952063040022,0.00940670245749411,0.0203639111691827,1.02177348384788e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSTL3,Follistatin-related protein 3,40293,0.0156932636922448,0.00295518758991712,0.00990109601600729,0.0214854313684824,1.10854638467584e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB1A1,Uteroglobin,40384,0.0284919185195289,0.00536734798375297,0.0179719164713731,0.0390119205676848,1.12087071811535e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTB,Lymphotoxin-beta,37900,0.01784388029823,0.00336255307936837,0.011253276262668,0.024434484333792,1.13433399045537e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA7,Carbonic anhydrase 7,37714,-0.0177029688612748,0.00333962599072779,-0.0242486358031013,-0.0111573019194483,1.17091322722781e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.022761505050296,0.00429695504068231,0.0143394731705587,0.0311835369300333,1.19495459734877e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD109,CD109 antigen,40332,-0.0167575690040733,0.00316410346290655,-0.0229592117913702,-0.0105559262167765,1.19845684554186e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA11,Integrin alpha-11,40341,-0.0170491535005788,0.00322268561733253,-0.0233656173105506,-0.0107326896906071,1.23698071528267e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOB,Apolipoprotein B-100,37987,0.0111634116648591,0.00211694157495567,0.00701420617794599,0.0153126171517722,1.3600450274986e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN4,Contactin-4,40332,-0.0121233967097427,0.00230154253043006,-0.0166344200693856,-0.00761237335009977,1.40091969476558e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA9,Carbonic anhydrase 9,40489,-0.0223236224797129,0.00426086575431316,-0.0306749193581667,-0.0139723256012591,1.63295446263148e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHB4,Ephrin type-B receptor 4,40536,-0.0121926809994013,0.0023295824879284,-0.016758662675741,-0.00762669932306164,1.68103268885886e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LUZP2,Leucine zipper protein 2,37900,0.0221761507888928,0.00423866082460066,0.0138683755726755,0.0304839260051101,1.7031865800001e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS11D,Transmembrane protease serine 11D,37921,0.019133467085415,0.00366322582223579,0.0119535444738328,0.0263133896969971,1.78555466600162e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.0180122057607233,0.00345338254780813,0.0112435759670193,0.0247808355544272,1.85282558053788e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.0342118343068255,0.00655889828241678,-0.0470672749403624,-0.0213563936732886,1.85447919091304e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PODXL,Podocalyxin,40305,0.00749362376553757,0.00143770721814217,0.00467571761797892,0.0103115299130962,1.88951386536742e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YAP1,Transcriptional coactivator YAP1,37942,0.013156702362452,0.00252647878157284,0.00820480395056919,0.0181086007743347,1.94190312757224e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.0176279345118048,0.00339036922017974,0.0109828108402525,0.0242730581833571,2.02925090624722e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0199267931558384,0.00384368955842589,0.0123931616213236,0.0274604246903531,2.20071811122809e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA4,Apolipoprotein A-IV,38013,0.0180765238852608,0.00348980122467783,0.0112365134848922,0.0249165342856293,2.25288996127166e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNXB,Tenascin-X,40332,-0.0124686508259504,0.00241233696152303,-0.0171968312705355,-0.00774047038136521,2.38583569040198e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECM1,Extracellular matrix protein 1,37655,0.0181395881788999,0.00350997399395683,0.0112600391507445,0.0250191372070553,2.40048957142569e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH6,Cadherin-6,40359,-0.018435514936764,0.00358540720240693,-0.0254629130534815,-0.0114081168200464,2.75318549623837e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.0506452482293267,0.00985611347124196,0.0313272658256925,0.0699632306329609,2.80976127817133e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0164265288174311,0.00319999188676134,0.0101545447193788,0.0226985129154833,2.88028561232986e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKAP4,Cytoskeleton-associated protein 4,40457,0.0126760245502893,0.00247464058053378,0.00782572901244314,0.0175263200881355,3.05224034050231e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.00751632981862281,0.00146805718481681,0.00463893773638187,0.0103937219008638,3.09198066380199e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HYAL1,Hyaluronidase-1,40214,0.0111232534259025,0.00217435939915229,0.00686150900356397,0.0153849978482409,3.16338177891906e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD80,T-lymphocyte activation antigen CD80,37990,0.0164898402501645,0.00322693776365935,0.0101650422333922,0.0228146382669369,3.26444803336209e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL9,C-X-C motif chemokine 9,40422,0.0326872672315902,0.00640719185495089,0.0201291711958864,0.0452453632672939,3.40558944927407e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.0181993067687866,0.00357511301253563,-0.0252065282733565,-0.0111920852642168,3.61961673706129e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.0109094998981431,0.00214520279144435,0.00670490242691217,0.015114097369374,3.70796030281981e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RALY,RNA-binding protein Raly,37900,0.0232327213381084,0.00457811167664795,0.0142596224518785,0.0322058202243384,3.93206426169121e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPS10,40S ribosomal protein S10,37562,-0.0203824898258467,0.00401988240516826,-0.0282614593399765,-0.0125035203117169,4.02356192073757e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINI1,Neuroserpin,37642,0.0153482664042198,0.003027077695553,0.00941519412093595,0.0212813386875037,4.02523352290376e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN3,CCN family member 3,40522,0.0161436720957374,0.00319374730655762,0.00988392737488449,0.0224034168165903,4.35634531869272e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.0135511105888312,0.00268170388692674,-0.0188072502072076,-0.00829497097045482,4.39390604397588e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN2,Ataxin-2,37541,0.0550967780486006,0.010939862747484,0.0336546470635321,0.0765389090336692,4.80855748121759e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MATN3,Matrilin-3,40203,-0.0148137713345949,0.00295997969996798,-0.0206153315465321,-0.00901221112265765,5.655649109609e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.0275819803038033,0.00551612124085347,0.0167703826717305,0.038393577935876,5.78657299311426e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPM3,Tropomyosin alpha-3 chain,37562,-0.0201414019126625,0.00403542187039182,-0.0280508287786304,-0.0122319750466945,6.07908051339079e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHI3L1,Chitinase-3-like protein 1,40054,0.0349305430048938,0.00703561813028602,0.0211407314695332,0.0487203545402544,6.94926099678363e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.0124404074972859,0.00250888827188382,-0.0173578285101782,-0.00752298648439364,7.19214488067673e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,-0.00960757884893323,0.00194422635356894,-0.0134182625019283,-0.00579689519593812,7.84381715838099e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.0118344799798285,0.00239609968810722,0.0071381245911384,0.0165308353685187,7.92902593275055e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.0181476417284482,0.00367589340714985,-0.0253523928064619,-0.0109428906504345,8.03053284391584e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.0258660362741783,0.005251938493477,0.0155722368269634,0.0361598357213932,8.52045675336844e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALB1,Calbindin,40305,0.0197529465902788,0.00401188999466334,0.0118896422007387,0.027616250979819,8.58206800395676e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.0240179053472805,0.00488534956327808,0.0144426202032555,0.0335931904913055,8.90902592621765e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNLY,Granulysin,40332,0.023600980853878,0.00480697710490697,0.0141793057282603,0.0330226559794956,9.21058378330101e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAM1,Neural cell adhesion molecule 1,40403,-0.0128275237512802,0.002612875780523,-0.0179487602811053,-0.00770628722145515,9.2281852661245e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.0159136557865403,0.00324173573395208,0.00955985374799424,0.0222674578250864,9.26418961943106e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD1,Bromodomain-containing protein 1,37714,-0.0144228949823105,0.00294567775788451,-0.0201964233877641,-0.00864936657685682,9.88128685470092e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.0126850385606749,0.00259297682898124,0.00760280397587171,0.0177672731454782,1.00750106106386e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF16,Fibroblast growth factor 16,37598,0.0228416856856864,0.00466874466811644,0.0136909461361782,0.0319924252351946,1.00758888671797e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC16,Mucin-16,40305,0.0865651939225235,0.0177264019500309,0.0518214461004629,0.121308941744584,1.05285842315873e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.0135786073160931,0.00278511570838336,0.00811978052766171,0.0190374341045245,1.09618197679142e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCN,Decorin,40042,-0.0105018166958884,0.00215980021128783,-0.0147350251100125,-0.00626860828176423,1.17100299400561e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF3,Granulocyte colony-stimulating factor,40044,0.0225136522993515,0.0046304247229609,0.0134380198423482,0.0315892847563549,1.1727046919092e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.0195530761846242,0.00402648916576375,0.0116611574197272,0.0274449949495212,1.20848683074486e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.0187814427648138,0.00387129103730142,0.0111937123317031,0.0263691731979246,1.23721521759107e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUCA1,Tissue alpha-L-fucosidase,40437,0.0372195071716859,0.00767921246560924,0.0221682507390918,0.05227076360428,1.26655074685076e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.0333415097573286,0.00689183126533964,0.0198335204772629,0.0468494990373943,1.32713253385352e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX1,Peroxiredoxin-1,39953,-0.0408169874386988,0.00844491105914993,-0.0573690131146327,-0.0242649617627649,1.3555854695957e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMMD9,COMM domain-containing protein 9,37900,0.0180094303404679,0.00372602765626044,0.0107064161341975,0.0253124445467384,1.35694885518364e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.0158379143930752,0.00327739931690542,0.00941421173194054,0.0222616170542098,1.36115625407346e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.0127283717217224,0.00263792387057614,0.00755804093539314,0.0178987025080516,1.41190261727124e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRLB,Fc receptor-like B,39980,0.0278456441534329,0.00578274307572533,0.0165114677250113,0.0391798205818545,1.48364105451897e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCG3,Secretogranin-3,40379,-0.01518598807424,0.00315734244732866,-0.0213743792710041,-0.00899759687747579,1.52511198928284e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CENPF,Centromere protein F,37714,0.0248754663531548,0.00518287286577608,0.0147170355362337,0.0350338971700759,1.6075519216837e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,40359,-0.0121729815307328,0.0025408330942307,-0.017153014395425,-0.00719294866604067,1.67498562523587e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSAB1,Tryptase alpha/beta-1,40498,0.0238924480418929,0.00499000712899207,0.0141120340690684,0.0336728620147173,1.69904844217824e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.0179042429506759,0.0037395510647428,0.01057472286378,0.0252337630375718,1.70410875117852e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX18,Sorting nexin-18,37901,0.0206339418021824,0.00431570071500215,0.0121751684007782,0.0290927152035866,1.76156011543156e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSM,Oncostatin-M,40268,0.0327876176588038,0.00686219985688344,0.0193377059393122,0.0462375293782953,1.78633779335686e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.0190286039754504,0.00398626002062075,0.0112155343350338,0.0268416736158671,1.82651224160784e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC14A,C-type lectin domain family 14 member A,40332,-0.0141966577004176,0.00297864878513031,-0.020034809319273,-0.00835850608156216,1.89452080156665e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP3,Dual specificity protein phosphatase 3,39961,0.0383055452333297,0.00804289122690514,0.0225414784285956,0.0540696120380637,1.92787090518844e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD14,Monocyte differentiation antigen CD14,40048,0.0186376861897081,0.00392990170320776,0.0109350788514209,0.0263402935279953,2.12930734077352e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAT,Catalase,37786,0.0244435160093379,0.0051617916083166,0.0143264044570374,0.0345606275616384,2.20796965259964e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRUNE2,Protein prune homolog 2,37714,0.0132862786964005,0.00280704115693066,0.00778447802881637,0.0187880793639846,2.23294698783408e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.018171123728079,0.00384898646799585,0.0106271102508071,0.0257151372053508,2.36719827815155e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.0635202881487934,0.0135007873647247,0.037058744913933,0.0899818313836538,2.56141986072572e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.0278007685485367,0.00591179229777641,0.0162136556448949,0.0393878814521785,2.59419833696546e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.0184961250505203,0.00393546915750953,0.0107826055018017,0.026209644599239,2.62584002804491e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.014851090434206,0.0031612738275059,-0.0210471871361176,-0.00865499373229447,2.65629880380943e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.0168495526420754,0.00359113606486383,0.00981092595494231,0.0238881793292085,2.72800587951667e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWF,von Willebrand factor,40536,-0.0316465482428484,0.00676383810674475,-0.0449036709320681,-0.0183894255536287,2.9092910101459e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLPS,Colipase,40311,0.0303078692698878,0.00649230361266554,0.0175829541890633,0.0430327843507122,3.06223849803992e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA1,Annexin A1,37608,0.018361182026136,0.00393661655349707,0.0106454135812817,0.0260769504709902,3.12863979125343e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.0165590286311077,0.00355562789010498,0.00958999796650191,0.0235280592957134,3.23700959697357e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OLFM4,Olfactomedin-4,37177,0.0544092304084792,0.0116978605421513,0.0314814237458626,0.0773370370710957,3.33312700952738e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLL4,Delta-like protein 4,37628,0.0372185905417846,0.00800385951011799,0.0215310259019533,0.0529061551816158,3.35029026627518e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHISA5,Protein shisa-5,37998,0.0109250862449295,0.00235924594978269,0.00630096418335546,0.0155492083065036,3.67725237149933e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.0214839231399934,0.00464360108362665,0.0123824650160852,0.0305853812639016,3.75339727222087e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIF,Leukemia inhibitory factor,39961,0.0230775627788359,0.00499257750223001,0.013292110874465,0.0328630146832067,3.82430596625777e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF5,Eukaryotic translation initiation factor 5,37562,0.0199201088645469,0.00431892481234265,0.0114550162323554,0.0283852014967385,4.02036217370805e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.025607270399943,0.00556035436148243,0.0147089758514375,0.0365055649484486,4.15079841378413e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0271921306493764,0.00593750942702458,0.0155546121724082,0.0388296491263446,4.69201805781312e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE1,Ribonuclease pancreatic,37987,0.0104782335423918,0.00229015788899326,0.00598952407996498,0.0149669430048186,4.79688787244851e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.0284843163524274,0.00622915005576156,-0.04069345046172,-0.0162751822431347,4.85657036175397e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L15,Bcl-2-like protein 15,37598,0.0245104477801873,0.00536250591574501,0.0139999361853271,0.0350209593750475,4.9050914073343e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH3,Cadherin-3,40471,0.015332155947144,0.00335561653697756,0.00875514753466799,0.02190916435962,4.9347300908187e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,40332,0.0187502999704966,0.00410478557299715,0.0107049202474222,0.026795679693571,4.96311567831986e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLASP1,CLIP-associating protein 1,37482,0.0309545920164061,0.00678621786762916,0.0176536049958529,0.0442555790369592,5.12794543250006e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.0135891881331406,0.00298002366344797,0.00774834175278255,0.0194300345134986,5.15925179349262e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.0156598039311603,0.00343713982943172,0.0089230098654741,0.0223965979968464,5.25920325666451e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHAD,Chondroadherin,37671,0.0232171882297962,0.00510290918110854,0.0132154862348235,0.0332188902247689,5.41764535685136e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UROS,Uroporphyrinogen-III synthase,37572,0.0302872129849453,0.00666357238767942,0.0172266111050937,0.043347814864797,5.53757990829763e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.0149732703658845,0.00330151506043728,0.00850230084742744,0.0214442398843416,5.79452899812149e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AZU1,Azurocidin,39809,0.0333680624520556,0.00736734301385252,0.0189280701449047,0.0478080547592066,5.96572855408476e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.0374106280416928,0.00830124483861015,0.0211401881580169,0.0536810679253687,6.63367511709315e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B2M,Beta-2-microglobulin,38013,0.0135198505831385,0.00300819791385054,0.00762378267199146,0.0194159184942856,7.03653291084204e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1D,V-type proton ATPase subunit D,40305,0.0111778830804315,0.00248906961871242,0.00629930662775517,0.0160564595331079,7.14610866763407e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROCR,Endothelial protein C receptor,37562,-0.0157573443400552,0.00351349569291565,-0.0226437958981698,-0.00887089278194048,7.36005292459238e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM3,Intercellular adhesion molecule 3,40536,-0.0107053725171691,0.00238818670912015,-0.0153862184670446,-0.00602452656729362,7.42357921621351e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNPY2,Protein canopy homolog 2,40042,0.0259546393843669,0.00579100163672538,0.0146042761763852,0.0373050025923487,7.45114205116578e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0109081825882279,0.00243751694183399,0.00613064938223328,0.0156857157942225,7.68981419280955e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL3,Myosin light chain 3,37628,-0.0290054376023145,0.00648756709470796,-0.0417210691079421,-0.0162898060966869,7.85318882372847e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.0190041538265233,0.00425505433521498,0.010664247329502,0.0273440603235447,8.01511789542708e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF1,Macrophage colony-stimulating factor 1,40422,0.0114333634152192,0.00256123314241932,0.00641334645607739,0.0164533803743611,8.09915984633206e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP1,Caspase-1,39961,0.0284020709343847,0.00637751300444169,0.015902145445679,0.0409019964230904,8.50834053682117e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL1A1,Collagen alpha-1(I) chain,40536,-0.0109460576189467,0.0024579245719662,-0.0157635897800005,-0.00612852545789294,8.51007212102326e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIT,Vitrin,37990,0.0155139423955174,0.00349677216839916,0.00866026894545509,0.0223676158455798,9.20922475863319e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4M,C-type lectin domain family 4 member M,37969,-0.0203909483376581,0.00459932649197821,-0.0294056282619354,-0.0113762684133808,9.34620021443981e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLYR1,Putative oxidoreductase GLYR1,37900,0.0254821422186133,0.00575210841080783,0.0142080097334299,0.0367562747037966,9.49544310917252e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH1,Protocadherin-1,40475,0.00912566499213304,0.00206152056945794,0.00508508467599548,0.0131662453082706,9.63327042243271e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD7,T-cell antigen CD7,37567,0.0180269208908249,0.00407459745868937,0.0100407098717937,0.026013131909856,9.75709537521032e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRAL,GDNF family receptor alpha-like,37477,-0.0259290667850901,0.00588552955982718,-0.0374647047223514,-0.0143934288478289,1.06352458778376e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6,Interleukin-6,40305,0.0304051722308655,0.00690278911266805,0.0168757055700361,0.0439346388916948,1.06592013490184e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFLAM,Pikachurin,37901,0.0128072595057815,0.00292056354834664,0.0070829549510221,0.0185315640605409,1.16758879515711e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.0244780258413322,0.00559011608342023,0.0135213983178285,0.0354346533648358,1.20227184369211e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,0.0109863353665712,0.00250942056567735,0.00606787105784357,0.0159047996752988,1.20514788303455e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGMA,Repulsive guidance molecule A,40471,-0.0128116580522709,0.00292928313653321,-0.018553052999876,-0.00707026310466586,1.22957638518622e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.0111259927261634,0.00254484337344098,0.0061380997142191,0.0161138857381078,1.23908168698703e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST1,Cystatin-SN,36179,0.0431983880128192,0.00991493954930618,0.0237651064961791,0.0626316695294593,1.33039975194497e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAA4,Serum amyloid A-4 protein,38013,0.0134874624713403,0.00309719625486865,0.00741695781179774,0.0195579671308828,1.34206648967101e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK4,Kallikrein-4,40489,-0.025002690726433,0.00576025811607893,-0.0362927966339477,-0.0137125848189183,1.42996638897607e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIFR,Leukemia inhibitory factor receptor,40341,-0.0100332316899434,0.00231795690199777,-0.014576427217859,-0.00549003616202773,1.51059717105513e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFB,Vascular endothelial growth factor B,37598,0.0116754341169192,0.00270880297216967,0.00636618029146664,0.0169846879423717,1.64307098336487e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EP300,Histone acetyltransferase p300,37598,0.0121907534572115,0.00283455681982727,0.00663502209035007,0.017746484824073,1.71440238462356e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.0107258981335457,0.00249941791350152,0.00582703902308275,0.0156247572440087,1.78628948152097e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEK,Angiopoietin-1 receptor,40411,0.00874145206103942,0.00203743318982901,0.00474808300897456,0.0127348211131043,1.79382191864899e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LHB,Lutropin subunit beta,39980,0.0344475708679289,0.00804528494182163,0.0186788123819586,0.0502163293538993,1.86576692797605e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP9,Fatty acid-binding protein 9,40341,0.022588568220588,0.00528987484175464,0.0122204135307489,0.032956722910427,1.96474330397529e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.0241217280124574,0.00565164464513997,0.0130445045079831,0.0351989515169317,1.98547900091894e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CILP,Cartilage intermediate layer protein 1,37998,0.0217949321516739,0.00510697061279168,0.0117852697506022,0.0318045945527456,1.98856477539151e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFPI2,Tissue factor pathway inhibitor 2,40357,0.0160474024283349,0.00376999863086736,0.00865820511183491,0.0234365997448349,2.08742250647154e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.0200506990251765,0.00471724737121045,-0.029296503872749,-0.010804894177604,2.14501779555645e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOSB,Protein fosB,39961,0.0157589888027431,0.00370910279953438,0.00848914731565572,0.0230288302898305,2.16237323853839e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK11,Kallikrein-11,40260,0.0119516161514673,0.0028138100041038,0.00643654854342382,0.0174666837595107,2.17419918268057e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRLF1,Cytokine receptor-like factor 1,40422,0.0105413495082888,0.00248767455434376,0.00566550738177506,0.0154171916348026,2.27360187500429e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.0276108013511069,0.00651593225463009,0.0148395741320319,0.0403820285701819,2.27621788078205e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO1,Alpha-enolase,40299,0.031742379367854,0.00750173071049339,0.017038987175287,0.0464457715604211,2.33608572449539e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D17,TBC1 domain family member 17,39961,0.0184028023085926,0.00436182128230684,0.00985363259527115,0.026951972021914,2.46712831749086e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTN2,Alpha-actinin-2,37562,-0.0219256780353793,0.00519766561134407,-0.0321131026336137,-0.0117382534371449,2.47728245328138e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.0248152718952017,0.00588361451291183,0.0132833874498946,0.0363471563405089,2.48476380646305e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6,Seizure protein 6 homolog,37572,-0.012528383037366,0.00297056734789136,-0.018350695039233,-0.00670607103549889,2.48677736115647e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.0180865892528154,0.00428875937729932,-0.0264925576323221,-0.00968062087330874,2.48702860271021e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0277901773919783,0.00659765357926321,0.0148587763766224,0.0407215784073342,2.54377667581384e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM2,Myomesin-2,37562,-0.0187660614926577,0.00446716957851992,-0.0275217138665568,-0.0100104091187587,2.67633453548617e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPH1,Neurexophilin-1,39961,0.0149851800110766,0.00357623790457932,0.00797575371810117,0.0219946063040521,2.80241858905802e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,40009,0.020495541273714,0.00489328620021461,0.0109047003212934,0.0300863822261347,2.8234847244191e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0151397234650437,0.00361701050326758,0.00805038287863923,0.0222290640514481,2.85815892789152e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST7,Cystatin-F,40376,0.0364258900292024,0.00871160030633782,0.0193511534287803,0.0535006266296245,2.91385983214982e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKD1,Polycystin-1,37990,0.0102360238912513,0.00245438747359318,0.00542542444300871,0.015046623339494,3.05825184869e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDS,Iduronate 2-sulfatase,40516,0.00341052690618727,0.000818516201947709,0.00180623515036976,0.00501481866200478,3.10631582173519e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCB,Calcitonin gene-related peptide 2,37942,0.0157606299698212,0.00378847996292446,0.00833520924248928,0.0231860506971532,3.20014031053e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHB6,Ephrin type-B receptor 6,40192,0.0122848662355276,0.00295671801441945,0.00648969892726549,0.0180800335437897,3.27149204989679e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ODAM,Odontogenic ameloblast-associated protein,39934,0.0211093036195954,0.00508202756959452,0.0111485295831902,0.0310700776560007,3.28872423450482e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.0108717816828902,0.00261807950213001,0.00574034585871534,0.016003217507065,3.30507726469839e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.0205513499289088,0.00495399079883005,-0.0302611718946157,-0.0108415279632019,3.36854517560969e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP1,"Fatty acid-binding protein, liver",40357,0.0364604020676489,0.00879433910544302,0.0192234974209806,0.0536973067143172,3.40244181920991e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.0132364158312253,0.00319856489542628,0.00696722863618983,0.0195056030262608,3.51779230030461e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLC,Galectin-10,40333,-0.02572618348782,0.00622090357230471,-0.0379191544895373,-0.0135332124861028,3.56094201157626e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAP,Cartilage-associated protein,37572,0.0190231237712118,0.00460061670796182,0.0100059150236067,0.028040332518817,3.57307640754255e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00767561755053592,0.00185646392232915,-0.011314286838301,-0.00403694826277079,3.57812432241198e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDHB15,Protocadherin beta-15,37900,-0.0158103887666765,0.00382561138722045,-0.0233085870856286,-0.00831219044772445,3.60582074064036e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPA2,Replication protein A 32 kDa subunit,37598,0.0128100570456757,0.00310068569410515,0.00673271308522959,0.0188874010061218,3.62851510990895e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLIN3,Perilipin-3,40359,0.0165420039456834,0.00401232742921923,0.00867784218441373,0.0244061657069531,3.76201681378221e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.0103565589274175,0.00251277225185073,0.00543152531379006,0.0152815925410449,3.78545681504133e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSC2,Desmocollin-2,40177,-0.0131362458534675,0.00319256238830405,-0.0193936681345434,-0.00687882357239157,3.89759010692611e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL34,Interleukin-34,39934,0.0139981908495637,0.00340363160768396,0.00732707289850314,0.0206693088006243,3.93040615882597e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.0114115778282075,0.0027754416551077,0.00597171218419639,0.0168514434722186,3.95291982263257e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNG,Interferon gamma,40044,0.0442884720352216,0.0107776130312707,0.023164350493931,0.0654125935765121,3.98884788554546e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPT2,Angiopoietin-2,40489,-0.0149857270668838,0.00366714178982915,-0.0221733249749489,-0.00779812915881862,4.40085200221615e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QL2,Complement C1q-like protein 2,37598,0.0166777099839007,0.0040814961423766,0.00867797754484255,0.0246774424229588,4.41145396055833e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP2,Guanylate-binding protein 2,40044,0.023055653559582,0.00564400106267846,0.0119934114767322,0.0341178956424318,4.43001878067687e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF3,Trefoil factor 3,40309,0.0206263654131448,0.0050539311988981,0.0107206602633045,0.0305320705629851,4.50131844131752e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST6,Cystatin-M,39992,0.018468968160624,0.00452966812700663,0.00959081863169096,0.027347117689557,4.57819379598791e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.0156036284781924,0.00383258496340938,-0.0231154950064748,-0.00809176194991003,4.70246415479402e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.0218741837385289,0.00539702597745538,0.0112960128227163,0.0324523546543414,5.08098050377932e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOC,Myocilin,40332,-0.0175786751040976,0.004342571582526,-0.0260901154058485,-0.00906723480234663,5.19048252136242e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR1,Folate receptor alpha,40299,0.0108621467383046,0.00268625782969269,0.00559708139210689,0.0161272120845022,5.28861705432625e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH15,Cadherin-15,40435,0.0169295654337924,0.0041954695931034,0.00870644503130979,0.0251526858362751,5.48093354946056e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EXTL1,Exostosin-like 1,37562,0.0183077202996916,0.00453933391614214,0.00941062582405304,0.0272048147753302,5.53507702474099e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.0202030482857664,0.0050267861209365,0.0103505474887309,0.030055549082802,5.87445760377331e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.019386311198332,0.00482824318052327,-0.0288496678321576,-0.00992295456450634,5.96698294872976e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AOC3,Membrane primary amine oxidase,40403,-0.0115409825856956,0.00287568324938449,-0.0171773217544892,-0.00590464341690203,6.01489743169042e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PADI4,Protein-arginine deiminase type-4,39934,0.0264041101224942,0.00658644060041209,0.0134946865456865,0.0393135336993019,6.12988434535876e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.00968462210791539,0.00241587482681624,0.00494950744735557,0.0144197367684752,6.13234383542193e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBLN2,Fibulin-2,37998,-0.0117332541378028,0.00292760773766836,-0.0174713653036328,-0.00599514297197283,6.16161041463512e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RAP,Interleukin-1 receptor accessory protein,40332,-0.0163227272227823,0.00408037271448705,-0.0243202577431769,-0.00832519670238766,6.35481450538973e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP4,Bone morphogenetic protein 4,40203,-0.0171696061405354,0.00430122059443148,-0.0255999985056211,-0.00873921377544973,6.58712917401812e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.0102652033719009,0.00257378877074724,0.00522057738123633,0.0153098293625655,6.68255595994685e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD200,OX-2 membrane glycoprotein,40341,-0.00978763008635754,0.00246209917900756,-0.0146133444772123,-0.00496191569550274,7.05958225632479e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO4,Roundabout homolog 4,37628,-0.0067449367411265,0.00169688433748014,-0.0100708300425876,-0.00341904343966543,7.07859159395991e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,0.0144236122534198,0.0036332525235535,0.00730243730725492,0.0215447871995846,7.22219728535136e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTG,Protogenin,40489,0.00943810774036906,0.00238382872656387,0.00476580343630388,0.0141104120444342,7.55187445807762e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHNAK2,Protein AHNAK2,37628,0.0107427167348116,0.00271700362872797,0.00541738962250478,0.0160680438471184,7.72947166275795e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD58,Lymphocyte function-associated antigen 3,40335,-0.00660695925540975,0.00167405588704562,-0.00988810879401917,-0.00332580971680033,7.95842476099826e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYAR,Cell growth-regulating nucleolar protein,39980,0.0196555937849477,0.00498233669218003,0.00989021386827479,0.0294209737016205,8.01323775509317e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0185123445944369,0.004698641732627,0.00930300679848796,0.0277216823903858,8.19257761098776e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELAVL4,ELAV-like protein 4,37541,0.0324866553872261,0.00828514853068933,0.016247764267075,0.0487255465073772,8.86057960135462e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.0147255189757943,0.00375829086255212,0.00735926888519216,0.0220917690663965,8.96167796112633e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0664688476060032,0.0170016174327763,0.0331456774377615,0.0997920177742448,9.28495996610069e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.0141717345613971,0.00362553158728162,0.00706569265032514,0.0212777764724691,9.31826716281362e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM5,Intercellular adhesion molecule 5,40359,0.0163047410330093,0.00417304114795895,0.00812558038300977,0.0244839016830088,9.3773634519325e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.0218549744082003,0.00562156481658938,0.0108367073676851,0.0328732414487155,0.00010169039761656
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.0179029774150836,0.00461184227191398,-0.026942188268035,-0.00886376656213216,0.000104123880978164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.0199939014409351,0.00516347515845676,-0.0301143127515103,-0.00987349013035982,0.000108391080330515
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBQ1,Hemoglobin subunit theta-1,40489,-0.0215837602484039,0.00559595248370186,-0.0325518271164596,-0.0106156933803483,0.000115221443122277
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPEP1,Dipeptidase 1,40192,-0.0185572199054615,0.0048135740112786,-0.0279918249675676,-0.00912261484335546,0.000116101766204782
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.00784950589648653,0.00203886308007676,0.00385333425953607,0.011845677533437,0.000118692548526568
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.0128635461260073,0.00338354055663811,0.00623180663499656,0.019495285617018,0.000144282722350889
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSN,Gelsolin,37928,-0.00684206623849259,0.00180346635360748,-0.0103768602915632,-0.00330727218542194,0.000148982656009271
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.025815348623718,0.00683688191296755,0.0124150600743016,0.0392156371731344,0.000160009982466819
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM1,Myomesin-1,37541,0.0167897466800724,0.00445336135737062,0.00806115841962596,0.0255183349405188,0.000163880527465139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.0191572833283181,0.00509882809687677,0.00916358025843966,0.0291509863981966,0.000172458120549319
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.0134851709351135,0.00359174582456351,-0.020524992751258,-0.00644534911896904,0.000174423789535638
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00885290102770907,0.00236933434245788,-0.0134967963389265,-0.00420900571649163,0.000187402904864262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.0111233765485314,0.00297707153008144,-0.016958436747491,-0.00528831634957177,0.000187497580662492
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGBL1,Integrin beta-like protein 1,37998,0.0123757715448583,0.00331319987976798,0.00588189978051302,0.0188696433092035,0.00018826601789117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F3,Tissue factor,40393,-0.00991529646944047,0.00265997158623999,-0.0151288407784709,-0.00470175216041008,0.000193984265964793
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.0113626346716269,0.00305515407815204,0.00537453267844885,0.0173507366648049,0.000200574380984558
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTK7,Inactive tyrosine-protein kinase 7,39961,0.013556758956012,0.0036592235949461,0.00638468070991761,0.0207288372021063,0.000212276988950092
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC13A1,Solute carrier family 13 member 1,37900,0.0216635435360429,0.00589751982277125,0.0101044046834113,0.0332226823886746,0.000240337745400202
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMH,Granzyme H,40042,0.0258444966462408,0.00706878160064901,0.0119896847089688,0.0396993085835129,0.000256877507422139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.0142040901022663,0.00388569816197916,0.00658812170478716,0.0218200584997455,0.000257549519708582
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOE,Apolipoprotein E,38013,0.0259924659552666,0.00711050857671207,0.0120558691449109,0.0399290627656222,0.000257650661171412
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0268574925194791,0.00735219929912702,0.0124471818931901,0.0412678031457681,0.000260223388505868
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0208502701818925,0.00571414648785647,0.00965054306569386,0.0320499972980912,0.000264239158393142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,-0.00720604168940622,0.00198016167376801,-0.0110871585699915,-0.00332492480882092,0.000274457441710118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL9A2,Collagen alpha-2(IX) chain,37714,0.0160431030759832,0.00440856617720488,0.00740231336866167,0.0246838927833048,0.000274658403931977
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMS1,PMS1 protein homolog 1,37572,0.0179612407996665,0.00494092011312315,0.00827703737794511,0.0276454442213878,0.00027882556110214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNU13,NHP2-like protein 1,37562,0.0215460533793664,0.00593039063056814,0.00992248774345282,0.0331696190152799,0.00028104139154049
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMB,Granzyme B,40341,0.0216419809126308,0.00595774431989194,0.00996480204564263,0.0333191597796191,0.000281485397787555
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.024757320462616,0.00681718521276291,0.0113956374456007,0.0381190034796313,0.000282726230382974
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.0118318327397648,0.00325816243485267,-0.0182178311120761,-0.00544583436745357,0.000282916592910823
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEFL,Neurofilament light polypeptide,39903,0.0146771035351329,0.00405031846255579,0.00673847934852359,0.0226157277217423,0.00029136007289224
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.0113783693856788,0.0031442056551287,-0.017541012469731,-0.0052157263016265,0.000296844399773547
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIL1,Nucleotide exchange factor SIL1,37628,0.010985567546192,0.00303810253435503,0.00503088657885614,0.0169402485135279,0.000300387825578033
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.0296734200895927,0.00820761806928982,-0.0457603515054007,-0.0135864886737847,0.000300899970364302
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.00922157781424244,0.00255270395774069,0.00421827805707068,0.0142248775714142,0.000304389405647589
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC10A,C-type lectin domain family 10 member A,40228,-0.0123339900392894,0.00341618743769937,-0.0190297174171801,-0.00563826266139859,0.000306608021646948
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.010333718100452,0.00286356855435506,0.0047211237339161,0.0159463124669879,0.000308719820938586
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.0150864194234503,0.00418200018397971,0.00688969906285005,0.0232831397840505,0.000310324137103713
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD3,Extracellular superoxide dismutase,37987,-0.020232070111978,0.00560933986647147,-0.0312263762502621,-0.00923776397369396,0.000311047538276151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLIC5,Chloride intracellular channel protein 5,37572,-0.011027761228868,0.00306686352772517,-0.0170388137432093,-0.00501670871452665,0.000324610511397239
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.0133195423814138,0.00372793672829228,-0.0206262983688667,-0.00601278639396092,0.000354316069871664
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX5,Syntaxin-5,37598,0.0141973482704062,0.00398116139930264,0.00639427192777305,0.0220004246130394,0.000363575363907698
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACRV1,Acrosomal protein SP-10,37598,0.0119045151365902,0.00335096722494138,0.00533661937570511,0.0184724108974753,0.000382836586325071
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.0211174199668997,0.00594468142241408,-0.0327689955548313,-0.00946584437896807,0.00038318467768636
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERC2,ERC protein 2,37572,0.0258896024549618,0.00731033058422114,0.0115613545098883,0.0402178504000352,0.000399224809589914
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB39B,Ras-related protein Rab-39B,37562,0.0299968242378654,0.00847257921281028,0.0133905689807573,0.0466030794949735,0.000400815544356347
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB44,Ras-related protein Rab-44,37900,0.0133834341321352,0.00378279652131621,0.00596915295035543,0.020797715313915,0.00040456949656641
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA1,Carbonic anhydrase 1,40003,0.0209446183658594,0.00592048339860582,0.00934047090459198,0.0325487658271268,0.000404875722242713
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEPD,Xaa-Pro dipeptidase,37987,0.00863810957957793,0.00244838061322903,0.00383928357764903,0.0134369355815068,0.000419955446207817
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.0181571360287816,0.00514662619605395,0.00806974868451586,0.0282445233730474,0.000420153990861641
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRR4,Proline-rich protein 4,37577,-0.0230377773877289,0.00654669144725089,-0.0358692926243406,-0.0102062621511171,0.000434650459152943
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSPN,Persephin,40341,0.0330563670586068,0.00941056140944812,0.0146116666960884,0.0515010674211251,0.000444829729185502
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.00886129561913636,0.00253243467774289,-0.0138248675875124,-0.0038977236507603,0.000468335534679546
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYB5A,Cytochrome b5,37482,0.0243793726306214,0.00698156057279408,0.010695513907945,0.0380632313532978,0.000481067613607218
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.0204736585969905,0.0058817220195576,0.00894548343865757,0.0320018337553234,0.000501358711129682
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFR4,Fibroblast growth factor receptor 4,37671,0.0176708925329654,0.00508019173447667,0.00771371673339115,0.0276280683325397,0.000506057237467177
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM171B,Protein FAM171B,37900,0.00914578345517545,0.00263003740162256,0.00399091014799524,0.0143006567623557,0.000507836081850142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.0126897017440923,0.00365378510389247,-0.0198511205477215,-0.00552828294046303,0.000516282778993574
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SATB1,DNA-binding protein SATB1,37959,0.00989278478961519,0.00286039860135775,0.00428640353095401,0.0154991660482764,0.000544798960997056
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB2A2,Mammaglobin-A,37562,-0.0104859973348219,0.00304961379338039,-0.0164632403698474,-0.00450875429979629,0.000586835659358119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.0187679262411363,0.00547263297787912,-0.0294942868777794,-0.00804156560449327,0.000606425875979045
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NME1,Nucleoside diphosphate kinase A,37598,-0.00715524273693222,0.00208806250842733,-0.0112478452534498,-0.00306264022041466,0.000612748334137288
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH17,Cadherin-17,40359,-0.021840413261521,0.00640622157100811,-0.0343966075406969,-0.00928421898234509,0.000653033042250251
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPK13,Mitogen-activated protein kinase 13,37482,0.013368016645548,0.0039254688149442,0.00567409776825736,0.0210619355228386,0.000662526264292166
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0336720557730831,0.0098974829416318,0.0142729892074848,0.0530711223386814,0.000670404038678053
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.0112479158799918,0.0033171284795833,0.00474634406000848,0.017749487699975,0.000698467562445721
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.0173455227330333,0.00511606471973012,0.0073180358823623,0.0273730095837044,0.000699955773850575
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACAN,Aggrecan core protein,40224,0.00908836465104944,0.00268429805484636,0.00382714046355057,0.0143495888385483,0.000711569107852276
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.0112957995987454,0.00334101154482271,0.00474741697089291,0.0178441822265979,0.000724454655335773
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRC1,Macrophage mannose receptor 1,37987,0.00905410844415636,0.00268021400058392,0.00380088900301187,0.0143073278853009,0.000731865750839079
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA4,Carboxypeptidase A4,37410,0.0140847857474551,0.00417462011213365,0.00590253032767311,0.022267041167237,0.000743262300025244
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEDD9,Enhancer of filamentation 1,37598,0.010588772362469,0.00314013408685592,0.00443410955223134,0.0167434351727066,0.000748188075131239
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,40341,0.0208180839709446,0.00618470025962261,0.00869607146208428,0.0329400964798049,0.000764302425073394
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN8,Septin-8,37921,0.0101708699948467,0.0030238035207858,0.00424421509410654,0.0160975248955869,0.000771470074347773
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA2,Ephrin type-A receptor 2,39759,0.00980638850508729,0.0029178016162855,0.00408749733716771,0.0155252796730069,0.000778838447886051
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.0103306853812992,0.00307608819896135,-0.0163598182512634,-0.00430155251133492,0.000785880797298398
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37998,-0.00674589226492916,0.00201034449103756,-0.0106861674673628,-0.00280561706249554,0.000794134055905004
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS53,Serine protease 53,37942,0.011691751559926,0.00348709513552592,0.00485704509429516,0.0185264580255568,0.000802003247465734
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH23,Cadherin-23,37942,-0.00841295792430417,0.00251079138566698,-0.0133341090402114,-0.0034918068083969,0.000808230365457395
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF8,SLAM family member 8,39980,0.0169438215405391,0.00507318497158974,0.00700037899622326,0.026887264084855,0.000840124308165991
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUP50,Nuclear pore complex protein Nup50,37562,-0.0112855307234646,0.00338086645847158,-0.0179120289820689,-0.00465903246486027,0.000846008083128751
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC4A1,Band 3 anion transport protein,37998,-0.0146271330978904,0.00438604052275919,-0.0232237725224984,-0.00603049367328237,0.000855503207621517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN1,Nectin-1,37598,0.0100889108856069,0.0030351094492444,0.00414009636508788,0.0160377254061259,0.000889569981765827
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0217612723688641,0.00656199701969008,-0.0346227865274566,-0.0088997582102715,0.000914366665976308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD5,Sushi domain-containing protein 5,37604,-0.0107662734521237,0.0032509164295698,-0.0171380696540805,-0.00439447725016692,0.000929590181844186
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA1549,UPF0606 protein KIAA1549,37714,0.0223058098958482,0.00673803996917214,0.00909925155627084,0.0355123682354256,0.000934013307002202
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,0.0138441149573452,0.00418583679790917,0.00563987483344323,0.0220483550812472,0.000944265638805704
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.00767713011496081,0.00232405914133103,0.003121974197952,0.0122322860319696,0.000957558902357038
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA1,Alpha-1-antitrypsin,37779,-0.00254103081052366,0.000770944202274761,-0.00405208144698219,-0.00102998017406512,0.000983288594245164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.0172607536924461,0.00524500607199526,0.00698054179133537,0.0275409655935568,0.00100092835426361
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN5,Contactin-5,40367,-0.0115471732485095,0.00350950182675471,-0.0184257968289488,-0.00466854966807029,0.00100312452779374
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAMDC2,MAM domain-containing protein 2,37990,-0.0105649312079795,0.00322417955397646,-0.0168843231337734,-0.00424553928218567,0.00105261967216016
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHGA,Chromogranin-A,37998,-0.0280285719009917,0.00857041123319454,-0.0448265779180529,-0.0112305658839304,0.00107668218784749
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.0102206423882382,0.00312715025960435,-0.0163498568970627,-0.00409142787941365,0.00108400944559711
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0153047076997103,0.00469769493298616,0.00609722563105746,0.0245121897683632,0.00112473966684339
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.0190381098007989,0.00584506530773425,-0.0304944378039581,-0.00758178179763982,0.00112833334825473
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKCQ,Protein kinase C theta type,40044,0.0136843077033088,0.00421125890657824,0.00543024024641549,0.0219383751602022,0.0011587024865071
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.00983166445507848,0.00302701668915192,-0.0157646171658162,-0.00389871174434072,0.00116523265051175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.0156456515719325,0.00484283788856583,0.00615368931034343,0.0251376138335215,0.0012379377593016
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRELP,Prolargin,40357,0.00708320082454449,0.00219685885041637,0.00277735747772841,0.0113890441713606,0.00126562264142671
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,0.00807891522578035,0.00250690062009098,0.00316539001040203,0.0129924404411587,0.00127257700932228
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FMR1,Synaptic functional regulator FMR1,39980,0.0107120721634627,0.00333071252882267,0.00418387560697026,0.0172402687199551,0.00130188845694308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSC1,Hamartin,37598,0.0232026341877779,0.00725193527378929,0.00898884105115093,0.0374164273244049,0.00137988499798368
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.0116635821382627,0.00368812368923028,0.00443485970737133,0.018892304569154,0.00156793034858179
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMRK2,Nicotinamide riboside kinase 2,37482,-0.0131100303049192,0.00414904757782689,-0.0212421635574599,-0.00497789705237851,0.00158255566998192
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPP1,Osteopontin,40497,-0.0142217122271968,0.00450743259622944,-0.0230562801158065,-0.00538714433858707,0.001607013532638
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.0131105028070532,0.00415587707063204,0.00496498374861439,0.021256021865492,0.00161030896852629
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCR1,Natural cytotoxicity triggering receptor 1,40306,0.010726330023429,0.00341075211478718,0.0040412558784461,0.0174114041684119,0.00166474532165396
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00439368933125249,0.00139842133540135,0.00165278351386585,0.00713459514863913,0.00168222412774535
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.0117131150222864,0.00373646875492601,0.00438963626263147,0.0190365937819414,0.00172333871073916
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RCC1,Regulator of chromosome condensation,37900,0.0151966787107773,0.00485235271439918,0.00568606739055488,0.0247072900309996,0.00174100930851842
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.00916464140178428,0.0029315225142641,0.00341885727382663,0.0149104255297419,0.00177377271857118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD3,Bromodomain-containing protein 3,37562,0.0143859538765319,0.00460569412894498,0.00535879338379979,0.0234131143692641,0.00179094167147412
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENG,Endoglin,40536,-0.0050376580518343,0.00161340861424877,-0.00819993893576189,-0.00187537716790672,0.00179719635463282
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3D,Protein FAM3D,37901,0.024322711722669,0.0078118177570885,0.00901154891877559,0.0396338745265625,0.00185220950095695
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0862535105030308,0.0277067841721516,0.0319482135256137,0.140558807480448,0.00185472486454893
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.0120788075885203,0.00388591523345742,-0.0196952014460968,-0.00446241373094377,0.00188533935792399
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASPN,Asporin,37990,0.00799930415125375,0.0025887084202129,0.00292543564763647,0.013073172654871,0.00200511480099501
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARTN,Artemin,40044,0.0130354060927953,0.00422637166543595,0.00475171762854085,0.0213190945570498,0.00204387198191915
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.0438915475778066,0.0142448241153143,0.0159716923117906,0.0718114028438226,0.00206501312821237
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD6,Programmed cell death protein 6,40359,-0.0203220534108484,0.00660314987159766,-0.0332642271591798,-0.007379879662517,0.00209008449426328
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL11,Interleukin-11,40044,0.0186352138844927,0.00606161900195537,0.00675444064066013,0.0305159871283252,0.00211364206010584
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.0256494235884571,0.00834499394952958,0.00929323544737913,0.0420056117295351,0.0021190460349291
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.0127449967365625,0.00415016561090017,0.00461067213919812,0.0208793213339268,0.00213794932201305
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNPEP,Aspartyl aminopeptidase,37942,0.0173053433135745,0.00564296764737661,0.00624512672471635,0.0283655599024327,0.00216857328771117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL14,C-X-C motif chemokine 14,40044,0.0178377775708947,0.00583186398121122,0.00640732416772066,0.0292682309740686,0.00222695080605631
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.0188634390007138,0.00617704603619738,0.00675642876976695,0.0309704492316607,0.00226353735786894
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CR2,Complement receptor type 2,40403,0.0133711097407918,0.00439844828296089,0.00475015110618846,0.0219920683753951,0.00236992559414233
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYT1,Synaptotagmin-1,37942,0.0112970568137463,0.00371633325308841,0.00401304363769301,0.0185810699897996,0.00237157834717579
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TERF1,Telomeric repeat-binding factor 1,37598,-0.00857835866028224,0.00282598818124074,-0.0141172954955141,-0.00303942182505038,0.00240586829320339
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRXN3,Neurexin-3,37572,0.0100544119634416,0.00331321471243882,0.00356051112706154,0.0165483127998217,0.00241294995800301
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.00727349923914354,0.0024047375711727,0.00256021359964505,0.011986784878642,0.00249403401563797
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.0104989284861515,0.00347268074198798,0.00369247423185511,0.017305382740448,0.00250523673440607
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM19,Probable RNA-binding protein 19,37562,-0.0137692167528744,0.00455510143613542,-0.0226972155676998,-0.00484121793804897,0.00250921322510107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRPB1,Signal-regulatory protein beta-1,40335,0.0128405291857122,0.00425153037551571,0.00450752964970136,0.021173528721723,0.00252998097295812
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLMP,CXADR-like membrane protein,40489,0.00583254181751949,0.00193146690854438,0.00204686667677252,0.00961821695826647,0.00253383756660459
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.0176903559760488,0.00587893428915826,0.00616764476929862,0.029213067182799,0.00262511298107781
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.0147653230550196,0.00491193549364777,0.00513792948746998,0.0243927166225692,0.00265189489022309
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBPMS,RNA-binding protein with multiple splicing,37598,0.01838549132612,0.00614513231152698,0.00634103199552712,0.0304299506567129,0.00277780759491142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFAP,Glial fibrillary acidic protein,39959,0.0132248015162566,0.00444145257517702,0.00451955446890959,0.0219300485636035,0.00290978357030045
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G1B,Phospholipase A2,40514,-0.011803825706235,0.00396785599304851,-0.0195808234526101,-0.00402682795985993,0.00293555919185383
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PI16,Peptidase inhibitor 16,37987,-0.00691737265928843,0.0023371382549864,-0.0114981636390618,-0.0023365816795151,0.00308410367509344
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDN1,Endothelin-1,37628,0.00817328867162491,0.0027619891096739,0.00275979001666407,0.0135867873265858,0.00308983641002702
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KITLG,Kit ligand,40359,-0.0101544459465594,0.00344209161985769,-0.0169009455214805,-0.00340794637163833,0.00318154340228454
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTF4,Neurotrophin-4,39980,0.0113907696900713,0.00387137544751072,0.00380287381295031,0.0189786655671923,0.00326259740924722
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMPD3,AMP deaminase 3,37942,0.0202580704936638,0.00688501577299181,0.00676343957859985,0.0337527014087277,0.00326294277364795
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.0103019385980395,0.0035013646917804,0.00343926380214992,0.0171646133939291,0.00326389761162743
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAG,S-arrestin,37541,-0.0149401093132134,0.00508197399709237,-0.0249007783475144,-0.00497944027891231,0.00328972769447999
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRDL1,Chordin-like protein 1,40396,0.00847555629550084,0.00288862393111459,0.00281385339051625,0.0141372592004854,0.00334976310609055
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACE,Angiotensin-converting enzyme,37987,-0.00706598528055748,0.00242378860512556,-0.0118166109466036,-0.00231535961451137,0.00355969743999788
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYMP,Thymidine phosphorylase,40257,0.0183371776361282,0.00630429729976336,0.00598075492859199,0.0306936003436644,0.00363464702911475
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDA1,DET1- and DDB1-associated protein 1,37562,0.0112658491955087,0.00387823886152546,0.00366450102691878,0.0188671973640986,0.0036799856784019
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.00838560253263145,0.00289404456683698,0.00271327518163097,0.0140579298836319,0.00376725863203204
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON1,Serum paraoxonase/arylesterase 1,37987,-0.00710349453761694,0.00245596126104177,-0.0119171786092588,-0.00228981046597507,0.00382983464371841
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP1,Peptidoglycan recognition protein 1,40451,0.0117048948397975,0.00405017166265909,0.00376655838098568,0.0196432312986093,0.00385790225421175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPC2,PDZ domain-containing protein GIPC2,37942,0.00798970568667688,0.00276703246367742,0.00256632205786915,0.0134130893154846,0.00388978531608988
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.00714654683332778,0.00247693212374728,-0.0120013337958724,-0.00229175987078311,0.00391733479409126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.0137420565936833,0.00478232965389183,0.00436869047205532,0.0231154227153113,0.00406578133963826
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,0.0153080449508965,0.00533670631116637,0.00484810058101039,0.0257679893207826,0.00413154232408206
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD160,CD160 antigen,40516,0.0123689337434639,0.00432579009201095,0.00389038516312249,0.0208474823238054,0.00425061161202965
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS5,Transmembrane protease serine 5,40159,-0.0102289191865372,0.00357885862969787,-0.017243482100745,-0.00321435627232934,0.0042667760096113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGF,Beta-nerve growth factor,40228,0.00329946094145947,0.00115552603947198,0.00103462990409439,0.00556429197882454,0.00430420308460967
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN2B,Sodium channel subunit beta-2,37572,-0.00804162451920967,0.00282015028128903,-0.0135691190705362,-0.00251412996788317,0.00435830699283977
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSAP,Gamma-secretase-activating protein,39980,0.0241635196526465,0.00847633254725598,0.00754990786002475,0.0407771314452682,0.00436799632376147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA6,Corticosteroid-binding globulin,38013,0.00482852322887509,0.00169542279105299,0.00150549455841123,0.00815155189933896,0.00440644149253835
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAT1,Diamine acetyltransferase 1,37562,-0.0141582229588392,0.00497181443077506,-0.0239029792431583,-0.00441346667452006,0.00441052455759765
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMOD4,Tropomodulin-4,37482,-0.0113352980714626,0.00398449585285715,-0.0191449099430626,-0.00352568619986261,0.00445014222071894
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NELL1,Protein kinase C-binding protein NELL1,40411,-0.0114128518091498,0.00402300752544516,-0.0192979465590223,-0.0035277570592773,0.00456119101902072
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.00764351088783294,0.00270012487190696,0.0023512661388953,0.0129357556367706,0.00465007632863322
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.015857252004048,0.00560816070163723,0.00486525702883905,0.026849246979257,0.00469677014131351
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.00840747047076643,0.00298145132303448,0.00256382587761885,0.014251115063914,0.0048094321492816
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKAP12,A-kinase anchor protein 12,37671,-0.0058302268358576,0.00207101340918705,-0.00988941311786422,-0.00177104055385098,0.00488256042266276
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INHBB,Inhibin beta B chain,37671,0.0137506489939269,0.00489282158663982,0.00416071868411283,0.0233405793037409,0.00495570109462067
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.0177558051339774,0.00632495880127892,0.00535888588347075,0.0301527243844841,0.00500377897982819
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM26,Tripartite motif-containing protein 26,37482,0.014681122836568,0.00523248666377485,0.0044254489755693,0.0249367966975667,0.00502718650810469
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.0109853758572703,0.00391766344695347,-0.0186639962132991,-0.0033067555012415,0.00505372149523435
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRC,Chymotrypsin-C,40360,0.0165766773494153,0.00593867217531884,0.00493687988579039,0.0282164748130402,0.00525576751387055
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JUN,Transcription factor AP-1,40044,0.0136945978632899,0.00491995850030377,0.00405147920269452,0.0233377165238853,0.00538441966933666
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.00830830341708008,0.00298520714984271,0.00245729740338837,0.0141593094307718,0.00539094049445
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTTG1,Securin,37714,0.0108992679276002,0.0039312373702594,0.00319404268189179,0.0186044931733087,0.0055708956667266
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPTC,Opticin,40305,-0.0118203038830359,0.00426593111123891,-0.0201815288610641,-0.00345907890500761,0.00559733385706517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH12,Protocadherin-12,37959,0.00673826506743746,0.00243236232254174,0.00197083491525565,0.0115056952196193,0.0056088855287379
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.0157943359833417,0.00570259175441643,-0.0269714158219979,-0.00461725614468551,0.00561908604140221
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.0171704935096997,0.00620690872705347,-0.0293360346147245,-0.00500495240467487,0.00567668419066726
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3GL3,Endophilin-A3,37643,0.0218015206383777,0.00788394908892144,0.00634898042409164,0.0372540608526637,0.00569487049619183
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDK1,Cyclin-dependent kinase 1,37482,0.00962170327363599,0.0034814651247473,0.0027980316291313,0.0164453749181407,0.00572314014212932
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF21,Immunoglobulin superfamily member 21,37628,0.0102554472703292,0.00371263645554921,0.00297867981745279,0.0175322147232057,0.00574737658750379
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PADI2,Protein-arginine deiminase type-2,40044,0.0146027321251931,0.00532259193120328,0.0041704519400347,0.0250350123103515,0.00608505107965852
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBS4,Thrombospondin-4,40355,0.0116776583772125,0.00426754780168315,0.00331326468591357,0.0200420520685115,0.00621870487539146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.00730920993003786,0.00267163402833155,0.00207280723450802,0.0125456126255677,0.00622869615387358
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEO1,Neogenin,37959,0.00553817413514942,0.00202595227360201,0.00156730767888947,0.00950904059140937,0.00627247584662417
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLH1,Glutamate carboxypeptidase 2,37598,0.0278317265372851,0.0102390214883716,0.00776324442007672,0.0479002086544934,0.00657238475474605
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX3,Syntaxin-3,37942,0.0099878666076997,0.00367572128251279,0.00278345289397464,0.0171922803214248,0.00659101577392787
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.00745587759520185,0.0027607330628771,0.00204484079196273,0.012866914398441,0.00692849359031901
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CENPJ,Centromere protein J,37714,0.018763150767742,0.0069707094206463,0.00510056030327525,0.0324257412322088,0.00711752325915972
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPA,Apolipoprotein(a),37735,-0.0448458128111368,0.0166695363014188,-0.0775181039619175,-0.012173521660356,0.00714801639468421
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK14,Kallikrein-14,40489,-0.0116740362698765,0.00435256861108361,-0.0202050707476004,-0.00314300179215261,0.00732359251767777
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTF3,Neurotrophin-3,40341,0.00886326611780591,0.00330937768578327,0.0023768858536707,0.0153496463819411,0.00740890681520724
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM25,Transmembrane protein 25,37959,-0.011137501917236,0.00416199953857451,-0.0192950210128421,-0.00297998282163,0.00745970012893611
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPS,Calcyphosin,37942,0.0241086539445862,0.00901472407925863,0.00643979474923926,0.0417775131399331,0.00749613663278535
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCP2,Non-specific lipid-transfer protein,39980,0.0197132472827754,0.00739980095706693,0.00520963740692419,0.0342168571586266,0.00772917866674048
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.0122823746762497,0.00461443412630201,-0.0213266655638016,-0.00323808378869771,0.00778351567861875
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.00873755254256868,0.00330238486614802,0.00226487820491856,0.0152102268802188,0.008157103245059
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.00807263130100124,0.00305413158937176,-0.0140587292161699,-0.00208653338583258,0.00822280262873582
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.0223576903053641,0.00846400136168003,0.00576824763647126,0.038947132974257,0.00826374633437264
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAC1,Cartilage acidic protein 1,40536,0.00731283328394723,0.00277170925971967,0.00188028313489668,0.0127453834329978,0.00833824261867229
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN8,Tetraspanin-8,37901,0.0259128516767632,0.00986661052693707,0.00657429504396652,0.0452514083095598,0.00864120726436143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEO1,RNA polymerase-associated protein LEO1,37959,0.0077146360101261,0.0029421640286088,0.00194799451405285,0.0134812775061993,0.00874888892989539
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIRREL2,Kin of IRRE-like protein 2,39961,0.00997860226020557,0.00380942742388907,0.00251212450938299,0.0174450800110282,0.00881575775849433
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH4,Myosin-4,37562,-0.0118301711926287,0.00452903573239809,-0.0207070812281289,-0.0029532611571284,0.0090097681758002
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADA2,Adenosine deaminase 2,40258,-0.0103096668268548,0.00396686261817583,-0.0180847175584794,-0.00253461609523012,0.00935969819864833
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DRAXIN,Draxin,40228,0.0106453657090937,0.00410389299906364,0.00260173543092895,0.0186889959872584,0.00949630961299761
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR1,Cadherin-related family member 1,39961,0.0108044488267261,0.00417232793338067,0.00262668607729996,0.0189822115761522,0.00961914655998593
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.00939396551091937,0.00363519693440599,-0.0165189515023551,-0.00226897951948363,0.0097720886421909
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00566292881949717,0.00219182682395853,0.00136694824453845,0.00995890939445588,0.00978477798242109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD2,T-cell surface antigen CD2,37562,0.00938700277255251,0.00363456943183682,0.00226324668615233,0.0165107588589527,0.00981378548430616
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN7,Septin-7,37714,0.0128904756745273,0.00499221474241781,0.00310573477938836,0.0226752165696662,0.0098302898036222
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.0087231812886502,0.0033803393364792,0.00209771618915097,0.0153486463881494,0.00987296861706623
NMR metabolomics,X23508.Triglycerides in Medium VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.0103363069386235,0.00401626160787814,0.00246443418718239,0.0182081796900647,0.010075079405483
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTP1,Glutathione S-transferase P,39871,-0.0169902261667754,0.00662666019425751,-0.0299784801475201,-0.00400197218603071,0.0103591314723632
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDRG1,Protein NDRG1,39961,0.0166202830109141,0.00652767922826135,0.00382603172352185,0.0294145342983063,0.0109022231557609
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEG1,Protein LEG1 homolog,37231,-0.0168453654995609,0.00662078957087479,-0.0298221130584755,-0.00386861794064634,0.0109609351131255
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.029009228277366,0.011402298704804,0.00666072281595017,0.0513577337387819,0.0109637723984606
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REN,Renin,40359,-0.0171406209655965,0.00674720764588235,-0.0303651479515259,-0.00391609397966713,0.0110819306724894
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANSC4,MANSC domain-containing protein 4,37562,0.0158404439374732,0.00625342884986569,0.00358372339173646,0.02809716448321,0.0113180293795018
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTA2,"Actin, aortic smooth muscle",40042,-0.0104596140438397,0.00413958816896192,-0.0185732068550051,-0.00234602123267436,0.0115228666440879
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.0167679271089917,0.00664150163308933,0.00375058390813661,0.0297852703098468,0.0115886102048758
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.0116314355985754,0.00461110255001938,0.00259367460053739,0.0206691965966134,0.0116642939228879
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,0.0100233190719622,0.00398783114032347,0.00220717003692817,0.0178394681069962,0.0119645960884515
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMBS,Porphobilinogen deaminase,40489,0.0108141782899318,0.00430568784704886,0.00237503010971607,0.0192533264701476,0.0120281676424466
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.0144265575808719,0.00574719590143697,0.00316205361405543,0.0256910615476884,0.0120765248358331
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MELTF,Melanotransferrin,37990,0.00695788130761486,0.00277207613630674,0.00152461208045365,0.0123911505347761,0.0120850544934579
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEF,Thyrotroph embryonic factor,37562,0.0102800683436685,0.00409856284577993,0.00224688516593989,0.0183132515213972,0.0121463308530541
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.00878905212483273,0.00351210912905108,0.00190531823189262,0.0156727860177728,0.0123440153907371
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RETN,Resistin,40283,0.00980408642142738,0.00392404402431588,0.00211296013376825,0.0174952127090865,0.0124833053753263
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.0143061873159208,0.00574694881699267,0.0030421676346152,0.0255702069972265,0.0128098558248196
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.0125319349081257,0.00504507739830257,0.00264358320745263,0.0224202866087987,0.0130041022582393
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFD,Complement factor D,38013,0.00447132166851421,0.00180683124677775,0.00092993242482983,0.0080127109121986,0.0133478512272691
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYO6,Unconventional myosin-VI,37959,0.00879182883956672,0.00355830607874499,0.00181754892522655,0.0157661087539069,0.0134937274982438
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMBN,Ameloblastin,40044,-0.00696031664677243,0.00281787614141685,-0.0124833538839495,-0.0014372794095954,0.013519748662456
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.00722253322294426,0.00293493867972929,-0.0129750130352137,-0.00147005341067485,0.0138704544137368
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.0117492524235925,0.00477439709042939,-0.0211070707208341,-0.00239143412635093,0.0138722086413884
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDK2,Protein sidekick-2,37671,0.00891248618867489,0.00362407431397238,0.00180930053328904,0.0160156718440608,0.0139356769931582
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNR,Tenascin-R,40228,-0.00981403251829031,0.00402074937832569,-0.0176947012998087,-0.00193336373677196,0.0146637973242508
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CADPS,Calcium-dependent secretion activator 1,37572,-0.0104213702455974,0.00428359181954792,-0.0188172102119113,-0.00202553027928347,0.0149934493964526
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA2,GDNF family receptor alpha-2,40305,0.0048681023525185,0.00200997704580012,0.000928547342750269,0.00880765736228672,0.0154478028061904
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH22,Cadherin-22,37714,-0.00677833863943761,0.00280436046509117,-0.0122748851510163,-0.00128179212785892,0.015659363460042
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.00636025922719678,0.00263686350592699,-0.0115285116988137,-0.00119200675557988,0.0158761051543746
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.0113885803714668,0.00472231897900269,0.0021328351726215,0.0206443255703121,0.0158920611827647
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC7A,C-type lectin domain family 7 member A,40516,0.0133604010273917,0.00554751515234052,0.0024872713288043,0.0242335307259791,0.0160356602784588
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_DRA,,40288,-0.00822054185212487,0.00341525213179454,-0.0149144360304422,-0.00152664767380756,0.0160951540746625
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH7B,Myosin-7B,37482,-0.0104601270114349,0.00434883398043187,-0.0189838416130813,-0.00193641240978843,0.0161742993100061
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.00672355208701708,0.0028067156866651,0.00122238934115348,0.0122247148328807,0.0166081595883913
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.0110514136464454,0.00461445071297461,0.00200709024901512,0.0200957370438756,0.0166340790396185
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TK1,"Thymidine kinase, cytosolic",37714,0.0101681848282816,0.00425078377533279,0.00183664862862934,0.0184997210279339,0.0167673511084129
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.0149589839337108,0.00626673705674713,-0.0272417885649352,-0.00267617930248644,0.0169984849438091
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,-0.0103832541817953,0.00437001180863243,-0.0189484773267148,-0.00181803103687572,0.0175119997519949
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00608225893927075,0.00256868746908573,0.00104763149986272,0.0111168863786788,0.0179040650547446
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP290,Centrosomal protein of 290 kDa,37714,0.0119718227030084,0.0050689646034692,0.00203665208020876,0.021906993325808,0.0182013793017633
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNW1,Interferon omega-1,37562,-0.00825726123355419,0.00350336045550606,-0.0151238477263461,-0.00139067474076231,0.0184401244719175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAL,Galanin peptides,40422,0.0139075943951118,0.00591160350091852,0.00232085153331149,0.0254943372569121,0.0186551150175149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP164,Centrosomal protein of 164 kDa,40044,0.0142577573556933,0.00607241269112833,0.00235582848108173,0.0261596862303048,0.018889182228293
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCN1,Transcobalamin-1,37766,0.0073667099958217,0.0031377488172845,0.00121672231394409,0.0135166976776993,0.0189007777463403
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.0073440422957038,0.00313241743220048,0.00120450412859085,0.0134835804628168,0.0190655206829976
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.00769708256523674,0.00329617637024623,0.00123657687955413,0.0141575882509193,0.0195475599825018
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FDX1,"Adrenodoxin, mitochondrial",37562,0.0139570143158348,0.00598197299008101,0.00223234725527601,0.0256816813763936,0.0196537903403022
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT19,"Keratin, type I cytoskeletal 19",40310,0.0150057948861421,0.00643849808428366,0.00238633864094616,0.0276252511313381,0.0197850389413252
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBS2,Thrombospondin-2,40332,-0.00789819770147697,0.00339195215860609,-0.0145464239323449,-0.00124997147060903,0.0198974760318884
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RLN2,Prorelaxin H2,37643,0.0309588515783926,0.0133910953808385,0.00471230463194906,0.0572053985248361,0.0207986102478777
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSPN,Claspin,39925,0.00747671277357901,0.00324065201476096,0.00112503482464754,0.0138283907225105,0.0210588652202295
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC6A,C-type lectin domain family 6 member A,39980,0.0102351252297708,0.00443892311412769,0.00153483592608049,0.0189354145334611,0.0211367305203488
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.00884565875977484,0.00383695425826298,-0.0163660891059703,-0.00132522841357941,0.02116052798419
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF2,Trefoil factor 2,40396,0.0124349457942892,0.00539707403631454,0.00185668068311271,0.0230132109054657,0.021234530584036
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC12A,C-type lectin domain family 12 member A,37598,0.00447852209776094,0.00194580785223925,0.000664738707372005,0.00829230548814986,0.0213718278760447
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG1B,Lithostathine-1-beta,40536,0.0121306366330617,0.00529005132699759,0.00176213603214641,0.022499137233977,0.0218548717971531
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.0156782075460199,0.00684896547008706,-0.0291021798673905,-0.00225423522464926,0.0220873252248951
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSB,Lupus La protein,39961,0.0131003577273057,0.00573490587433737,0.00185994221360447,0.024340773241007,0.0223662043194104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.00799048232757097,0.00351237962895142,0.0011062182548262,0.0148747464003157,0.0229222972416937
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JCHAIN,Immunoglobulin J chain,40044,-0.0133179894782624,0.00586245767287732,-0.0248084065171019,-0.00182757243942286,0.0231156798245014
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NINJ1,Ninjurin-1,39980,0.0120627449615302,0.00534271460011972,0.00159102434529552,0.0225344655777648,0.0239723786463122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.00474824251209182,0.00211515123995473,0.000602546081780555,0.00889393894240309,0.0247901031229309
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.0190193506505472,0.00848106447186983,0.00239646428568237,0.0356422370154121,0.024941564192199
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAFB2,Scaffold attachment factor B2,37959,0.0058915539316863,0.00263007299711074,0.000736610857349245,0.0110464970060234,0.0251024202020799
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QSOX1,Sulfhydryl oxidase 1,37761,0.00953301356408739,0.00425886017838008,0.00118564761446243,0.0178803795137124,0.0252117407289077
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUCA2A,Guanylin,40276,-0.00708830391939592,0.00317210399213194,-0.0133056277439745,-0.000870980094817317,0.0254591761144799
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAV,Integrin alpha-V,40489,0.00345277407000941,0.00155074047130334,0.000413322746254853,0.00649222539376396,0.0259923691421508
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOP56,Nucleolar protein 56,37562,0.0232890904547995,0.0105319097062641,0.00264654743052186,0.043931633479077,0.0270330566999564
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.00967243226533729,0.00439098550425524,0.00106610067699701,0.0182787638536776,0.0276239158607868
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL15,Interleukin-15,40341,0.00683500573079745,0.00310470161448533,0.000749790566406209,0.0129202208951887,0.0277148520688989
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAN,Brevican core protein,40228,-0.00696905596499659,0.00317592430510276,-0.013193867602998,-0.000744244326995172,0.0282255432495104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.0142417169952388,0.00649739364361988,0.00150682545374385,0.0269766085367338,0.0284029232662339
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB116,Beta-defensin 116,37541,-0.0165046834470623,0.00753126610134714,-0.0312659650057027,-0.0017434018884219,0.0284340160570275
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNL1,Thioredoxin-like protein 1,37525,0.0198567221386916,0.00907930531449524,0.00206128372228089,0.0376521605551022,0.0287579183579267
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.00695421334051774,0.00318064767393857,0.000720143899598137,0.0131882827814373,0.0287998494987619
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.0116835478567397,0.00534384247142732,0.00120961661274218,0.0221574791007373,0.0288069073724583
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTX1,Neuronal pentraxin-1,40332,0.00814081060701998,0.00373795136420189,0.000814425933184267,0.0154671952808557,0.0294296149820352
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMG,Oligodendrocyte-myelin glycoprotein,40305,-0.0129652973940909,0.00595710859171626,-0.0246412302338548,-0.00128936455432701,0.0295369856958684
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FDX2,"Ferredoxin-2, mitochondrial",37562,0.0119188842654501,0.0054769846044619,0.00118399444070477,0.0226537740901954,0.0295598706091182
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00806810354561853,0.00371720052608028,0.00078239051450118,0.0153538165767359,0.0299885108318042
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.00850970041345484,0.00392951546730735,-0.0162115507293772,-0.000807850097532437,0.0303609021711289
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPN1,Epsin-1,37714,0.00904106133042564,0.00420693063527664,0.00079547728528343,0.0172866453755679,0.0316455192136345
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLVRB,Flavin reductase,40332,0.0134570169991078,0.00628523307928728,0.00113796016370478,0.0257760738345109,0.0322849438431362
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TUBB3,Tubulin beta-3 chain,37541,-0.00565971050185852,0.00264709183255482,-0.010848010493666,-0.000471410510051073,0.0325282121023245
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUK1,Guanylate kinase,37562,-0.00816728541435531,0.00382267033836713,-0.0156597192775549,-0.000674851551155732,0.0326539411241581
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.00811049271744841,0.00381232849292224,0.000638328871320817,0.015582656563576,0.0334023137876261
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.00987521925618248,0.0046616590306397,-0.0190120709562363,-0.00073836755612868,0.0341606634258772
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.0115049519947708,0.0054443768981496,0.00083397327439759,0.022175930715144,0.0346011524897091
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.00721537914943824,0.00342091745014005,0.000510380947163741,0.0139203773517127,0.0349465179131052
NMR metabolomics,X23508.Triglycerides in Medium VLDL,L1CAM,Neural cell adhesion molecule L1,40411,-0.00564849355236545,0.00268079046991563,-0.0109028428734001,-0.000394144231330807,0.0351309427738351
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTN,Titin,37562,-0.0131645182617037,0.00624828956034847,-0.0254111657999867,-0.000917870723420667,0.0351452376464311
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BSND,Barttin,37482,-0.00686199115261667,0.00326432019320325,-0.013260058731295,-0.000463923573938301,0.0355619500875638
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA11,Carbonic anhydrase-related protein 11,39980,0.00659438815998494,0.00313934576512677,0.000441270460336476,0.0127475058596334,0.0356955792803974
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.0188983876823605,0.00901461991816696,0.00122973264275326,0.0365670427219678,0.0360639970448888
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0274200978108216,0.0130827801447835,-0.0530623468945973,-0.00177784872704594,0.0361102579123892
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD99,CD99 antigen,40332,-0.00384162724665174,0.00184019693119647,-0.00744841323179682,-0.00023484126150667,0.0368482540245483
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIF1L,Allograft inflammatory factor 1-like,37628,0.0114900478271332,0.00550697595176868,0.000696374961666598,0.0222837206925998,0.0369567663071971
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GKN1,Gastrokine-1,39602,0.00552682292928888,0.00265342352113127,0.000326112827871589,0.0107275330307062,0.0372768260165809
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.0058386017295605,0.00280448463060017,0.000341811853584175,0.0113353916055368,0.0373727251771958
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL5,ADAMTS-like protein 5,37990,-0.00765342341913721,0.0036811816188416,-0.0148685393920667,-0.000438307446207678,0.0376299684824374
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR101,Probable G-protein coupled receptor 101,37541,-0.0127515247179977,0.0061476057315966,-0.0248008319519271,-0.000702217484068381,0.0380778119481674
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA3G,Semaphorin-3G,37671,0.00851609864426304,0.00410626394997545,0.000467821302311161,0.0165643759862149,0.0381052477642017
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MN1,Transcriptional activator MN1,37572,-0.0117304579436772,0.00567497723860278,-0.0228534133313386,-0.000607502556015702,0.0387490732196776
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPEP2,Dipeptidase 2,40305,-0.00559801008955204,0.00271532366489376,-0.0109200444727438,-0.000275975706360279,0.0392586306662126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLI2,Zinc finger protein GLI2,37598,-0.00659005227484759,0.00320288352440519,-0.0128677039826818,-0.000312400567013416,0.0396542491606296
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.00934909653437442,0.0045459495432933,0.000439035429519549,0.0182591576392293,0.0397461554298121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY9,T-lymphocyte surface antigen Ly-9,40182,0.0055919687334438,0.00272140787122538,0.000258009305842057,0.0109259281610456,0.0399141014964846
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,0.00532482858640796,0.00259250501222091,0.000243518762454976,0.0104061384103609,0.040001577283128
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRDL2,Chordin-like protein 2,40359,0.0110429129586297,0.00538709167602969,0.000484213273611532,0.0216016126436479,0.0403921120726473
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,40305,0.0105783758670668,0.00517661362772814,0.000432213156719692,0.020724538577414,0.0410201138569858
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,40424,-0.00405758474092105,0.00198739919000186,-0.00795288715332471,-0.000162282328517403,0.0412020986327711
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00744128015623638,0.00364865436486713,0.000289917601096803,0.014592642711376,0.0414242700040018
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.00567871820194106,0.00279954962444766,0.00019160093802364,0.0111658354658585,0.042535488910971
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC12A2,Solute carrier family 12 member 2,37562,-0.00551822067769914,0.00272172153296429,-0.0108527948823091,-0.000183646473089139,0.0426341107573124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.0110210738239285,0.00544715401521605,0.000344651954105078,0.021697495693752,0.0430654030703096
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39865,0.00723237782461908,0.00357913203469479,0.000217279036617299,0.0142474766126209,0.0433273432346109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.00908100510105127,0.00449419953993813,0.000272374002772541,0.01788963619933,0.0433402547503388
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00363296156125446,0.00180362285688802,9.78607617539502e-05,0.00716806236075498,0.0440021719128868
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,-0.00510017367110856,0.00253221500165991,-0.010063315074362,-0.00013703226785514,0.0440171883884971
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.0105495968261652,0.00524235123903146,-0.0208246052546669,-0.000274588397663525,0.044200459948582
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMI,N-myc-interactor,37857,0.0136161009000685,0.00679619278090662,0.000295563049491481,0.0269366387506454,0.0451448629103964
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.0140475774245062,0.00701659271652341,-0.0278000991488921,-0.000295055700120355,0.0452995589933388
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUMF1,Formylglycine-generating enzyme,37598,0.0127607756993624,0.0063840312108229,0.000248074526149519,0.0252734768725753,0.0456442073106476
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT8,"Keratin, type II cytoskeletal 8",37541,0.0116503701804342,0.00585628917214266,0.000172043403034557,0.0231286969578338,0.0466803236287705
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.0108928084176793,0.00547837286246721,-0.021630419228115,-0.000155197607243536,0.046796186201987
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNN,Tenascin-N,37998,0.0082643550044222,0.00415648662706859,0.000117641215367758,0.0164110687934766,0.0467982757779036
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMP,Cartilage oligomeric matrix protein,40198,0.00635712299002139,0.00320358817202598,7.8090172850466e-05,0.0126361558071923,0.0472312868003793
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.0049856959523198,0.00252133031035897,4.38885440162181e-05,0.00992750336062337,0.0480166955613772
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP10,Bone morphogenetic protein 10,37671,-0.00538796634810789,0.00272596374988379,-0.0107308552978801,-4.50773983356615e-05,0.0481148188802088
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK1,Kallikrein-1,40209,-0.0238327118317978,0.012087349371951,-0.0475239166008218,-0.000141507062773719,0.048660524789479
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.0097558953008086,0.0049544991011306,4.50770625926213e-05,0.0194667135390246,0.0489628420631955
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B4,Protein ATP1B4,37482,-0.00792262614044609,0.00402458216451449,-0.0158108071828945,-3.44450979976856e-05,0.0490249558091656
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAD1,Glutamate decarboxylase 1,37482,-0.00480774676152453,0.00246086407992151,-0.00963104035817068,1.55468351216289e-05,0.0507601598376285
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFRC,Transferrin receptor protein 1,40391,-0.00729193986111459,0.00374228462995728,-0.0146268177358309,4.29380136016703e-05,0.0513695500083861
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,0.0105824799510694,0.00543699420539166,-7.40286914982652e-05,0.021238988593637,0.0516261811099936
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL4,Early placenta insulin-like peptide,37900,-0.00999820400379943,0.00514380760611623,-0.0200800669117872,8.3658904188386e-05,0.0519481269399567
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.00597489996493738,0.00307904401332387,-0.0120098262310522,6.00263011774037e-05,0.052336036561372
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.00445842244521117,0.0022979184286518,-4.54976749463525e-05,0.00896234256536869,0.0523729250353583
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.00789097272166982,0.00409196182766965,-0.00012927246056269,0.0159112179039023,0.0538226044570672
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC2,Mucin-2,37998,0.0165711252849236,0.00861168226944328,-0.000307771963185217,0.0334500225330325,0.0543427868337575
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF75D,Zinc finger protein 75D,37714,0.0108728698654171,0.00565965446068837,-0.000220052877532078,0.0219657926083663,0.0547381150283766
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFHD1,EF-hand domain-containing protein D1,37959,0.00631971803705999,0.00329648888710281,-0.000141400181661516,0.0127808362557815,0.0552455611653193
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,40203,-0.00607638489996924,0.00318212229291215,-0.0123133445940771,0.000160574794138582,0.0562108132790124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP29,Dual specificity phosphatase 29,37572,-0.0120644018659204,0.00633983219875814,-0.0244904729754864,0.000361669243645507,0.0570685630958512
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX1B,Syntaxin-1B,37572,0.00774537352445614,0.00408567944400223,-0.000262558185788238,0.0157533052347005,0.0580167898287833
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.00413472112929386,0.00218194544125907,-0.000141891935573913,0.00841133419416163,0.0581143662442538
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40536,-0.00528990722728087,0.00279241940515267,-0.0107630492613801,0.000183234806818353,0.0581923323829157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP6,Guanylate-binding protein 6,37562,-0.00853099448268959,0.00451922015707832,-0.0173886659905631,0.000326677025183915,0.0590864417829668
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,0.00593746119448027,0.00316286943214137,-0.000261762892516821,0.0121366852814774,0.0605036355605174
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCLRE1C,Protein artemis,37482,-0.00567056082094671,0.00302281981135634,-0.0115952876512051,0.000254166009311704,0.0606889367319866
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCC,Netrin receptor DCC,37572,0.00416538294129405,0.00222091956893897,-0.000187619413826335,0.00851838529641444,0.0607431706377681
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTNNA1,Catenin alpha-1,37541,-0.00647768286898831,0.00345400455899553,-0.0132475318046195,0.000292166066642926,0.0607582582837876
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPO,Lactoperoxidase,39831,-0.0104482142440026,0.00561488907825365,-0.0214533968373797,0.000556968349374581,0.062790774839453
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA2013,Uncharacterized protein KIAA2013,37900,0.0101475493566599,0.00546565552444674,-0.000565135471255694,0.0208602341845755,0.0633895902301585
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOX9,Transcription factor SOX-9,37572,0.00478344777895751,0.00258112067259978,-0.000275548739338065,0.00984244429725308,0.0638697526299383
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.00531886651412681,0.00287350398368744,-0.0109509343221542,0.000313201293900566,0.0641916349517485
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOH,Beta-2-glycoprotein 1,40332,0.00621092214506038,0.00336178044813396,-0.000378167533282183,0.0128000118234029,0.0646918832556002
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.0104347558477024,0.00564810546811875,-0.0215050425652151,0.000635530869810391,0.0646966890827303
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00797023390883668,0.00433209053557971,-0.0164611313585729,0.000520663540899552,0.0658181185371547
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM132A,Transmembrane protein 132A,37628,0.0109146121378099,0.00597109523887315,-0.000788734530381474,0.0226179588060013,0.0675859767255807
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,0.00890739690681698,0.00487859202613346,-0.000654643464404614,0.0184694372780386,0.0678976245621832
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DENND2B,DENN domain-containing protein 2B,37562,-0.00911601696879256,0.00499637613351862,-0.0189089141904891,0.000676880252903947,0.068095373644611
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.0061323185547053,0.00336310811893086,-0.000459373358399174,0.0127240104678098,0.0682643477215455
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENDOU,Poly(U)-specific endoribonuclease,36973,0.00870558295446778,0.00478256463880912,-0.000668243737598082,0.0180794096465337,0.0687409951464561
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR158,Probable G-protein coupled receptor 158,37959,0.00637943179340044,0.00350503314493182,-0.00049043317066592,0.0132492967574668,0.0687693328332672
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDI2,Protein DDI1 homolog 2,37671,0.0134729208125023,0.00742652652483901,-0.00108307117618215,0.0280289128011868,0.0696754779790138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TJP3,Tight junction protein ZO-3,37541,-0.00758150746835895,0.00418416248830749,-0.0157824659454416,0.000619451008723731,0.0700163028620147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALY,Neuron-specific vesicular protein calcyon,37562,-0.00659879024829605,0.00364239890137365,-0.0137378920949884,0.000540311598396308,0.0700615416268572
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1B,Protein phosphatase 1B,37598,0.0109282786447808,0.00603468582131212,-0.000899705564990959,0.0227562628545526,0.0701774539590647
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHPK,Sedoheptulokinase,37714,-0.00734977135803342,0.00407749265065127,-0.0153416569533099,0.000642114237243065,0.0714859667038991
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RELB,Transcription factor RelB,37598,0.00880547927972397,0.00490591507905772,-0.000810114275229173,0.0184210728346771,0.0726973952820873
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN2,Contactin-2,40489,0.00760017144844193,0.00424803623474931,-0.000725979571666704,0.0159263224685506,0.0736172055601062
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.010321587295166,0.00576971075471049,-0.0216302203743986,0.00098704578406655,0.0736454978269431
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MKI67,Proliferation marker protein Ki-67,37598,0.00642281818576191,0.00359027045806491,-0.000614111912045307,0.0134597482835691,0.0736457114229002
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL19,Interleukin-19,39924,0.0114722081309788,0.00642566760936996,-0.00112210038338633,0.0240665166453439,0.0742205514447104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100G,Protein S100-G,37959,-0.00750053093472609,0.00422566083631586,-0.0157828261739052,0.000781764304453002,0.0759210691278224
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIM,Vimentin,40042,0.019921981735896,0.0112267994086718,-0.0020825451051007,0.0419265085768927,0.0759996074209519
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WIF1,Wnt inhibitory factor 1,40489,-0.00574567575757229,0.00324285193744674,-0.0121016655549679,0.000610314039823323,0.0764472241683348
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPH3,Neurexophilin-3,37598,0.00509772116041688,0.00288161155074336,-0.000550237479040107,0.0107456797998739,0.0769083515808031
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.00714576576533215,0.00405065503758348,-0.0150850496389958,0.000793518108331472,0.0777382507764351
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1,Integrin beta-1,40333,0.00364818666135098,0.00207226830063552,-0.000413459207894644,0.0077098325305966,0.0783457209875264
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAP1,Antigen peptide transporter 1,37714,-0.0103190215548761,0.00586612919324466,-0.0218166347736356,0.00117859166388345,0.0785860809948289
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00755983491774407,0.00429895011409962,-0.000866107305891184,0.0159857771413793,0.078680028436495
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.0115540496224903,0.00657962348701017,-0.00134201241204966,0.0244501116570302,0.0791021563148054
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RLN1,Prorelaxin H1,37959,-0.0137560114499214,0.00784217304230517,-0.0291266706128395,0.00161464771299677,0.0794348326421383
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOCK9,Dedicator of cytokinesis protein 9,37541,0.0199144846705355,0.011375470118515,-0.00238143676175401,0.0422104061028249,0.0800293718936867
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARG1,Arginase-1,40227,0.00876969247840618,0.0050105445202595,-0.00105097478130245,0.0185903597381148,0.0800950743084689
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BEX3,Protein BEX3,37482,-0.00794203751856658,0.00454697199779188,-0.0168541026342387,0.000970027597105497,0.0807190010702548
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6ST,Interleukin-6 receptor subunit beta,40359,0.002884701977196,0.00165351797321312,-0.000356193250301712,0.00612559720469372,0.0810765177850413
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH17,Protocadherin-17,40359,-0.0057460184365133,0.00329772086278205,-0.0122095513275661,0.000717514454539527,0.0814541108584922
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.00812354096190597,0.00466558542755988,-0.0172680883999233,0.0010210064761114,0.0816786096962168
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN4,Prefoldin subunit 4,37482,0.00900638072467544,0.00517359549990302,-0.00113386645513448,0.0191466279044854,0.0817359530875679
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AXL,Tyrosine-protein kinase receptor UFO,40403,-0.00452865434158995,0.00260391971669978,-0.00963233698632151,0.000575028303141609,0.0820244742268397
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP9,Matrix metalloproteinase-9,40312,0.0100302951416317,0.0057927274123465,-0.0013234505865674,0.0213840408698309,0.0833762986299286
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.00551763189485234,0.00319114712963638,-0.0117722802689397,0.000737016479234963,0.0838248684879187
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.00856901514412004,0.00496461260531332,-0.0182996558505341,0.00116162556229406,0.0843675575575332
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.00923885152179189,0.00536461864593724,-0.0012758010242451,0.0197535040678289,0.0850594138126151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOX2,Transcription factor SOX-2,37937,0.00379654388323708,0.00221672766947748,-0.000548242348938778,0.00814133011541294,0.0867945195850243
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP8,Neutrophil collagenase,40442,0.0118402489812525,0.00693575146139059,-0.00175382388307309,0.025434321845578,0.0878167815437729
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.00804664250908087,0.00471599041830151,-0.00119669871079008,0.0172899837289518,0.0879858643664353
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.0057321532827802,0.00336027952268387,-0.0123183011472406,0.000853994581680183,0.0880542406286281
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.00787764864472901,0.00463831437105296,-0.00121344752253479,0.0169687448119928,0.0894593480380003
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSLNL,Mesothelin-like protein,37572,-0.00607025446186588,0.00357634402891917,-0.0130798887585475,0.000939379834815687,0.0896570307020315
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CORO6,Coronin-6,37541,-0.00588433160855493,0.00346902210591385,-0.0126836149361461,0.000914951719036207,0.089862168150008
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.0101984894041024,0.00602339114431749,-0.00160735723875985,0.0220043360469647,0.0904473814830717
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A16,Protein S100-A16,39934,0.00998261300542048,0.00590085032201176,-0.00158305362572258,0.0215482796365635,0.090718641104849
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00897651078251711,0.00531133495133508,-0.00143370572209964,0.0193867272871339,0.0910352754925672
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NLGN2,Neuroligin-2,37541,-0.00776805715427906,0.00459877387740055,-0.0167816539539841,0.00124553964542603,0.0912129114873254
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL4,Myosin light chain 4,37628,-0.00842876221465443,0.00499702298351916,-0.018222927262352,0.00136540283304313,0.0916738086820638
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.0109559168211747,0.00649601134830326,-0.00177626542149971,0.0236880990638491,0.091711600195893
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAD51,DNA repair protein RAD51 homolog 1,37714,0.0087148979319259,0.0051673067165849,-0.0014130232325805,0.0188428190964323,0.0917142975770567
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RYR1,Ryanodine receptor 1,37562,-0.00552250934364284,0.00328980238951168,-0.0119705220270857,0.000925503339800055,0.0932392140854656
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTO1,Protein LTO1 homolog,40044,0.00655971833559684,0.00390801294304224,-0.00109998703276595,0.0142194237039596,0.0932636495659462
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THY1,Thy-1 membrane glycoprotein,40471,-0.00445266697364578,0.00265347347067066,-0.00965347497616028,0.000748141028868711,0.0933564173510154
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNG,Uracil-DNA glycosylase,37900,0.00539641773856982,0.00322016184695595,-0.000915099481463836,0.0117079349586035,0.0937963299468409
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPNMB,Transmembrane glycoprotein NMB,39957,0.00447874304759799,0.00267452205972524,-0.000763320189463475,0.00972080628465946,0.0940337576851518
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPO,Erythropoietin,40341,0.0124145314581288,0.00741382813661537,-0.0021165716896373,0.0269456346058949,0.0940500352460402
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAU,Urokinase-type plasminogen activator,40332,-0.00465604323599952,0.00278282438422653,-0.0101103790290835,0.000798292557084473,0.0943202525686067
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.00916628483032679,0.00548524721697785,-0.0199173693756034,0.0015847997149498,0.0947298585764563
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD48,CD48 antigen,40396,0.00462574239541456,0.00277784486498372,-0.000818833539953526,0.0100703183307827,0.0958871141461454
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00576242154041186,0.00346583728662298,-0.0125554626221929,0.00103061954136919,0.096409620830471
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.0143131888889213,0.00862434757489117,-0.00259053235786543,0.031216910135708,0.0970138392449185
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.00461589650273217,0.00279762797497829,-0.0100992473336896,0.000867454328225275,0.0989806926705774
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17C,Interleukin-17C,40044,-0.0109868502732493,0.0066612427227463,-0.024042886009832,0.00206918546333347,0.0990921130121973
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERVV_1,,37562,-0.0075426284386718,0.00460217740187818,-0.016562896146353,0.00147763926900943,0.101252656490149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.00604199480989297,0.00370699371177147,-0.013307702484965,0.00122371286517911,0.103148610018035
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.00502556594602524,0.00309777090113114,-0.0110971969122423,0.00104606502019179,0.104759714594661
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00580776380164083,0.00358499473861129,-0.0012188258860373,0.012834353489319,0.105251719133077
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRND,Prion-like protein doppel,37942,-0.00825527873037631,0.00510143432911186,-0.0182540900154356,0.00174353255468294,0.10563706633298
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP152,Centrosomal protein of 152 kDa,37482,0.00637200326235001,0.00395309658331047,-0.00137606604093851,0.0141200725656385,0.107007542694523
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.0108007950847239,0.00671880509616734,-0.0239696530732119,0.0023680629037641,0.107958505452245
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSTN,Osteocrin,37572,-0.0065730533248777,0.00409357360826715,-0.0145964575970813,0.00145035094732592,0.108363790742686
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA3,GDNF family receptor alpha-3,40194,-0.00433340341140646,0.00270522545993482,-0.0096356453128787,0.000968838490065791,0.109205740151031
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPON1,Spondin-1,40379,0.00497814396194553,0.00311542750386482,-0.00112809394562952,0.0110843818695206,0.110084903278316
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF12,Fibroblast growth factor 12,37598,0.00732856088929751,0.00458741609530647,-0.00166277465750317,0.0163198964360982,0.110170385451668
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2RB,Cytokine receptor common subunit beta,37598,-0.0066969205345863,0.00421333793928598,-0.0149550628955868,0.00156122182641421,0.111981245399085
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCUN1D1,DCN1-like protein 1,37541,-0.01130538810968,0.00711975923422697,-0.0252601162087649,0.00264933998940487,0.112335571894445
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN1,Calsyntenin-1,39961,0.00791540646422553,0.00499035203657217,-0.00186568352745593,0.017696496455907,0.112727510843933
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.00958923525088557,0.00605841863029368,-0.00228526526449004,0.0214637357662612,0.113488005847355
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00355274247247011,0.00224551130136873,-0.00795394462315281,0.000848459678212597,0.113638057254047
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SULT1A1,Sulfotransferase 1A1,40471,-0.0192125675968164,0.0121811579226858,-0.0430876371252806,0.0046625019316478,0.114760850096147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLK,STE20-like serine/threonine-protein kinase,37714,0.011641042838048,0.00739244038496275,-0.00284814031647901,0.026130225992575,0.115344345375713
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.0125199340083604,0.0079532716051211,-0.00306847833767698,0.0281083463543977,0.115468415910006
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.0103082488093462,0.00656320351533975,-0.0025556300807197,0.0231721276994121,0.116296132041786
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.0144425195994064,0.00920040737644969,-0.0324753180572478,0.00359027885843496,0.116492861076431
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA6C,Semaphorin-6C,37598,0.00396915127714702,0.00253230725375654,-0.000994170940215806,0.00893247349450984,0.117044103876109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.00381059666662628,0.00243125578954072,-0.00857585801412609,0.000954664680873527,0.117060271245669
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD33,Myeloid cell surface antigen CD33,40411,0.0117617022043463,0.00751931705792969,-0.00297615922919591,0.0264995636378885,0.117790857480287
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL6,Fc receptor-like protein 6,40341,0.0099511806760206,0.00639575895934691,-0.00258450688429935,0.0224868682363406,0.11975107195544
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSH1,Chorionic somatomammotropin hormone 1,37987,0.005152643287746,0.00331789176840628,-0.00135042457833032,0.0116557111538223,0.120449584655922
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.0131036725117632,0.00844280828129083,-0.00344423171956685,0.0296515767430932,0.120674061036531
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COPE,Coatomer subunit epsilon,39961,0.00710967825247553,0.00458904609552691,-0.00188485209475722,0.0161042085997083,0.121336876171705
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.00747244450587016,0.00483845652989652,-0.0169558193044673,0.00201093029272703,0.122518968953081
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD5L,CD5 antigen-like,37934,0.00681467679300251,0.00442361279866744,-0.00185560429238567,0.0154849578783907,0.123456415585351
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.0072482396985634,0.00471401274083343,-0.0164877046705969,0.00199122527347011,0.124172093442843
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17RA,Interleukin-17 receptor A,40332,0.00639036464510798,0.00415749666739661,-0.00175832882298937,0.0145390581132053,0.124296018697594
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.00585366355562871,0.00381968251832119,-0.0133402412915382,0.00163291418028082,0.125419168652401
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCL2,Phosducin-like protein 2,37482,0.00786760627834295,0.00513393703964848,-0.00219491031936807,0.017930122876054,0.125430687057261
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REST,RE1-silencing transcription factor,37482,-0.00520352979704035,0.00341293095896641,-0.0118928744766145,0.00148581488253381,0.127370351571047
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIP1,Huntingtin-interacting protein 1,37562,0.0049256993190672,0.00324047713333024,-0.00142563586226007,0.0112770345003945,0.128521590619441
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTM4,Glutathione S-transferase Mu 4,37562,-0.0103443532374234,0.00682007443145215,-0.0237116991230697,0.00302299264822277,0.129353728304057
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.00658126155884438,0.00434850828043513,-0.00194181467080847,0.0151043377884972,0.130188815387908
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RALB,Ras-related protein Ral-B,37598,0.0042601809224308,0.00281682953922132,-0.00126080497444298,0.00978116681930458,0.130455457556595
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC1,Sialoadhesin,40422,0.00617298873941519,0.00410099943977542,-0.00186497016254463,0.014210947641375,0.132282140110417
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,-0.00456429208521558,0.0030409538005639,-0.0105245615343208,0.00139597736388967,0.133391086975967
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.00901645246482166,0.00601183491638995,-0.020799648900946,0.00276674397130264,0.133693740223392
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,-0.00405737941849732,0.00271614530607327,-0.00938102421840093,0.0012662653814063,0.135251856219376
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RG,Cytokine receptor common subunit gamma,37900,0.00547152241892438,0.00367019008820479,-0.001722050153957,0.0126650949918058,0.136037248732017
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TG,Thyroglobulin,37900,-0.0166180622867077,0.0111583593683218,-0.0384884466486184,0.0052523220752029,0.136433779963345
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCAR,Immunoglobulin alpha Fc receptor,40341,0.00660311176368353,0.00445546217775611,-0.00212959410471845,0.0153358176320855,0.138353150163691
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZPR1,Zinc finger protein ZPR1,37541,0.0137099195507571,0.00925534839685309,-0.00443056330707496,0.0318504024085892,0.138551526663868
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMA1,Laminin subunit alpha-1,37562,-0.00790403997940862,0.00534422347825659,-0.0183787179967915,0.00257063803797429,0.139167668870033
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.0102950285233441,0.00696726946083728,-0.0239508766665852,0.00336081961989697,0.13952723131175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRING1,SREBP regulating gene protein,37482,0.00807446978529616,0.00548287498064052,-0.00267196517675926,0.0188209047473516,0.140863982371904
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRNN,Cornulin,39857,0.00927043861160455,0.00629699230477252,-0.00307166630574958,0.0216125435289587,0.140987025662839
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL25,Interleukin-25,37429,0.00487899319606315,0.00332345858386561,-0.00163498562831344,0.0113929720204397,0.142115710219636
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTN4,Alpha-actinin-4,40044,0.00452731664865373,0.00308464004909309,-0.00151857784756873,0.0105732111448762,0.14220674308696
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTN3,Myeloblastin,39897,-0.00653612631907339,0.00445835236760146,-0.0152744969595723,0.00220224432142547,0.142657539251799
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.0132702801583254,0.00908302857819483,-0.0310730161715873,0.00453245585493642,0.14404029713183
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.0126902730273115,0.00871706205755123,-0.00439516860548889,0.0297757146601119,0.145472408969397
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL5A1,Collagen alpha-1(V) chain,37671,0.00549588730445855,0.00377581750654155,-0.0019047150083629,0.01289648961728,0.145541089060432
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.0075579530414323,0.00522249112587301,-0.00267812956527879,0.0177940356481434,0.147866801367177
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.00903712832285216,0.00626411331600617,-0.0213147904222242,0.00324053377651993,0.149133538994462
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALPI,Intestinal-type alkaline phosphatase,37598,0.0165943863289351,0.011540380963933,-0.00602476036037362,0.0392135330182439,0.150474613780281
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRTN,Neurturin,40044,0.00675609595354778,0.00470009010918502,-0.00245608066045487,0.0159682725675504,0.150613172302692
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA8,Carbonic anhydrase-related protein,37598,-0.00379276437878817,0.00264702265479144,-0.00898092878217941,0.00139540002460306,0.151926867215686
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGS8,Regulator of G-protein signaling 8,40044,0.00904200820173961,0.00631220206042382,-0.00332990783669108,0.0214139242401703,0.152030849801266
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSLP,Thymic stromal lymphopoietin,40042,0.00825461676512596,0.00577786786697609,-0.00307000425414717,0.0195792377843991,0.153121612933561
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.00398212697378015,0.0027981636643134,-0.00946652775583442,0.00150227380827412,0.154724022155671
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00867549444144926,0.00610860517755623,-0.0206483605894595,0.00329737170656096,0.155570846931141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL36A,Interleukin-36 alpha,37598,-0.00798866570569218,0.0056262380482505,-0.0190160922802632,0.0030387608688788,0.155662046127232
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN15,Tetraspanin-15,37562,-0.00688695642858187,0.00486042780937153,-0.0164133949349501,0.00263948207778632,0.15652291833238
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.00391991256069517,0.00277916142375056,-0.00152724382985594,0.00936706895124627,0.158421482395559
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIPK2B,Divergent protein kinase domain 2B,37671,0.00356720974324909,0.00253733299468426,-0.00140596292633205,0.00854038241283023,0.15978045189645
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00441907884205621,0.00314434174207561,-0.00174383097241198,0.0105819886565244,0.159923414707368
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF20B,Kinesin-like protein KIF20B,37541,0.0104543633700665,0.00743871641178265,-0.00412552079702752,0.0250342475371605,0.159926447622248
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTOA,Otoancorin,37541,-0.00731380777631945,0.00521834140225969,-0.0175417569247485,0.00291414137210955,0.161071008207929
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRP15,RRP15-like protein,37541,-0.0121601261600071,0.00867994460356606,-0.0291728175829966,0.00485256526298236,0.161254187854728
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.00620730870690135,0.00447244752827398,-0.0149733058623184,0.00255868844851565,0.165191311774448
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.00823336811493534,0.00596129124842077,-0.01991749896184,0.00345076273196936,0.167259958395126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARB1,Scavenger receptor class B member 1,39961,0.0077741611867663,0.00562906303556503,-0.00325880236294115,0.0188071247364738,0.1672756388845
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.00692090155580576,0.00502531608871937,-0.0167705210896957,0.00292871797808421,0.168471706022566
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR1,TGF-beta receptor type-1,37598,0.00282116613399305,0.00204917743187793,-0.00119522163248768,0.00683755390047378,0.168618870062857
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.0108017817255338,0.00784708762404469,-0.0261820734686614,0.00457851001759379,0.168679805909788
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR4,Toll-like receptor 4,37598,0.00372029628247742,0.00270421737847539,-0.00157996977933435,0.0090205623442892,0.16892600916046
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC39A14,Zinc transporter ZIP14,39961,0.00435236154193126,0.00317110007287045,-0.00186299460089483,0.0105677176847573,0.169925068010691
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PODXL2,Podocalyxin-like protein 2,40411,-0.003533301480168,0.00258533701964323,-0.00860056203866874,0.00153395907833273,0.171748147115632
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNGR1,Interferon gamma receptor 1,40422,0.00263932145290289,0.00193964933812537,-0.00116239124982284,0.00644103415562861,0.173621099990929
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP1,DNA topoisomerase 1,37901,0.0137327409509674,0.0101450456650916,-0.00615154855261215,0.033617030454547,0.175873964815311
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.00810682132172367,0.00599190451874646,-0.0036373115350194,0.0198509541784667,0.176090983974896
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK15,Kallikrein-15,37880,0.0065850457470685,0.00486785004470923,-0.00295594034056159,0.0161260318346986,0.176154243819117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTKN2,Rhotekin-2,37562,-0.0067642753784342,0.00501571190493369,-0.0165950707121042,0.00306651995523584,0.177483246744895
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDF15,Growth/differentiation factor 15,40536,0.00548262386431845,0.00407151313252275,-0.00249754187542615,0.013462789604063,0.178134061849788
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.00903160121174593,0.00675676041652195,-0.0222748516281289,0.00421164920463709,0.181351568814165
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0107863425886313,0.0081016699272917,-0.0266656156461231,0.00509293046886039,0.183088958227954
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLHL41,Kelch-like protein 41,37959,0.00600687739232047,0.00451283439707439,-0.00283827802594533,0.0148520328105863,0.183189983151143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.00559174066405896,0.00420173467185735,-0.0138271406208994,0.00264365929278144,0.183272320092916
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00717031592592051,0.00539871822310631,-0.00341117179136785,0.0177518036432089,0.184151207658746
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA7A,Semaphorin-7A,40490,0.0033734506655744,0.00254714209311367,-0.00161894783692839,0.00836584916807719,0.185387064027646
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP13,Collagenase 3,39961,-0.00412254037589445,0.00312963777172863,-0.0102566304084826,0.00201154965669366,0.187771620684893
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPLA2,Acyl-protein thioesterase 2,37541,0.0134205365327495,0.0102996368653062,-0.00676675172325074,0.0336078247887497,0.192594047220953
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM171A2,Protein FAM171A2,37959,0.0198708046951903,0.0152856228080302,-0.010089016008549,0.0498306253989295,0.19363447477087
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGBL2,Cytosolic carboxypeptidase 2,37541,0.0112597500205129,0.00866997809107271,-0.00573340703798964,0.0282529070790154,0.194067823977246
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL33,Interleukin-33,40044,0.0047677001767046,0.00367244633705982,-0.00243029464393264,0.0119656949973418,0.194225627830739
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GH2,Growth hormone variant,39980,0.0206923057321715,0.0160149251473602,-0.0106969475566546,0.0520815590209975,0.196354264664923
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KDM3A,Lysine-specific demethylase 3A,37598,-0.0113829109469754,0.00881427374076258,-0.0286588874788701,0.00589306558491927,0.196581510566722
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00517120185394811,0.00402013427000384,-0.0130506650231556,0.0027082613152594,0.198352130379331
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY6D,Lymphocyte antigen 6D,40268,0.004540914535033,0.00354104567019427,-0.00239953497854777,0.0114813640486138,0.199733281755306
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA4,Ephrin type-A receptor 4,37671,0.00342413343956781,0.00267739328546353,-0.00182355739994071,0.00867182427907633,0.20095272802697
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACHE,Acetylcholinesterase,37671,-0.00386911280974361,0.00303394508900971,-0.00981564518420263,0.00207741956471542,0.202234511342401
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSMB,Beta-microseminoprotein,40236,0.00833129295182506,0.00655604390869988,-0.00451855310922671,0.0211811390128768,0.203825466068681
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,-0.00486834313869031,0.00383562706837437,-0.0123861721927041,0.00264948591532345,0.204376724255303
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.0036321781151198,0.00286234107563842,-0.0092423666233711,0.00197801039313151,0.204479561578931
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLGAP5,Disks large-associated protein 5,37959,-0.00644606735480664,0.00510809428633035,-0.0164579321560141,0.00356579744640084,0.206995066358149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.00505570104562509,0.0040185266764799,-0.00282061124027552,0.0129320133315257,0.20837800404331
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX1,ATP-dependent RNA helicase DDX1,37901,0.0061437642080319,0.00491782848478792,-0.00349517962215242,0.0157827080382162,0.21158297716711
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN3,Neuronal-specific septin-3,37959,-0.00872706340354525,0.00700533266107957,-0.0224575154192612,0.00500338861217071,0.212868875023971
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHH,Sonic hedgehog protein,37598,-0.0051381334407515,0.00413512732039144,-0.0132429829887187,0.00296671610721572,0.21405310504525
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.00386153619516285,0.0031112304819063,-0.00223647554937349,0.0099595479396992,0.214568581859782
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.0076547073995474,0.00617484652909714,-0.00444799179748298,0.0197574065965778,0.215122980514584
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,-0.00439186783500061,0.00354489126169758,-0.0113398547079279,0.00255611903792664,0.215390931992234
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK1,SLIT and NTRK-like protein 1,37598,-0.00379190915329362,0.00306447808920272,-0.00979828620813094,0.00221446790154371,0.215969926815073
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAGE2A,G antigen 2A,37482,0.00732801379006119,0.00592903861923341,-0.00429290190363629,0.0189489294837587,0.216498269785279
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GID8,Glucose-induced degradation protein 8 homolog,37959,0.00395807551457615,0.00321491267889562,-0.00234315333605928,0.0102593043652116,0.218284043860845
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDC1,Syndecan-1,40359,0.0046391098099923,0.0037863441008049,-0.0027821246275853,0.0120603442475699,0.220509955824192
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.0132439332767708,0.0108220241751086,-0.00796723410644207,0.0344551006599837,0.22105112038203
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCN15,Lipocalin-15,37959,-0.00735311930446626,0.00606276517791113,-0.0192361390531721,0.00452990044423957,0.225215036707951
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSV,Cathepsin L2,40444,0.0048695803956593,0.0040220501444253,-0.00301363788741429,0.0127527986787329,0.226020260799643
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKLR,Pyruvate kinase PKLR,40374,-0.00751062392308314,0.00629978014209484,-0.019858193001589,0.00483694515542276,0.233198981316105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCUN1D2,DCN1-like protein 2,37482,0.00917665858557994,0.00770044631622721,-0.00591621619422539,0.0242695333653853,0.233398732901059
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.00253477738126904,0.00212875974084748,-0.00163759171079203,0.0067071464733301,0.233781226770163
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXDC2,Plexin domain-containing protein 2,37942,-0.00301939072106971,0.00253840610529865,-0.00799466668745506,0.00195588524531564,0.234270621086519
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,-0.00354769611285701,0.0029827904617263,-0.00939396541784056,0.00229857319212655,0.234304651084345
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDAC8,Histone deacetylase 8,37598,0.00707986879043617,0.0059526884330764,-0.00458740053839357,0.0187471381192659,0.234320884747454
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLL1,Delta-like protein 1,40411,-0.00329508155935784,0.0027735671645577,-0.00873127320189094,0.00214111008317525,0.234839190914301
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,-0.00227463183880613,0.00192255641010228,-0.00604284240260659,0.00149357872499433,0.236779563696363
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSAPL1,Proactivator polypeptide-like 1,37901,-0.00567361441576166,0.00480634682485856,-0.0150940541924844,0.00374682536096113,0.237845280075504
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.00530870234324943,0.00451803372914104,-0.00354664376586702,0.0141640484523659,0.240014930424556
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,-0.00427678326536731,0.00365029290612433,-0.011431357361371,0.00287779083063638,0.241367790476232
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00561769922100363,0.00481557757855065,-0.00382083283295565,0.0150562312749629,0.24340617926555
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEX33,Testis-expressed protein 33,37714,-0.00437746464055494,0.00375679882399193,-0.0117407903355791,0.00298586105446923,0.243954408495462
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.00578828235506822,0.00496983971588704,-0.0155291681982068,0.00395260348807038,0.244168971421699
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.0042842736247375,0.00369549265776984,-0.0115274392339664,0.00295889198449138,0.246341566943162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.00901632609875105,0.00781587512786838,-0.00630278915187098,0.0243354413493731,0.248688897508451
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD70,CD70 antigen,40341,-0.00453447939715413,0.00393806758700368,-0.0122530918676813,0.00318413307337309,0.249565370161447
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGLC2,Immunoglobulin lambda constant 2,37978,-0.00265077374844074,0.00230599447091109,-0.00717052291142648,0.001868975414545,0.250364275598345
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBQLN3,Ubiquilin-3,37562,-0.00492974702919039,0.00429640651495056,-0.0133507037984935,0.0034912097401127,0.251232453466905
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRCAM,Neuronal cell adhesion molecule,40359,0.00303056266884187,0.00264745974666893,-0.00215845843462923,0.00821958377231297,0.252348249208239
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAPPA,Pappalysin-1,40044,0.00510143400997148,0.00446435858018874,-0.00364870880719844,0.0138515768271414,0.253179649515754
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBN2,Fibrillin-2,37572,0.00661975415015569,0.00579578369421006,-0.00473998189049603,0.0179794901908074,0.25340536228517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF9,Fibroblast growth factor 9,37457,0.00440992568267429,0.00386440606968683,-0.0031643102139119,0.0119841615792605,0.253822200316285
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNLZ,DNL-type zinc finger protein,37541,-0.0103168952327569,0.00905853168455031,-0.0280716173344755,0.00743782686896169,0.254759561876256
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP1,Methionine aminopeptidase 1,39961,0.00330141811693776,0.00291670282613826,-0.00241531942229323,0.00901815565616874,0.257693663818498
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD86,T-lymphocyte activation antigen CD86,37901,0.00313834751537702,0.00277652090662317,-0.0023036334616044,0.00858032849235843,0.258363023111696
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB118,Beta-defensin 118,37541,0.00624459121568868,0.0055484150137664,-0.00463030221129346,0.0171194846426708,0.260409294417139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNMA2,Paraneoplastic antigen Ma2,37541,0.00462090817287083,0.00413647123765894,-0.00348657545294068,0.0127283917986823,0.263966271879644
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAGLN3,Transgelin-3,37482,-0.00647374850852208,0.00580756208391119,-0.017856570192988,0.00490907317594386,0.264995201740723
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.0051682322811398,0.00464136145768189,-0.0142653007381963,0.00392883617591671,0.265507005079879
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,40225,0.00613286394296343,0.00552132715738849,-0.00468893728551802,0.0169546651714449,0.266689022049693
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRMD7,FERM domain-containing protein 7,37572,0.00350970683587614,0.00316578648872335,-0.00269523468202162,0.0097146483537739,0.267607295065004
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL24,Interleukin-24,40044,0.00518261167773521,0.0046839930211377,-0.00399801464369469,0.0143632379991651,0.268548162719213
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM3,Paralemmin-3,37562,0.00762263362438051,0.00690198478869685,-0.00590525656146531,0.0211505238102263,0.269434802377672
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,0.00393749667313269,0.00356546027947116,-0.00305080547463077,0.0109257988208962,0.269463396255178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHP1,Calcineurin B homologous protein 1,37541,0.00766279235259577,0.00695139713877526,-0.00596194603940374,0.0212875307445953,0.27033482719935
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMNB1,Lamin-B1,37874,0.00594008627015577,0.00540957535206134,-0.00466268141988446,0.016542853960196,0.272194117014972
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAYN,Layilin,40192,-0.00354980417029098,0.00325645413848844,-0.00993245428172831,0.00283284594114636,0.275693424224019
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY96,Lymphocyte antigen 96,40228,-0.00357450348374902,0.00328835292283597,-0.0100196752125075,0.00287066824500948,0.277044835297416
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.00443397341481998,0.00407996982296712,-0.00356276743819556,0.0124307142678355,0.277160101940513
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC44A4,Choline transporter-like protein 4,37572,-0.00717947120223967,0.00666521032107911,-0.0202432834315547,0.00588434102707537,0.281430389317812
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,-0.00322008125132223,0.00301299673596753,-0.0091255548538186,0.00268539235117413,0.285210871575831
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00300861464642773,0.00282628899687728,-0.00253091178745174,0.00854814108030719,0.287113512335275
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHIT1,Chitotriosidase-1,40398,0.0150379664269715,0.0141396599748333,-0.0126757671237018,0.0427516999776448,0.287557328743985
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF1,Trefoil factor 1,40261,0.00783440082615844,0.00736747587837661,-0.00660585189545971,0.0222746535477766,0.287627480859795
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.00363804641743397,0.00344531180837732,-0.0103908575618535,0.00311476472698558,0.291014573159392
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,-0.00738828894888514,0.00702817552346313,-0.0211635129748729,0.00638693507710259,0.293165043902144
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA4C,Semaphorin-4C,40305,-0.00280992692598993,0.00268172767460626,-0.0080661131682182,0.00244625931623833,0.294744559827834
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.0050873398566224,0.0048576948151302,-0.0146084216942776,0.0044337419810328,0.294992305632083
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,-0.00594657086147456,0.00569738350658294,-0.0171134425343771,0.005220300811428,0.296622958292186
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.00467605589906412,0.004490224760139,-0.00412478463080833,0.0134768964289366,0.297715211397433
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.00408554386257816,0.00393165052583628,-0.00362049116806095,0.0117915788932173,0.298754241391123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NLGN1,Neuroligin-1,37572,-0.00687409648174071,0.0066305887632546,-0.0198700504577197,0.00612185749423831,0.299883190210597
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.00665417103299019,0.0064276484409736,-0.00594401991131807,0.0192523619772984,0.300572093407375
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GJA8,Gap junction alpha-8 protein,37482,0.00612577010989744,0.00592947554607324,-0.00549600196040611,0.017747542180201,0.301573994915548
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,-0.00370348294263526,0.00360235549380891,-0.0107640997105007,0.00335713382523021,0.303934650199269
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTN,Neuroplastin,39980,0.00821746419151462,0.00801664811689413,-0.00749516611759788,0.0239300945006271,0.305355620443169
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.00480364876192229,0.00468783385024588,-0.0139918031084042,0.00438450558455965,0.305517780594858
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.00787899924420091,0.00769481099043593,-0.00720283029705351,0.0229608287854553,0.305881152734883
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASA1,Ras GTPase-activating protein 1,39961,0.00316297871010818,0.00309315270942912,-0.0028996006003729,0.00922555802058926,0.306525078600555
NMR metabolomics,X23508.Triglycerides in Medium VLDL,H2AP,Huntingtin-interacting protein M,37482,-0.0050725138864336,0.00496096285831537,-0.0147960010887317,0.00465097331586453,0.306570030882165
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.00351537974116232,0.00345326413592096,-0.00325301796524277,0.0102837774475674,0.308702628314163
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCNE1,G1/S-specific cyclin-E1,37598,0.00902254526019387,0.00891354891451469,-0.00844801061225492,0.0264931011326427,0.311447602276334
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,-0.00262910654861928,0.00259829151593042,-0.0077217579198429,0.00246354482260433,0.311620347976381
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSP90B1,Endoplasmin,39878,-0.00672831025192379,0.00666246628878484,-0.0197867441779421,0.00633012367409449,0.312567273869472
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC15,Thioredoxin domain-containing protein 15,40411,-0.00259448582154032,0.00257452776919821,-0.00764056024916882,0.00245158860608818,0.313588754939741
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PITHD1,PITH domain-containing protein 1,37457,-0.00786647675082782,0.00781448675499651,-0.023182870790621,0.00744991728896535,0.314120271262463
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC1A,C-type lectin domain family 1 member A,40042,-0.00314954532424685,0.00313342821719012,-0.00929106462993948,0.00299197398144578,0.314843307721355
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP112,Centrosomal protein of 112 kDa,37562,0.004504555846522,0.00449344880257821,-0.00430260380653129,0.0133117154995753,0.316134267211001
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXDC1,Plexin domain-containing protein 1,39980,0.00321393073979359,0.00322027127391731,-0.00309780095708433,0.00952566243667151,0.318279851483531
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUOX2,Dual oxidase 2,40042,0.00682982656612119,0.00687712609066025,-0.00664934057157291,0.0203089937038153,0.320665821912482
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,0.00241215821216803,0.00243251277871538,-0.00235556683411412,0.00717988325845018,0.321394659694566
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.0113562254028793,0.0114941560819328,-0.0111723205177091,0.0338847713234676,0.323168077062371
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTNAP4,Contactin-associated protein-like 4,37572,0.00947156000216046,0.00965815331877272,-0.00945842050263406,0.028401540506955,0.326768539830313
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORF4L1,Mortality factor 4-like protein 1,37714,-0.00380873145441729,0.00388876790250864,-0.0114307165433342,0.00381325363449965,0.327391076669782
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.00477219701540762,0.00489123722437207,-0.0143590219751769,0.00481462794436165,0.329249860696139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTPP1,dCTP pyrophosphatase 1,40359,0.00291100809414225,0.0030015589080555,-0.00297204736564654,0.00879406355393103,0.332144949510151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF5,Fibroblast growth factor 5,40044,-0.00296836076924312,0.0030616888596825,-0.00896927093422081,0.00303254939573457,0.332302117810881
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRAS,GTPase Hras,37697,-0.00904336309011028,0.00936555739032696,-0.0273998555751511,0.00931312939493056,0.334263027315175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NELL2,Protein kinase C-binding protein NELL2,40422,0.0025803696430364,0.00267541858576679,-0.00266345078506652,0.00782419007113931,0.334823320250882
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00203726757523495,0.00213744505292193,-0.00215212472849203,0.00622665987896194,0.340537447493923
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.00415343872195171,0.00436688460725461,-0.0127125325521708,0.00440565510826734,0.341560084858778
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDAN1,Codanin-1,37942,0.00208984755528105,0.00220667620292906,-0.00223523780245991,0.00641493291302202,0.343626834301784
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPN3,Calpain-3,37900,0.00334165235042308,0.00352858299026399,-0.00357437031049434,0.0102576750113405,0.343643627302712
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESPL1,Separin,37482,-0.0051655046433835,0.00545720346365232,-0.015861623432142,0.00553061414537505,0.343886740342377
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.00358277712712161,0.00379016377279766,-0.0038459438675618,0.011011498121805,0.344531379736006
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEX101,Testis-expressed protein 101,37572,0.00348837965636827,0.00373688881007739,-0.0038359224113834,0.0108126817241199,0.350579884633143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AREG,Amphiregulin,40305,-0.00436337349280934,0.00468676069619618,-0.0135494244573539,0.00482267747173518,0.351867820164381
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.00398009618674371,0.00427785966229168,-0.00440450875134799,0.0123647011248354,0.352183910951316
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTLA,B- and T-lymphocyte attenuator,37482,0.00776213804886982,0.00845814066873485,-0.00881581766185048,0.0243400937595901,0.358786596301386
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUCL3,Mucin-like protein 3,37482,-0.00393760575555495,0.00429100472278583,-0.0123479750122152,0.00447276350110528,0.358823355218459
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPT,Microtubule-associated protein tau,39961,0.00461543860616199,0.00504494810537474,-0.00527265968037251,0.0145035368926965,0.360277545716162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELL,L-selectin,38013,-0.00198607418397908,0.00219896019764413,-0.00629603617136158,0.00232388780340341,0.366442235585094
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISM2,Isthmin-2,37998,-0.00381412673387677,0.00423576100154023,-0.0121162182968956,0.00448796482914207,0.367892341871935
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROK1,Prokineticin-1,40341,-0.00586716126026724,0.00652361236300498,-0.018653441491757,0.00691911897122252,0.368467609465958
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.00520261790035711,0.00578872676840513,-0.0165485223664312,0.00614328656571695,0.368802370160819
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STEAP4,Metalloreductase STEAP4,37541,-0.00640866147341024,0.00717307929680275,-0.0204678968951436,0.00765057394832314,0.371642082899595
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN3B,Sodium channel subunit beta-3,37541,0.00390372851405699,0.00437121726425247,-0.00466385732387786,0.0124713143519918,0.371845231160585
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL3A1,Collagen alpha-1(III) chain,37998,-0.00195581533433889,0.00219496169572416,-0.00625794025795823,0.00234630958928046,0.372919464494858
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTXR,Neuronal pentraxin receptor,40359,0.0028529970747295,0.00321305653542708,-0.00344459373470758,0.00915058788416658,0.374587179947518
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDNRB,Endothelin receptor type B,37598,0.00397713858954944,0.00450991061986347,-0.00486228622538296,0.0128165634044818,0.37786518902724
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00243779624698783,0.00277492742523815,-0.00300106150647894,0.0078766540004546,0.379681576129772
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD4,Sushi domain-containing protein 4,37900,-0.00371677107806519,0.00423877223759177,-0.0120247646637451,0.00459122250761467,0.380583313509194
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMCN2,Hemicentin-2,37648,-0.00475692155024281,0.00543156153189903,-0.0154027821527649,0.00588893905227929,0.381158719282376
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.0144169977632272,0.0164805712094373,-0.0467189173337242,0.0178849218072698,0.381705158699242
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00414264286836033,0.00474394675278877,-0.00515549276710565,0.0134407785038263,0.382543838756862
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBX2,Chromobox protein homolog 2,37562,-0.00341032643968486,0.00391546321539373,-0.0110846343418566,0.00426398146248685,0.383775961556559
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.00660766634324004,0.00759873968695683,-0.00828586344319535,0.0215011961296754,0.384546647851578
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVPL,Envoplakin,37714,-0.00284892924514301,0.00328320956899026,-0.00928402000036393,0.00358616151007791,0.385559559354085
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHGB,Secretogranin-1,40406,-0.00330776135044731,0.00382068788869581,-0.0107963096122911,0.00418078691139648,0.386640176084774
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.00602386261178726,0.00696370869115671,-0.00762500642287989,0.0196727316464544,0.387034050268072
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.00205026313775476,0.00237285582578119,-0.00670106055628589,0.00260053428077637,0.387576403728442
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.00296375884954249,0.003437499908607,-0.00970125867041221,0.00377374097132723,0.388599056299689
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMG4,Proteasome assembly chaperone 4,37598,0.00462112594774289,0.00536352048431885,-0.00589137420152205,0.0151336260970078,0.388931935539008
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMIGO1,Amphoterin-induced protein 1,37572,0.00408232923608999,0.00475156678415983,-0.00523074166086327,0.0133954001330433,0.390271066055146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YY1,Transcriptional repressor protein YY1,37598,0.00228653215046564,0.00267225969441309,-0.00295109685058402,0.0075241611515153,0.392204277993158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00548533959636336,0.00646691156283086,-0.00718980706678513,0.0181604862595119,0.396332847085035
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTNAP2,Contactin-associated protein-like 2,40341,-0.00320977875065648,0.00380228326318662,-0.0106622539465023,0.0042426964451893,0.39858634834151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR2,Toll-like receptor 2,37714,0.00184472361154676,0.00218675129646032,-0.00244130892951546,0.00613075615260898,0.398913236351823
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD55,Complement decay-accelerating factor,39802,0.00209216845052284,0.00248853128733334,-0.0027853528726505,0.00696968977369617,0.40051556125158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEB,Nebulin,37562,0.00291192568533344,0.00346708230756159,-0.00388355563748727,0.00970740700815415,0.400992185458643
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB5,Integrin beta-5,40411,0.00294368304196079,0.0035094662333155,-0.0039348707753376,0.00982223685925917,0.401603267223884
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00502607811963737,0.00600331517793433,-0.00674041962911392,0.0167925758683886,0.4024856339612
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCN2,Transcobalamin-2,40497,0.00235935928204687,0.00282703693247745,-0.00318163310560893,0.00790035166970266,0.40397246998744
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PYDC1,Pyrin domain-containing protein 1,37628,-0.00338441302620081,0.00405662756326553,-0.0113354030502012,0.00456657699779963,0.404131430797784
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAX,Integrin alpha-X,37714,0.00438221243437981,0.0052557404051225,-0.00591903875966029,0.0146834636284199,0.404411276974407
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPHS2,Podocin,37598,-0.00827985410396557,0.00998350932349726,-0.0278475323780202,0.0112878241700891,0.406919707772372
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB5,Serpin B5,40042,-0.00382146421406555,0.00462907726256913,-0.012894455648701,0.00525152722056994,0.409080685466538
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRRT3,Proline-rich transmembrane protein 3,37628,0.00294583959646127,0.00357164228547976,-0.00405457928307906,0.00994625847600161,0.40950817961748
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM2,Intercellular adhesion molecule 2,40536,-0.00241180282247184,0.00295042742367687,-0.0081946405728785,0.00337103492793482,0.413688081780692
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPEP,Glutamyl aminopeptidase,37562,-0.00359758914746058,0.00441573125064509,-0.0122524223987249,0.00505724410380379,0.415246807444266
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBR1,T-box brain protein 1,37572,0.0037748131362796,0.00464084920923887,-0.00532125131382858,0.0128708775863878,0.416010140805286
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FZD10,Frizzled-10,37572,0.00469371088870179,0.00579470382634832,-0.00666390861094091,0.0160513303883445,0.417954788086452
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCIN,Adseverin,37541,0.00563794142777194,0.00699170275244869,-0.0080657959670275,0.0193416788225714,0.420040720870637
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,0.00349557276280288,0.00440547640625615,-0.00513916099345918,0.0121303065190649,0.427521547688869
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.00232323537307832,0.0029472627567802,-0.00345339963021087,0.0080998703763675,0.43055332549504
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.008959468440081,0.0113764451243676,-0.0133383640036796,0.0312573008838416,0.430976827642662
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.00333387962039699,0.00424975568958186,-0.0116634007719774,0.00499564153118345,0.432768457460074
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALMS1,Alstrom syndrome protein 1,37714,0.00333349244877755,0.00428792874826094,-0.00507084789781389,0.011737832795369,0.436928888739743
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00514495671506364,0.00666836779729876,-0.0182149575977692,0.00792504416764194,0.440396888780062
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPHA2,Glycoprotein hormone alpha-2,37901,0.00357735782503288,0.00465564497063906,-0.00554770631741968,0.0127024219674854,0.442268145711697
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VNN2,Vascular non-inflammatory molecule 2,40305,-0.00325693824864877,0.00425151110197544,-0.0115899000085206,0.0050760235112231,0.443648417931918
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.00299308696229097,0.00392945759758919,-0.00470864992898384,0.0106948238535658,0.446247420187274
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA2,Protein disulfide-isomerase A2,37482,-0.00298409699836044,0.00395914483056593,-0.0107440208662697,0.00477582686954879,0.451029418113308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMMR,Hyaluronan mediated motility receptor,37460,-0.00348347738024163,0.00463804909153504,-0.0125740535996503,0.00560709883916705,0.452626990037219
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00393867321483849,0.0053451508026107,-0.0144151687879555,0.00653782235827848,0.461215593065517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPESP1,Sperm equatorial segment protein 1,37990,0.00193083614061673,0.00262072258100385,-0.00320578011815081,0.00706745239938427,0.461282803023214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNL2,Interferon lambda-2,37541,0.00453705322831622,0.00616613549229567,-0.0075485723365833,0.0166226787932157,0.461864546760293
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSCA,Prostate stem cell antigen,37901,0.0181536334962877,0.0247067082200001,-0.0302715146149125,0.066578781607488,0.462495214656295
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMA1,Proteasome subunit alpha type-1,39980,-0.00323752608397215,0.00441788492536778,-0.011896580537693,0.0054215283697487,0.46367767414265
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK12,Kallikrein-12,39980,-0.00982508846365889,0.0135859471608315,-0.0364535448988886,0.0168033679715708,0.469580052799505
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANGAP1,Ran GTPase-activating protein 1,39980,-0.00341342912619938,0.00472593266325911,-0.0126762571461872,0.00584939889378848,0.470135502028401
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR3,Folate receptor gamma,40355,-0.012599611149522,0.0174611613499796,-0.0468234873954821,0.021624265096438,0.470563828611982
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1A,Interleukin-1 alpha,40044,0.00368164157586344,0.00511508857828916,-0.00634393203758332,0.0137072151893102,0.471682912660514
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,-0.00542427030366172,0.00754787877837346,-0.0202181127092737,0.00936957210195025,0.472370439260876
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37942,-0.00486184959121596,0.00676944425020892,-0.0181299603216254,0.00840626113919353,0.472643252965001
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPLX2,Complexin-2,37482,-0.00210632969481452,0.00295026776068636,-0.00788885450575979,0.00367619511613075,0.475273814702819
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRG3,Proteoglycan 3,37998,-0.00339066607551395,0.00475773814410771,-0.0127158328379651,0.00593450068693718,0.476066314521546
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,-0.00331555135655207,0.0046844014887168,-0.012496978274437,0.00586587556133286,0.479091066873946
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.00486574689640314,0.00691781211034569,-0.00869316483987441,0.0184246586326807,0.481840795292545
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00576325877892667,0.0081944129226146,-0.0218243081072513,0.0102977905493979,0.481871631592319
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,-0.00228110872738402,0.00328672374065288,-0.00872308725906366,0.00416086980429562,0.487671217730333
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,-0.00222301418080904,0.00322602540949432,-0.00854602398341791,0.00409999562179983,0.490780342930827
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,-0.00330767635126977,0.0048108022415734,-0.0127368487447536,0.0061214960422141,0.491747013916783
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.00495809943720541,0.00728241799620872,-0.0192316387097745,0.00931543983536368,0.495988279023798
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A3,Protein S100-A3,37900,0.00296821538996408,0.00436492221188131,-0.00558703214532328,0.0115234629252514,0.496506260865846
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00431330153653999,0.00638791157448264,-0.00820700514944598,0.016833608222526,0.499542344000231
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20,Interleukin-20,40044,0.00323923160778803,0.00484428184911913,-0.00625556081648546,0.0127340240320615,0.503715161810401
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELENOP,Selenoprotein P,38013,0.00143185670274231,0.00214486899415291,-0.00277208652579738,0.00563579993128201,0.504417535244983
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAUR,Urokinase plasminogen activator surface receptor,40264,0.00168288175979771,0.00252935714845577,-0.00327465825117559,0.00664042177077101,0.505842939741064
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.00258790099168142,0.00390508369601459,-0.01024186503587,0.00506606305250717,0.507533995772867
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRR5,Proline-rich protein 5,37598,0.00302144712948266,0.00459099426564063,-0.00597690163117297,0.0120197958901383,0.510469473164468
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCND2,G1/S-specific cyclin-D2,37714,0.00228903980793051,0.00349020892686904,-0.00455176968873281,0.00912984930459382,0.511934548084983
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.00202593718446213,0.00309273610697828,-0.00403582558521531,0.00808769995413956,0.512438646128179
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTF,Ciliary neurotrophic factor,37541,-0.00211256872643622,0.0032250690629073,-0.00843370408973453,0.00420856663686209,0.512449621731111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NENF,Neudesin,37900,0.00669940981189271,0.0102880642773642,-0.0134651961717411,0.0268640157955266,0.514939661937595
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPE4,NXPE family member 4,37562,-0.00223529657836527,0.00346277360738174,-0.00902233284883349,0.00455173969210295,0.518600257112474
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00199461561799841,0.00309803011366648,-0.00407752340478789,0.00806675464078472,0.519694678864603
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVI2B,Protein EVI2B,37482,0.00257945483907261,0.0040116075839251,-0.00528329602542059,0.0104422057035658,0.520236843940738
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00389849170792865,0.00607070680119518,-0.0157970770382712,0.0080000936224139,0.520766859769479
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00219843751181818,0.00342968818684764,-0.00452375133440319,0.00892062635803955,0.52153248030575
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,-0.0027072364973903,0.00424745137818644,-0.0110322411986357,0.00561776820385512,0.523887118884204
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.00203418392069068,0.00319989879170807,-0.00830598555243849,0.00423761771105713,0.524979624974909
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENOPH1,Enolase-phosphatase E1,37900,0.00345493339456968,0.00544823973312133,-0.00722361648234812,0.0141334832714875,0.526001845320207
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,0.00197857660052139,0.00312120456797627,-0.0041389843527121,0.00809613755375489,0.526147405384907
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL36G,Interleukin-36 gamma,37551,0.00415659585116006,0.00656400939437087,-0.00870886256180685,0.017022054264127,0.526587730568902
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,37541,-0.00427954903944752,0.00676194000044168,-0.0175329514403132,0.00897385336141817,0.526817999824821
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKKL1,Dickkopf-like protein 1,40305,-0.00525882288197478,0.00832693913948731,-0.0215796235953699,0.0110619778314203,0.527694432391034
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.00563166066969666,0.00892577029124558,-0.0118628491011447,0.023126170440538,0.528088149394562
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00342852002167629,0.00544138054662202,-0.00723658584970287,0.0140936258930555,0.528651443804586
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MB,Myoglobin,40536,-0.00290943646654344,0.00465128304032793,-0.0120259512255862,0.0062070782924993,0.531643511360339
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00476837389185194,0.00784522782475472,-0.0201450204283712,0.0106082726446673,0.543326781140742
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN4,Nectin-4,40411,-0.00175030556111866,0.00289560786222445,-0.00742569697107859,0.00392508584884127,0.545540381200297
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP350,Centrosome-associated protein 350,37482,0.00212711212114033,0.00356820604371247,-0.0048665717245361,0.00912079596681676,0.551099216399602
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLNS1A,Methylosome subunit pICln,37572,0.00190510439061792,0.00319613646465409,-0.0043593230801041,0.00816953186133994,0.551142232000137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00259191553254037,0.0043710974793384,-0.0111592665920436,0.0059754355269629,0.553213639165853
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD177,CD177 antigen,40316,-0.00716037909479869,0.0121100364114663,-0.0308960504612726,0.0165752922716753,0.554343644124621
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPBGL,Trophoblast glycoprotein-like,37572,0.00234731901833989,0.00397270591958517,-0.00543918458404704,0.0101338226207268,0.554623395399023
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00326128457022944,0.00552156459243681,-0.0140835511714056,0.00756098203094672,0.554768482015209
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB6B,Ras-related protein Rab-6B,39961,0.00272959161598058,0.00463179736860923,-0.00634873122649351,0.0118079144584547,0.55565799640764
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCLN,Nicalin,40044,-0.00296795862708474,0.00507187606588711,-0.0129088357162235,0.00697291846205399,0.55843539951662
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.00226075725992265,0.00386546057269073,-0.00983705998239648,0.00531554546255117,0.558651177133206
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPR,Gastric inhibitory polypeptide receptor,37598,0.00270668016835009,0.00465640326355117,-0.00641987022821021,0.0118332305649104,0.561060843810917
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF6,Fibroblast growth factor 6,37598,-0.00236671540749196,0.00409396368755094,-0.0103908842350918,0.00565745342010788,0.563207333847287
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00475230774923589,0.00824228917540876,-0.0114025790345653,0.0209071945330371,0.564235673912219
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDAC9,Histone deacetylase 9,37541,-0.0034507311217816,0.00603885989106976,-0.0152868965082783,0.00838543426471514,0.567724135321805
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAND5,DAN domain family member 5,37598,-0.00294114646656569,0.00518158515072979,-0.0130970533619961,0.0072147604288647,0.570305980193401
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RSPO1,R-spondin-1,40228,0.00188770529477252,0.00335573385052951,-0.00468953305226532,0.00846494364181036,0.573762083553422
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C9orf40,Uncharacterized protein C9orf40,37901,-0.00437426986658976,0.00782761179508266,-0.0197163889849518,0.0109678492517723,0.57629005274529
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRR1B,Cornifin-B,37714,0.004515296414403,0.00810908199640593,-0.0113785042985526,0.0204090971273586,0.577660034699883
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP15,Matrix metalloproteinase-15,37990,0.00262665847188711,0.0047383321831368,-0.00666047260706103,0.0119137895508352,0.579353689371559
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASQ2,Calsequestrin-2,37562,-0.00263884366802325,0.00477453546781028,-0.0119969331849314,0.00671924584888491,0.580484313123003
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL9A1,Collagen alpha-1(IX) chain,40341,0.00246157399265476,0.00446671717091824,-0.00629319166234499,0.0112163396476545,0.581578067430673
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANPEP,Aminopeptidase N,40370,0.00145048467838768,0.00267682008962766,-0.00379608269728253,0.00669705205405789,0.587916633390056
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNC5D,Netrin receptor UNC5D,37598,0.00137749811920024,0.00254388541603585,-0.00360851729623003,0.00636351353463051,0.588176463043394
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00301693705596046,0.00557406258586129,-0.00790822561232766,0.0139420997242486,0.588347456824674
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGN,Cingulin,37572,0.00214617015633807,0.00399289519761251,-0.00567990443098245,0.00997224474365859,0.590933305473261
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP4,Caspase-4,37714,-0.00871228993088458,0.0162538438484011,-0.0405698238737508,0.0231452440119816,0.591957776105466
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOC2B,Double C2-like domain-containing protein beta,37572,0.00183593497195568,0.00342651158678013,-0.00488002773813338,0.00855189768204474,0.592103834806497
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.00183195931095642,0.00343373221181213,-0.00489815582419535,0.00856207444610818,0.593683719440535
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERCC1,DNA excision repair protein ERCC-1,37482,0.00170362472631849,0.00319793338710028,-0.00456432471239805,0.00797157416503504,0.594231816389109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTNL10,Butyrophilin-like protein 10,37482,0.00211848547372719,0.00398480329830986,-0.00569172899096012,0.00992869993841451,0.594983610296401
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTR,Methionine synthase,37562,0.00328790960565361,0.00623068026335107,-0.00892422371051448,0.0155000429218217,0.597718773190059
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPD1,Sphingomyelin phosphodiesterase,40380,-0.00234745116969087,0.00450344832791644,-0.0111742098924071,0.00647930755302534,0.602195430671033
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00182631228935711,0.00350475657745367,-0.00504301060245208,0.00869563518116631,0.602309157966324
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTR1A,5-hydroxytryptamine receptor 1A,37541,-0.00400582325200614,0.00770426381086328,-0.0191061803212982,0.0110945338172859,0.603108006559912
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH4,Cadherin-4,37541,0.00243799531363279,0.00471599223936929,-0.00680534947553103,0.0116813401027966,0.605190453515016
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAN,Neurocan core protein,40471,-0.00181794373542314,0.00353131667640052,-0.00873932442116816,0.00510343695032189,0.606695552075691
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF174,Zinc finger protein 174,37598,-0.00190188324008882,0.00369463227951658,-0.00914336250794133,0.00533959602776368,0.606722901146638
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL31,Interleukin-31,37598,-0.00284279000591092,0.005539304037592,-0.0136998259195912,0.0080142459077694,0.607817628993295
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLN1,Cerebellin-1,37541,-0.00476000746592275,0.00934595396782918,-0.0230780772428679,0.0135580623110224,0.61054206200903
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL6B,Myosin light chain 6B,37572,-0.00445839178694811,0.00880165596325294,-0.0217096374749239,0.0127928539010277,0.61248605091838
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MERTK,Tyrosine-protein kinase Mer,40516,-0.00124894913807377,0.00247757808467947,-0.00610500218404554,0.003607103907898,0.614197445929178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00121993978016011,0.00242510407819776,-0.00353326421310749,0.00597314377342771,0.614938678384756
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10,Interleukin-10,40044,0.00406752896570526,0.00816678258526605,-0.0119393649014162,0.0200744228328267,0.618450397212593
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HCG22,Protein PBMUCL2,37562,-0.00251550290032629,0.00508564521086339,-0.0124833675136185,0.00745236171296595,0.620870969240031
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00301232435759747,0.00613517210845041,-0.00901261297496534,0.0150372616901603,0.623439776670767
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.00262837710626327,0.00537459254807512,-0.00790582428796397,0.0131625785004905,0.624823405391691
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC2L,C-type lectin domain family 2 member L,37572,0.00230766376761522,0.00472119057257539,-0.00694586975463254,0.011561197289863,0.624999594128813
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSD1,Tryptase delta,37959,-0.00176802029453676,0.00363091678484844,-0.00888461719283969,0.00534857660376617,0.626312329396039
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POF1B,Protein POF1B,37598,0.00214803098233651,0.00441307494186734,-0.00650159590372348,0.0107976578683965,0.626448961441885
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,0.0030417221007998,0.00634435690703642,-0.00939321743699159,0.0154766616385912,0.631635488899099
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,0.00199777253500844,0.00418108741956794,-0.00619715880734473,0.0101927038773616,0.632790726349811
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHODH,Dihydroorotate dehydrogenase,37562,0.00219448000697651,0.00460268127641033,-0.00682677529478773,0.0112157353087408,0.633524627011099
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00327846157907125,0.00695388408971848,-0.010351151236777,0.0169080743949195,0.6373218415733
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM25,RNA-binding protein 25,37482,-0.00207800112299852,0.00441103130647751,-0.0107236224836944,0.00656762023769739,0.637582995184556
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABO,Histo-blood group ABO system transferase,37987,-0.0064267287796138,0.0136923001238748,-0.0332636370224083,0.0204101794631807,0.638814112580478
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,40332,0.00152141429377545,0.0032611390409735,-0.00487041822653262,0.00791324681408352,0.640843654719663
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HK2,Hexokinase-2,40042,-0.00122399849093008,0.00262428792820647,-0.00636760283021476,0.00391960584835461,0.640927383374487
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00268673134823091,0.00577200526982968,-0.0139998616770971,0.00862639898063527,0.641598222910023
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA10,Annexin A10,39961,0.00364357534535643,0.00783653125128317,-0.0117160259071586,0.0190031765978714,0.64197560558995
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA10,Ephrin type-A receptor 10,39961,-0.00287076324195931,0.0062057073008777,-0.0150339495516796,0.00929242306776098,0.643657246959327
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASN,Vasorin,40116,-0.00118144057219018,0.00259877081569041,-0.00627503137094338,0.00391215022656301,0.649392436694777
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.00153587146687703,0.00338247696908214,-0.00509378339252397,0.00816552632627802,0.649786887295702
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.00249217177755029,0.00551433167885473,-0.00831591831300497,0.0133002618681056,0.651316500701443
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17A,Interleukin-17A,40028,0.00182896289729931,0.00405050329687405,-0.00611002356457383,0.00976794935917244,0.651606931600659
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDSN,Corneodesmosin,40456,-0.001826228804665,0.00408931163701082,-0.00984127961320621,0.00618882200387621,0.655180140577613
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.0020913797538084,0.00470974022386383,-0.0071397110849647,0.0113224705925815,0.657010765810082
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLINT1,Clathrin interactor 1,37482,-0.00193477054784184,0.00437244098804086,-0.0105047548844019,0.00663521378871824,0.658140498276979
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,-0.00123268539453166,0.00280584979739685,-0.00673215099742948,0.00426678020836616,0.660431667179734
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STC2,Stanniocalcin-2,40309,-0.0011252288487237,0.00257310869760351,-0.00616852189602659,0.00391806419857918,0.661897379220278
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBZ,Hemoglobin subunit zeta,37990,-0.00431374246989966,0.00997113985179345,-0.0238571765794148,0.0152296916396155,0.66529571199411
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNL1,Interferon lambda-1,39961,-0.0018527088832709,0.00430332194512415,-0.0102872198957142,0.00658180212917244,0.666816184413659
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCARE,Photoreceptor cilium actin regulator,37541,0.00350047681891427,0.00820292767260967,-0.0125772614194007,0.0195782150572292,0.669579330705123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.0023358563665586,0.00551466775111337,-0.00847289242562361,0.0131446051587408,0.671885267318607
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFL4,Insulin growth factor-like family member 4,37598,-0.0031480101885355,0.00749117951657993,-0.0178307220410322,0.0115347016639612,0.674325106842341
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYBB2,Beta-crystallin B2,37942,-0.00274464117060864,0.00653327615197333,-0.0155498624284764,0.0100605800872591,0.674417767556634
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.00500405141109738,0.0120075432137256,-0.0185307332878048,0.0285388361099995,0.676872656953195
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCP11,T-complex protein 11 homolog,37714,-0.00239116913687863,0.00578336653043793,-0.013726567536537,0.00894422926277972,0.67927904254262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYTH3,Cytohesin-3,37482,0.00289763183314233,0.00702336012304511,-0.0108681540080261,0.0166634176743107,0.67992803993517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,0.00134800300954576,0.00328947571645884,-0.00509936939471358,0.00779537541380509,0.681963550053329
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNNI3,"Troponin I, cardiac muscle",40042,0.00328806133179904,0.00803227568510572,-0.0124551990110082,0.0190313216746062,0.682283949184341
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00219706453346609,0.00537441684280906,-0.00833679247843968,0.0127309215453719,0.682692758476573
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,0.00255768012078003,0.00628120916642201,-0.00975348984540711,0.0148688500869672,0.683871052928393
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00214493458003294,0.00531387633837665,-0.00827026304318529,0.0125601322032512,0.686478342111587
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD2,Bromodomain-containing protein 2,37541,-0.00131803174794085,0.00328920023789635,-0.00776486421421769,0.00512880071833599,0.688636534361653
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFAP2A,Transcription factor AP-2-alpha,37541,-0.00230232482660544,0.00577524773151797,-0.0136218103803807,0.00901716072716979,0.690154769426377
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP73,Tumor protein p73,37572,0.00132188809185337,0.0033264847563641,-0.00519802203062027,0.00784179821432702,0.691091602908727
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIRREL1,Kin of IRRE-like protein 1,37541,-0.00233502589854685,0.00587862390106504,-0.0138571287446343,0.00918707694754063,0.691221882456284
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGR,Progesterone receptor,37598,-0.00384741673994876,0.0098545767745756,-0.0231623872181169,0.0154675537382194,0.696232861593351
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD82,CD82 antigen,37714,-0.00155290290382215,0.00398438069622196,-0.00936228906841719,0.0062564832607729,0.696729436593579
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00220176515965732,0.00574520046945596,-0.00905882776047636,0.013462358079791,0.701551332545975
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL22,Interleukin-22,37900,-0.00233733620434506,0.00619880912906707,-0.0144870020973165,0.0098123296886264,0.706133379436438
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.00226679272145919,0.00606125764472444,-0.00961327226220072,0.0141468577051191,0.708424813249014
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPB41L5,Band 4.1-like protein 5,37572,-0.00226564590014448,0.00605925687716544,-0.0141417893793887,0.00961049757909979,0.708473737704804
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP10,Inactive dipeptidyl peptidase 10,40341,0.00120062611309238,0.00322500810477,-0.00512038977225682,0.00752164199844158,0.709684714071147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC123,Cell division cycle protein 123 homolog,37482,0.00226934029548148,0.00610344358335502,-0.00969340912789436,0.0142320897188573,0.710038053547942
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,-0.00202722459694093,0.00549741274134794,-0.0128021535699829,0.00874770437610103,0.712312765970599
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00114416260188032,0.00312127645045063,-0.00497353924100291,0.00726186444476356,0.713945649831182
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,-0.00118170368895754,0.00327843646194466,-0.00760743915436906,0.00524403177645399,0.718517391567011
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00261219127858323,0.00739312116674557,-0.0171027087654046,0.0118783262082381,0.723848646122608
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA5,Annexin A5,39896,0.00100057641228579,0.00290245823601156,-0.00468824173029686,0.00668939455486844,0.730298952065884
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53BP1,TP53-binding protein 1,37598,0.00289418016472872,0.0084597975999417,-0.013687023131157,0.0194753834606145,0.732273687081467
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,-0.00163231423988923,0.00478243176049896,-0.0110058804904672,0.00774125201068872,0.732871231700445
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00210981111823112,0.00639764076077013,-0.0104295647728783,0.0146491870093406,0.74157180615101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37572,-0.00121055291389003,0.00369063569826543,-0.00844419888249027,0.00602309305471021,0.742911896895624
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGM2,Phosphoglucomutase-2,37572,0.00182831494528183,0.00570666386629317,-0.00935674623265278,0.0130133761232164,0.74868353078066
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,-0.00224032359505781,0.00702991129343261,-0.0160189497301857,0.0115383025400701,0.749970872829643
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAP18,Histone deacetylase complex subunit SAP18,37714,0.0022572136484287,0.00710673333924304,-0.0116719836964876,0.0161864109933451,0.750781083413682
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCDC2C,Doublecortin domain-containing protein 2C,37482,-0.00189636408022772,0.00604506722014456,-0.0137446958317111,0.00995196767125562,0.753750593491427
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,0.00145220244245128,0.00463059555397949,-0.00762376484334853,0.0105281697282511,0.753822028090232
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC11A,C-type lectin domain family 11 member A,40296,0.00142500256129667,0.00454392649363875,-0.00748109336623528,0.0103310984888286,0.753824438799032
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTA4H,Leukotriene A-4 hydrolase,40489,0.00170792692864936,0.00548916505014693,-0.00905083656963862,0.0124666904269373,0.755694344178437
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSG1,Tryptase gamma,37598,-0.000805649492337189,0.00259759818526391,-0.00589694193545446,0.00428564295078008,0.756450515101227
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37714,-0.00197849048484939,0.00639502442649124,-0.0145127383607722,0.0105557573910734,0.757037601071541
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGLON5,IgLON family member 5,37482,-0.00276010352787371,0.00896845843762007,-0.020338282065609,0.0148180750098616,0.758272360622147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAP1A,Ras-related protein Rap-1A,37598,0.00203309772159622,0.00663431478674188,-0.0109701592604179,0.0150363547036103,0.759265525213676
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAG,Myelin-associated glycoprotein,37572,0.00131952076904073,0.0044344076180714,-0.00737191816237921,0.0100109597004607,0.766040545054244
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGN,Secretagogin,40044,0.0012369178232403,0.00416560189476435,-0.00692766189049783,0.00940149753697842,0.766519205576008
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FH,"Fumarate hydratase, mitochondrial",37541,-0.00240700450225143,0.00814819013879315,-0.018377457174286,0.0135634481697831,0.767690287788682
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDDM3B,Epididymal secretory protein E3-beta,37900,-0.00118379441018633,0.00405711848185672,-0.0091357466346255,0.00676815781425284,0.770457759224945
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORN4,MORN repeat-containing protein 4,37482,0.00216859985600496,0.00751133441518255,-0.0125536155977528,0.0168908153097628,0.772807647781586
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,0.00101232003445338,0.00350776037380243,-0.00586289029819938,0.00788753036710615,0.772896202539843
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37562,0.00113118045975542,0.00392027085421803,-0.00655255041451192,0.00881491133402275,0.772932998292138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.00109982310076175,0.00382615752431037,-0.00859909184841008,0.00639944564688657,0.7737735083371
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMP,Olfactory marker protein,37541,0.00138274351831118,0.00482311786684261,-0.00807056750070033,0.0108360545373227,0.774353620530625
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RB,Interleukin-2 receptor subunit beta,40044,-0.00105266615572701,0.00368687681375375,-0.00827894471068437,0.00617361239923035,0.775251843854163
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PXDNL,Peroxidasin-like protein,37900,0.00158641162898107,0.00556825644558493,-0.00932737100436539,0.0125001942623275,0.775723028662401
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00171993047751387,0.00606357725745841,-0.0101646809471046,0.0136045419021324,0.776683528190087
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP2BP,LRP2-binding protein,37572,0.00232138758055377,0.00826426459051463,-0.0138765710168549,0.0185193461779624,0.778795645475145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBH,Dopamine beta-hydroxylase,37967,-0.00279671454619375,0.0100195803502392,-0.0224350920326625,0.016841662940275,0.780153231724656
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARG2,"Arginase-2, mitochondrial",37900,0.00116183701713308,0.00422518019304516,-0.00711951616123543,0.00944319019550159,0.783336379594093
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRN1,Neuritin,37959,-0.000948274151796784,0.00348141214687023,-0.00777184195966244,0.00587529365606887,0.785332442382834
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.000923352470478798,0.00339347574714964,-0.0057278599939345,0.00757456493489209,0.785552058957632
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP7,Retinoid-binding protein 7,37901,0.00150971236100833,0.00554913511424897,-0.00936659246291965,0.0123860171849363,0.785578029968794
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6L,Seizure 6-like protein,40411,-0.000705317144200862,0.0026007121987708,-0.00580271305379163,0.00439207876538991,0.78623953895683
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMOD2,Leiomodin-2,37541,0.00164635917171429,0.0061907913084425,-0.010487591792833,0.0137803101362616,0.790292078782806
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00118300664625787,0.0044933960905758,-0.00762404969127069,0.00999006298378643,0.792340677211766
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGN,Mimecan,40332,0.00101067807142664,0.00385905789603245,-0.00655307540479697,0.00857443154765025,0.793403772792937
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.000944440944927665,0.0036326102671899,-0.00617547517876454,0.00806435706861987,0.79487586639697
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL3,Interleukin-3,37482,-0.00147241717599517,0.00573182859303078,-0.0127068012183355,0.00976196686634516,0.797272092823776
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNPO1,Transportin-1,37714,-0.000857933668467339,0.00337591201124718,-0.00747472121051182,0.00575885387357714,0.799396058253362
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.00100928895296119,0.00399993959674404,-0.00683059265665712,0.0088491705625795,0.800792916626124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.00415497054228567,0.0165750992314101,-0.0283322239512781,0.0366421650358494,0.802068324212369
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,-0.00122957323074033,0.00514861280176615,-0.011320854322202,0.00886170786072132,0.811251677134859
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANK2,Ankyrin-2,37562,0.00165348144693602,0.00706925889461538,-0.0122022659865101,0.0155092288803822,0.815068265063243
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.001453657435738,0.00622956331410251,-0.0136636015313789,0.0107562866599029,0.815494106736586
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY2A,Pancreatic alpha-amylase,39695,0.00104078784071185,0.00447385055776707,-0.00772795925251161,0.0098095349339353,0.816045606612824
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEBP1,Heme-binding protein 1,40042,0.00120104795312611,0.0051682884098909,-0.00892879733026005,0.0113308932365123,0.816239757017593
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORC3,MORC family CW-type zinc finger protein 3,37942,0.000624115528058251,0.00268574228494635,-0.0046399393504366,0.00588817040655311,0.816245615518755
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.000819173877085894,0.00356310964307181,-0.00616452102333485,0.00780286877750663,0.81816922737677
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPT1,Translationally-controlled tumor protein,40044,0.00144488689476617,0.0063158176069304,-0.0109341156148174,0.0138238894043497,0.81904855615025
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UGDH,UDP-glucose 6-dehydrogenase,37562,0.00211096336051125,0.00925347896214179,-0.0160258554052867,0.0202477821263091,0.819551491244808
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL12,Stromal cell-derived factor 1,40044,-0.000863802348381702,0.00385507116623467,-0.00841974183420165,0.00669213713743825,0.822706467250688
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,-0.000878633942764578,0.00393070425374995,-0.00858281428011448,0.00682554639458533,0.823125800443895
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NME3,Nucleoside diphosphate kinase 3,40379,0.000495496935024606,0.00226901882910265,-0.00395177997001658,0.00494277384006579,0.827139758222598
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL4A4,Collagen alpha-4(IV) chain,37688,-0.00108991941498793,0.00499393568970763,-0.0108780333668149,0.00869819453683902,0.82723879394272
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.00104375644830974,0.00480441033820106,-0.00837288781456433,0.0104604007111838,0.82801716752237
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00141371254674249,0.0066081356117672,-0.0115382332523212,0.0143656583458062,0.830600910380112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.00152091872125485,0.00719574553563691,-0.0125827425285935,0.0156245799711032,0.832606844361054
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.000591717980662491,0.00280342625825376,-0.00608643344683987,0.00490299748551489,0.832836160203175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIPK1C,Divergent protein kinase domain 1C,37572,0.000861432346996432,0.00408311856437639,-0.00714148003918129,0.00886434473317416,0.832910742446309
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF20,Fibroblast growth factor 20,37598,-0.000893961705887691,0.00425488710124425,-0.00923354042432643,0.00744561701255105,0.833591060807488
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL9,Interleukin-9,37714,0.00114249730488524,0.00547033543553043,-0.0095793601487544,0.0118643547585249,0.834566012146641
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.000651412945414944,0.00312301315976982,-0.0054696928477339,0.00677251873856379,0.834775650338003
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPGN,Epigen,37900,0.000980379138780541,0.00470267649808761,-0.00823686679747117,0.0101976250750323,0.834863141479486
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPVL,Probable serine carboxypeptidase CPVL,40465,0.000795913064206794,0.00384116286700541,-0.00673276615512381,0.0083245922835374,0.835851398654475
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,37482,-0.000968732915222676,0.00469571449108538,-0.01017233331775,0.00823486748730467,0.83655863478324
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMCH,Pro-MCH,37562,-0.00163605645841928,0.00809000795066045,-0.0174924720417138,0.0142203591248752,0.839738691630232
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL3RA,Interleukin-3 receptor subunit alpha,40044,0.000606522871895799,0.00302445972655771,-0.00532141819215731,0.00653446393594891,0.841061483343625
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,0.00160667214388716,0.00807040141649233,-0.0142113146324378,0.0174246589202121,0.842201101249348
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.000931316475785278,0.00480076303298586,-0.0103408120204376,0.008478179068867,0.846184052236274
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD27,CD27 antigen,40411,0.00074151750009276,0.00385396878929117,-0.00681226132691793,0.00829529632710345,0.847428514562189
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TET2,Methylcytosine dioxygenase TET2,37697,-0.00182363598676447,0.00958267834268768,-0.0206056855384323,0.0169584135649034,0.849072693774258
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.00437333898607563,0.0249588207030208,-0.0532926275639964,0.0445459495918451,0.860907748883805
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.00094198192140969,0.00542664551097892,-0.0115782071229284,0.009694243280109,0.8621946381167
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37901,0.00069056335708616,0.00413139100367673,-0.00740696301012023,0.00878808972429255,0.867254280797847
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EXOSC10,Exosome component 10,37562,0.000975543968857828,0.00598152665670412,-0.0107482482782822,0.0126993362159979,0.870447877457525
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF3,Fibroblast growth factor 3,37598,0.000470880374928511,0.00289998189256611,-0.00521308413450107,0.00615484488435809,0.871014188599694
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WNT9A,Protein Wnt-9a,40044,0.000432811501970988,0.00272201549432754,-0.004902338866911,0.00576796187085298,0.873667738256128
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL5,Interleukin-5,40044,-0.00219588656102207,0.0138517906056681,-0.0293453961481316,0.0249536230260875,0.874043386387912
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR1,Toll-like receptor 1,37598,-0.000387497910987867,0.00249048410562788,-0.00526884675801851,0.00449385093604278,0.876357492363157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB2,Integrin beta-2,40221,0.000422357456952634,0.00271807267639552,-0.00490506498878258,0.00574977990268785,0.876516974546702
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.00080413515836628,0.00522586663090806,-0.0110468337549461,0.00943856343821352,0.877709914461487
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS11B,Transmembrane protease serine 11B,37541,-0.00112479387134765,0.00748209380527839,-0.0157896977296933,0.013540109986998,0.88050545253878
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.00111193067437192,0.00746039610250408,-0.0135104456865361,0.0157343070352799,0.88152084508351
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.00110429436947209,0.0074539278281457,-0.0157139929126377,0.0135054041736935,0.882227135369594
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAGEA3,Melanoma-associated antigen 3,37714,0.0011737653933332,0.00804448117185674,-0.014593417703506,0.0169409484901724,0.883995131171516
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA3,Carbonic anhydrase 3,40500,0.000842822709555013,0.0057795698177316,-0.0104851341331989,0.0121707795523089,0.88405905726413
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHC1,SHC-transforming protein 1,37482,0.00160855051272645,0.0111191468555605,-0.0201849773241721,0.023402078349625,0.884977673339379
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN6,Prefoldin subunit 6,37572,-0.000909709554566636,0.00629140835452806,-0.0132408699294416,0.0114214508203084,0.885032444008356
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS1,"Nitric oxide synthase, brain",39961,-0.000683160701426632,0.00473459362798966,-0.00996296421228637,0.00859664280943311,0.885272317522843
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13,Interleukin-13,40044,0.000645533377207017,0.00455515590572514,-0.00828257219801426,0.0095736389524283,0.887307051123606
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37692,0.000740297686472325,0.00530337446590547,-0.0096543162667024,0.0111349116396471,0.888986118233096
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA11,Serpin A11,40536,0.000526427715839131,0.00380292227894688,-0.00692729995089675,0.00798015538257501,0.889904569120669
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.000632082575299175,0.00461845010187479,-0.00842007962437541,0.00968424477497376,0.891143296680784
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP1,Retinol-binding protein 1,37572,0.000884413038307237,0.00655435735545795,-0.0119621273783904,0.0137309534550048,0.892665236556203
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX2,Peroxiredoxin-2,37763,-0.000785635712293086,0.00595594269541234,-0.0124592833953013,0.0108880119707151,0.895059157650363
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALLD,Palladin,37598,-0.000517515969330219,0.00395116726237322,-0.00826180380358173,0.00722677186492129,0.89579471840012
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,0.000432159614827734,0.00343951406614828,-0.0063092879548229,0.00717360718447836,0.900014100513362
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG1A,Lithostathine-1-alpha,40274,-0.000576261094962778,0.00461974862727658,-0.00963096840442488,0.00847844621449932,0.9007320619792
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KEL,Kell blood group glycoprotein,39961,-0.000421094608193404,0.00338091965373564,-0.00704769712951526,0.00620550791312845,0.900881178985664
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,0.000596708133625529,0.00481259205342182,-0.00883597229108123,0.0100293885583323,0.901325923807869
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_A,,37959,-0.000385043911471116,0.00310717081612083,-0.00647509871106794,0.00570501088812571,0.901379619307805
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.000335179270834429,0.00274201560413713,-0.00503917131327435,0.00570952985494321,0.902711837970794
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.000695074649513452,0.00571036910311558,-0.0104972487925931,0.01188739809162,0.903121456877568
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC25A,M-phase inducer phosphatase 1,37482,-0.000474379341394352,0.00389979139063981,-0.00811797046704837,0.00716921178425967,0.903184238803468
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL4,Interleukin-4,40044,0.00102949077170602,0.00853127291366484,-0.0156918041390771,0.0177507856824891,0.903951927697648
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4C,C-type lectin domain family 4 member C,40341,0.00049042116389412,0.0043242018160744,-0.00798501439561169,0.00896585672339993,0.909704481606202
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT14,"Keratin, type I cytoskeletal 14",39530,0.000305838888756643,0.00271225788671283,-0.00501018656920051,0.00562186434671379,0.910220961750312
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,-0.00151828319563666,0.013473479859198,-0.0279263037196647,0.0248897373283914,0.910280610488824
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20RB,Interleukin-20 receptor subunit beta,37598,0.000444203983778972,0.00406119515448574,-0.00751573851901308,0.00840414648657103,0.912904629251912
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF7,Fibroblast growth factor 7,37482,0.000840829733356335,0.00771528609529708,-0.0142811310134259,0.0159627904801386,0.913218196170219
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IKZF2,Zinc finger protein Helios,39980,0.000914482848378575,0.00888937876230903,-0.0165086995257471,0.0183376652225043,0.918064578615281
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS2,"Nitric oxide synthase, inducible",37562,-0.000384314807661306,0.00374041890731535,-0.00771553586599939,0.00694690625067677,0.91816576919665
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRISP2,Cysteine-rich secretory protein 2,40489,-0.000575552518253745,0.00580580537231845,-0.0119549310479979,0.0108038260114904,0.921033142185968
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY2B,Alpha-amylase 2B,39311,-0.000452276276591986,0.00458005868288473,-0.00942919129504605,0.00852463874186208,0.921338883925019
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MLLT1,Protein ENL,37482,0.000664672164879343,0.00682085238425366,-0.0127041985082578,0.0140335428380165,0.922372854997822
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,-0.000393475686430654,0.0040506252417208,-0.00833270116020342,0.00754574978734211,0.92261705872142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.000466909688068593,0.00480817463428375,-0.00895711259512755,0.00989093197126473,0.922642533177238
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FZD8,Frizzled-8,37541,0.000414689148448141,0.00427480707046868,-0.00796393270967048,0.00879331100656676,0.922721774748643
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPK3A,Uroplakin-3a,37541,0.000432104372616184,0.0047674807684835,-0.00891215793361147,0.00977636667884384,0.927783381720674
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRX,Cone-rod homeobox protein,40042,-0.000921282908340256,0.0101940253263354,-0.0209015725479577,0.0190590067312772,0.927990549580566
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,-0.000957489297472974,0.01129024331491,-0.0230863661946966,0.0211713875997507,0.932416064169703
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.000202737232383404,0.00244276299110458,-0.00458507823018157,0.00499055269494838,0.933856744031417
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC12,WAP four-disulfide core domain protein 12,40465,0.000494441491413112,0.00605193871805205,-0.0113673583959689,0.0123562413787951,0.93488654935509
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK3,Prostate-specific antigen,37998,-0.000434434594141495,0.00543448585592994,-0.0110860268717642,0.0102171576834812,0.936285894429609
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP3,Microfibril-associated glycoprotein 3,40042,-0.000374469038307032,0.00472310771668976,-0.00963176016301896,0.00888282208640489,0.936807385207275
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLB1,"Phospholipase B1, membrane-associated",37942,-0.000441157132169278,0.0057646378923221,-0.0117398474011206,0.010857533136782,0.939000045934238
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF830,Zinc finger protein 830,37900,-0.000564396311951305,0.00767811149863992,-0.0156134948492855,0.0144847022253829,0.941403625206696
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,-0.00028516373283781,0.00391874071011421,-0.00796589552466167,0.00739556805898605,0.94199085658138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,-0.000283717815896738,0.00400379540214491,-0.00813115680410076,0.00756372117230728,0.943508492662748
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAD2,Glutamate decarboxylase 2,37598,-0.000307558813015484,0.00450874245537117,-0.00914469402554298,0.00852957639951201,0.945616416169279
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPA33,Cell surface A33 antigen,40305,-0.000868925187304112,0.0128980438089857,-0.0261490910529161,0.0244112406783079,0.946288990043899
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNB2,Ephrin-B2,37572,-0.000331555210603679,0.00550852996633568,-0.0111282739446216,0.0104651635234142,0.952005690692371
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKIV2L,Helicase SKI2W,37562,-0.000231995167369934,0.00386423203821903,-0.00780588996227923,0.00734189962753936,0.952127438064888
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL3,Insulin-like 3,37942,-0.000331454306737224,0.00567169053334523,-0.0114479677520939,0.0107850591386194,0.953398919413445
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,-0.000166283702716869,0.00285525546665589,-0.0057625844173624,0.00543001701192867,0.9535601270211
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,-0.000146487648590322,0.00258971540867136,-0.00522232984958619,0.00492935455240555,0.954892299350317
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,-0.000171435659751053,0.0032830752136743,-0.00660626307855267,0.00626339175905057,0.958355780652558
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,-0.000120804812409428,0.00268122555566512,-0.00537600690151307,0.00513439727669421,0.96406350158113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN7,Tetraspanin-7,37541,-0.000350811079374771,0.00872357063325441,-0.0174490095205534,0.0167473873618039,0.967923000757703
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC1A4,Neutral amino acid transporter A,37572,-0.000191621302016708,0.00499764479167592,-0.00998700509370152,0.0096037624896681,0.969415331476707
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXK,Tyrosine-protein kinase TXK,37714,-0.000271157336575491,0.00721995077669514,-0.014422260858898,0.013879946185747,0.970041718060418
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPT1,Palmitoyl-protein thioesterase 1,37572,0.00025854524146996,0.00742753530303897,-0.0142994239524864,0.0148165144354263,0.972232555831878
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2,Interleukin-2,40044,0.000103181118812767,0.00297503488432359,-0.00572788725446148,0.00593424949208701,0.972333501140641
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL21R,Interleukin-21 receptor,37598,0.000182079403177841,0.00533046316210767,-0.0102656283945532,0.0106297872009089,0.972751460933003
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB7,Integrin beta-7,40489,0.000133927180970806,0.00431306148589416,-0.00831967333138176,0.00858752769332337,0.975228826649099
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17F,Interleukin-17F,40044,0.000228893113583672,0.00755389166808466,-0.0145767345558623,0.0150345207830296,0.975827107930145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT3,Kunitz-type protease inhibitor 3,37901,-0.000367182278107856,0.0122362279801039,-0.0243501891191114,0.0236158245628957,0.976061277987251
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHD,SH2 domain-containing adapter protein D,37531,-0.000240928769784814,0.00835889452988908,-0.0166243620483674,0.0161425045087978,0.97700616325996
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.000129135202467898,0.00517555088795748,-0.0102732149428646,0.0100149445379288,0.980094418185471
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRC1,Protein regulator of cytokinesis 1,37900,9.9302769831729e-05,0.00443441166905651,-0.00859214410151903,0.00879074964118248,0.9821342586492
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNIP4,Kv channel-interacting protein 4,39961,-0.000103757872516123,0.00487442119881279,-0.00965762342218919,0.00945010767715694,0.983017631223943
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.00016855694091228,0.00807752693552714,-0.0160005097345455,0.0156633958527209,0.983351750328436
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC51B,Organic solute transporter subunit beta,37562,0.000157577171080251,0.0075765105899763,-0.0146923835852733,0.0150075379274338,0.983407014514522
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RUVBL1,RuvB-like 1,39980,0.000206566686720222,0.0101939379645753,-0.0197735517238474,0.0201866850972878,0.983833290144852
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOS,Proto-oncogene c-Fos,37457,6.07050682762356e-05,0.00334266496979422,-0.00649091827252044,0.00661232840907292,0.985510949006291
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,-8.00869654514913e-05,0.00540516719011543,-0.0106742146580777,0.0105140407271748,0.988178568841763
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,-3.08606391709039e-05,0.00260122563256218,-0.00512926287899278,0.00506754160065097,0.990534361615602
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESR1,Estrogen receptor,37598,-6.49887098588513e-05,0.00554038562077806,-0.0109241445265838,0.0107941671068661,0.990641208659681
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37901,-5.68083697477325e-05,0.00525074650687653,-0.0103482715232257,0.0102346547837303,0.991367933258594
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,40422,1.6677699118547e-05,0.00263568179966922,-0.00514925862823312,0.00518261402647021,0.994951370258027
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KHDC3L,KH domain-containing protein 3,37482,-1.84716556745462e-05,0.00649469165003235,-0.012748067289738,0.0127111239783889,0.997730770446693
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCNA,Proliferating cell nuclear antigen,37482,-3.58583323928749e-06,0.00595282682932608,-0.0116711264187184,0.0116639547522398,0.999519383648366
